Medical Devices & Equipment

Sunil Paul is a serial entrepreneur, inventor, and investor. He pioneered mobility and climate investment, co-founding Spring Free EV to make electric vehicles cheaper than gas. Previously, he ran Sidecar where modern ridesharing was invented. Sunil has a track record of successful investments, including IPOs like LinkedIn. He co-founded Brightmail and FreeLoader, both achieving significant acquisitions. Additionally, he has contributed to non-profits and political initiatives. Sunil’s diverse experience positions him as an influential figure in entrepreneurship and investment.

No answer

Rahul Jain is an investor with a track record of investing in companies like Licious and PB Fintech, with a net worth of over Rs 412.5 Cr. His investment thesis focuses on turning stocks into multibaggers using behavior science. He has a geographical preference for routing in wireless ad hoc networks. Rahul Jain’s investments span various sectors and industries. His investment check size varies, with notable investments like SPS International Ltd. and FIEM Industries Ltd. He has a partnership and collaboration style that emphasizes ownership and supporting business owners in doubling their profits.

Jelmer De Jong is a Partner and CTO at RTP Global, with investments typically ranging from $2.0M to $7.0M, with a sweet spot at $4.0M. He has focused on various sectors in Seed and Series A stages, including Cybersecurity, Enterprise Applications, Data Services, Cloud Infrastructure, Web3/Crypto, AI, SaaS, and FinTech. Jelmer has demonstrated a collaborative partnership style with a human, personable, trustworthy, and smart approach within RTP Global. His track record includes investments in companies like emma and aito.ai, with co-investors from RTP Global such as Alexander Pavlov, Galina Chifina, Joe Botsch, Jules Schwerin, and Louis Dussart. Jelmer De Jong’s geographical preference includes regions like Colorado / Utah, Austin, Los Angeles / Southern California, New York City, and the San Francisco Bay Area.

Jon-Michial Carter is the Chief Growth Officer & Founder at ChartSpan Medical Technologies, a healthcare technology company in Greenville, South Carolina. He has a track record of holding c-level and executive positions in companies like Iconixx and American Equity. Alongside his role at ChartSpan, he serves on various boards including SCRA, organizations supporting entrepreneurship. Jon-Michial Carter has a rich history of business leadership and innovation, contributing to the growth of startups and ventures. His collaboration style is focused on building strong partnerships and mentorship within the entrepreneurial ecosystem of Greenville and the broader South Carolina area.

Angel Capital Group is an angel investor and venture capital firm based in Knoxville, Tennessee. Founded in 2007, the firm specialized in seed, startup stage, and early growth stage investments. Their investment focus areas include social media, technology, medical device, software, clean technology, and entertainment sectors. Angel Capital Group invests domestically without a preference to geography and typically invests within six months before and after a company begins to generate revenue. Some of their previous investments include Light Line Medical, Arkis BioSciences, and Heilo in various industries. The firm has a track record of supporting early-stage companies with great potential and prefers to work with entrepreneurs aligning with their shared values and goals. Angel Capital Group’s check sizes can range from $1,000 to $1,000,000+. They emphasize collaborative partnerships that provide not only financial support but also strategic guidance, industry connections, and mentorship.

Oliver Heimes is a General Partner at Lakestar with a focus on US-based investments, particularly in the Healthcare sector. He has led investments in companies such as Oscar Health, Cedar Health, Rhino, and Public.com. Oliver’s geographical preference includes a focus on the US market with additional interests in the UK and Europe. His previous investments include partnerships with Auterion, Rhino, and Public.com. Oliver’s investment check size and partnership styles are not specifically mentioned on the Lakestar website.

Mr. Lester Grant is a Co-Founder and served as Board Member at Conductiv. Before founding MedPricer, Mr. Grant held various leadership roles at Corometrics, Siemens, and Oxford Instruments. After over 20 years in healthcare management positions negotiating contracts, Mr. Grant decided to found MedPricer, a company that would help hospitals, IDNs, and suppliers streamline the contracting process. He began his business career with Abbott Laboratories, after teaching in Newark, NJ, and at The School for the Foreign Born in Elizabeth, NJ. Mr. Grant holds a Bachelor’s Degree from Seton Hall University. He is a member of AHRMM and the HFMA.

Dr. Kostas Alevizopoulos brings over 20 years of expertise in developing and commercializing therapeutic, diagnostic, medical device, and OTC products. He focuses on mid-stage investments in the biotech and healthcare sectors and has a broad geographical reach in Europe, the US, and more. With a biology degree, a PhD in Molecular Biology, and post-doctoral studies in oncology research, he has a strong publication and patent record. His previous roles include CSO of Gerolymatos International SA and CEO of Medexis SA. Dr. Alevizopoulos is actively involved in evaluating technology opportunities, serving as a strategic advisor, and has a collaborative partnership style.

Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology.

Mr. Douglas Davenport serves as Chief Financial Officer & Senior Vice President at Maplewood Surgery Center. He is an angel investor. He serves as Board Member at RetraceHealth. Doug came to HealthEast in 2014, bringing more than 25 years of experience driving the strategic financial direction and health of multi-entity health care organizations. He leads finance, revenue cycle, materials management, managed care strategy and shared services, working across the organization to achieve the most affordable health care for our patients. Recognized for his innovative leadership, Doug is helping transform HealthEast to a value based health care system.

ATI Arizona Tech Investors focuses on early-stage information technology, medtech, and biotech companies. They typically look for outstanding founders and leadership teams with prototypes of products or services that are largely complete. ATI seeks opportunities where new capital can help move young businesses forward. Geographically, ATI primarily focuses on supporting companies in Arizona and the greater Southwest region. One of the key figures within ATI is Bob DeLean, who has been an investor with ATI for over 11 years and currently serves as the organization’s Chairman. Additionally, Kim Peterson is an investor and ATI member committed to supporting the capital needs of early-stage companies. The partnership and collaboration style at ATI involves financial sponsorship to build new companies and provide support for capital requirements in the region.

New York Angels invests between $100,000 to $1,500,000 per round in early-stage companies with core strengths in B2B platforms, digital media, financial services, medical devices, diagnostics, and digital health. They seek companies with an established proof of concept and poised for growth, accompanied by passionate, driven, and coachable teams. Their investments are focused on large and growing market segments, with clear differentiation points from competitors. New York Angels have a collaborative approach, partnering with incubators, accelerators, Angel groups, and venture capital firms to support early-stage startups in their journey from zero to one and beyond. They provide resources like investor perspectives, mock demo-days, and investor/Founder mentoring.

CRV is a venture capital firm that invests in early-stage investments in technology companies.

Mathew Farkash is an Advisor to Epsilon Health Investors and a Founding Partner of Blueprint Health, a healthcare-focused accelerator fund. He is involved in business development, sales, fundraising strategies for startups in the health and technology sector. Mr. Farkash has a track record of supporting over 70 health tech companies and evaluating innovation strategies for large healthcare organizations. His educational background includes Brown University (B.A., 2003) and NYU Stern School of Business (M.B.A., 2009). Blueprint Health focuses on investments in healthcare, medical, information technology, software, and mHealth sectors. They support startups at the seed stage and have a geographical preference for companies in New York. Mr. Farkash’s check sizes for investments are not specified, and Blueprint Health emphasizes mentorship-driven programs to support entrepreneurs building health and tech companies.

Mr. G. Bradford Jones is a Co-Founder and Partner at Redpoint Ventures. He serves as a Board Member and Member of the Executive Committee at Stamps.com and a General Partner at Brentwood Venture Capital. Additionally, he is a Board Member in True[X] Media and Sensydia, and serves as a Venture Partner at Colle Capital Partners. His investment thesis focuses on technology opportunities in Southern California, with successful investments across various sectors including biotechnology, communications, Internet commerce, medical devices, software, and more. Recognized for his contributions, Brad received accolades such as the Los Angeles Venture Association’s Lifetime Achievement Award and the Supporter of Entrepreneurship Award from the Ernst & Young Entrepreneur of the Year program. Brad’s educational background includes an A.B. in Chemistry and an A.M. in Physics from Harvard University, an M.B.A. from Stanford Graduate School of Business, and a J.D. from Stanford Law School.

Max Klement is a Principal at BGV (BioGeneration Ventures), a venture capital firm based in Amsterdam, Netherlands. The firm’s investment thesis focuses on early-stage European biotech companies. Max’s investment areas include Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. He primarily invests in seed-stage startups in these sectors. Max’s geographical preference is not specified. His previous investments include Complement Therapeutics Ltd, where BGV provided seed funding. Max is known for his professional career in identifying promising opportunities in complement biology. His check sizes range from $100K to $1M. Max’s partnership and collaboration style at BGV emphasizes co-investing with firms like Forbion and engaging in seed financing rounds.

Lindsey Brown, a Senior Associate at Echo Health Ventures, based in Portland, Oregon, supports the firm in all aspects of the investment process. With a background in healthcare finance, Lindsey plays a crucial role in deal sourcing, evaluation, and transaction management. She brings expertise from executing transactions at Cambia Health Solutions and overseeing streamlined reporting structures for the investment portfolio. Her investment focus areas include fostering the growth of companies in the healthcare sector, particularly in women’s health and digital health. Lindsey has a track record of success in supporting startups through strategic investments and providing financial and market support. Echo Health Ventures’ geographic preference leans towards the West Coast and Western US regions, with a partnership style that drives the success of the portfolio companies.

Brian Balfour is a tech entrepreneur, investor, and advisor. He has a strong focus on product, engineering, and marketing, scaling users from zero to millions of daily active users. Brian Balfour’s investment thesis revolves around the ‘Four Fits For $100M+ Growth,’ emphasizing product market fit, product channel fit, channel model fit, and model market fit for company growth. He has been part of building, advising, or investing in 40+ tech companies, with experiences at Reforge, HubSpot, Trinity Ventures, Boundless Learning, and Viximo. Brian Balfour’s geographical preference is not explicitly mentioned, but his investment check sizes range across various rounds including seed rounds. His partnership and collaboration style involves strategic growth loops and a guide to growing via partnerships, focusing on business evaluation, integration, and post-implementation management.

Therese Liechtenstein is an experienced Senior Investment Director in the Biotechnology team at M Ventures. She joined M Ventures in 2018 and has been instrumental in the creation and financing of companies in M Ventures’ portfolio, such as FoRx Therapeutics and Anavo Therapeutics. With a background in Immuno-Oncology and Biomedical Sciences, Therese actively leads investments, sits on multiple portfolio company boards, and has a professional career including managing strategic projects for Merck KGaA. The investment check size of M Ventures ranges between $500K to $1.5M. Therese’s investment focus areas include early-stage therapeutics companies in the fields of Oncology, Immunology, and Fertility. Geographically, she is involved in early-stage therapeutics and life science companies. Therese Liechtenstein’s track record showcases her commitment to the biotechnology field and her hands-on approach to investment.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new health-tech startups. Founded in 2010, they invest in technologies that democratize access to quality care for all. Their focus areas include Providers, Payers, Pharma, Patients, and Self-Insured Employers. HealthTech Capital invests in capital-efficient companies at the seed and series A rounds. They have a track record of success, raising over $1 billion and providing mentoring programs. Their previous investments include companies in the Biotechnology, Surgical Devices, and Devices and Supplies industries. The check size of their investments varies based on the company’s stage. HealthTech Capital engages in strategic partnerships and collaborations with healthtech startups to drive innovation and growth.

Ryan Barr, currently serving as a Principal at Colliers International in Chicago, Illinois, excels as a tenant representative specializing in commercial real estate counsel for various clients. His expertise spans across office, industrial, retail, and medical sectors. Ryan collaborates closely with major clients to craft and implement real estate strategies that maximize economic outcomes while aligning with business objectives. Employing a capital markets-based approach, Ryan identifies and capitalizes on potential distress in asset capital stacks, benefiting tenants economically. Over the past three years, he has successfully completed transactions totaling over 3 million square feet, yielding savings of over $35 million for his clients.

Salomon Horowitz is a passionate investor and Managing Partner at Operators VC. With a focus on early-stage healthcare startups, Salomon collaborates on the Hikeish initiative to promote diversity in outdoor spaces. Past investments include Lyft and Vendy, demonstrating a successful track record. Salomon’s collaboration styles emphasize partnerships that enhance accessibility and inclusivity, as seen in the Hikeish program. Check sizes vary based on the initiative, and Salomon leverages a hands-on approach to foster growth and innovation.

David Gandara is a highly distinguished Professor at UC Davis Comprehensive Cancer Center where he serves as the Director of Thoracic Oncology. With a track record of over 450 peer-reviewed papers, he focuses on developmental therapeutics and biomarker development in lung cancer. Prof. Gandara collaborates with experts to identify differences in cancer treatments. Cabin Ventures, an enterprise with 2-10 employees, is one of his partnership ventures. He is involved in technology incubation projects for global betterment. The investment check size is undisclosed, but his collaborations highlight a commitment to advance drug development in lung cancer.

Mr. Justin Darcy is an Angel Investor and serves as Advisor at CaliberMind. Additionally, he holds the position of ISV & OEM Alliances Representative at Salesforce.com.

Michael Hool is a Founding Partner at Hool Coury Law, PLC, focusing on corporate representation, finance, and venture capital. He has chaired and served on the board of various organizations and is actively involved as an angel investor in emerging companies. Michael’s investments span medical devices, software, clean-tech, and semiconductor industries. He has a track record of partnering with entrepreneurs, investors, and private equity funds. Michael also collaborates with organizations like BioAccel, TiE Arizona, and Biltmore Angel Group. With a background in corporate law and finance, Michael has extensive experience in counseling emerging growth companies and representing both issuers and investors in various financing transactions.

415 Capital is a venture capital firm specializing in breakthrough and life-saving medical innovation. They provide exceptional entrepreneurs with capital, clinical, scientific, and business expertise, as well as market access. With over 50 funded medical technology companies and 25 realized exits, their investment strategy focuses on value creation. Some of their investments include Laza Medical, Supira Medical, R3 Vascular, Moray Medical, CorFlow, Cardiac Success, Aktiia, Distalmotion, and TRiCares. Located in Munich, Germany, they are dedicated to collaborating closely with entrepreneurs to drive success and innovation in the medical field.

Alex Mace, Vice President at Thompson Street Capital Partners, focuses on investments with a value creation approach in business and healthcare services, as well as engineered products sectors. The firm’s investment thesis emphasizes the importance of ESG factors. Alex Mace’s investment check size typically ranges between $5 million to $50 million, with a sweet spot around $25 million. Thompson Street Capital Partners’ previous investments span a wide range, with a typical investment size of $5 to $20 million for EBITDA investments and $25 to $150 million for equity investments. Though specific details on partnership and collaboration styles are not available, the firm is known for its thesis-driven approach and commitment to value creation within its portfolio companies. Alex Mace and Thompson Street Capital Partners maintain a track record of successful investments in line with their strategic focus areas.

Jason Trachewsky is an experienced technical contributor, executive, and leader of R&D teams. He has an investment focus in biological target detection for clinical testing and biomedical research, 3D imaging, manufacturing, and logistics solutions. Jason has a hands-on investment style with a check size typically varying from $15 million to $40 million per round. He has a collaborative partnership style evidenced by his involvement in Series A funding rounds for Pleno Inc., a multi-omics startup, fostering innovation across industries.

Carl Byers is an Executive Partner at F-Prime Capital Partners. He focuses on investing in digital health and healthcare sectors. His recent investments include companies like Devoted Health, Doceree, SpectrumAi, Spry, Eleos Health, AmplifyMD, Rialtic, and Notable. Carl’s investment style includes leading rounds of financing and joining the board of directors of companies he invests in. He has led investments in Wellframe, a mobile-enabled care management provider, where he led a Series B round of financing. He primarily invests in Seed and Series A stages. Additionally, Carl Byers has experience in healthcare finance and serves as a key advisor to the senior leadership team. F-Prime Capital’s Investment Check Size is around $400M. In partnerships, Carl collaborates actively with other investors and industry partners to translate innovative ideas into real impact.

Florian Müellershausen, PhD, is a Managing Director at the Novartis Venture Fund in Basel, Switzerland. He focuses on Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Seed), and BioTech (Series A). Florian aims to invest in the development of novel therapeutics and platforms, medical devices, diagnostics, or drug delivery systems. He prefers the early stage for initial investments, with additional funding as companies progress. Florian anticipates total investments up to USD 30 to 50 million per company over its life. His partnership and collaboration styles are hands-on, leveraging his expertise in drug discovery and biochemistry to guide portfolio companies towards successful acquisitions. Previous investments include Anaveon, Granite Bio, and LoQus23 Therapeutics.

Antoine Boulanger Piette, an Associate at Forbion, has an impressive track record in venture capital investments. With experience in various roles at Forbion, including Analyst and Senior Associate, Antoine has been actively involved in the European venture capital scene. He specializes in Life Sciences and Biomedical Technology companies, focusing on late-stage preclinical and early-stage clinical development programs. Throughout his career, Antoine has contributed to the success of numerous portfolio companies, demonstrating a commitment to responsible investments that positively impact patients’ health and well-being.

Threshold is an early-stage venture capital firm that focuses on conviction investment strategy.

The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.

Dieter Manstein is an individual angel investor with a primary focus on seed-stage investments. He has invested in GME Medical Engineering with a check size of â¬750K. His investment focus areas are in dermatology-related procedures for scars, burns, aging skin, and fat removal. Dieter Manstein’s professional career includes roles as a Clinical Consultant and Assistant Professor of Dermatology at Harvard Medical School, and he is the Co-Founder of GME Medical Engineering in Nuremberg, Germany. His partnership and collaboration styles involve co-founding ventures like GME Medical Engineering and R2 Technologies.

Mr. Alan Hartman serves as Partner at Centerview Partners. He is also an angel investor. He has established himself as a leading advisor in the healthcare industry. Prior to Centerview, Alan spent several years with Merrill Lynch where he was Head of Americas Mergers & Acquisitions. He was twice named one of the ‘Dealmakers of the Year’ by Dealmaker Magazine. Prior to joining Merrill Lynch in 1993, Alan spent four years as a Mergers & Acquisitions attorney at Skadden, Arps, Meagher & Flom in New York. He received a B.S. in economics from the Wharton School of Finance and a J.D. from Harvard Law School.

Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.

MED Angels invests liberally across healthcare focusing on companies that can yield high potential impact with a focus on disease management.

Belle Capital USA focuses on building great companies in underserved capital markets across the USA. They invest in digital/mobile/internet (IT), technology-enabled products and services, life sciences/medical devices/health IT (Digital Health), and CleanTech sectors, primarily in early-stage companies. Their geographical preference is in underserved capital markets across the USA. Some of their previous investments include Current Motor, Unopsec, US Bancorp, among others. Belle Capital USA is known for being active investors, providing both financial and human capital. They seek enterprises that welcome their expertise insight and prefer teams with strong domain expertise and proven commercialization and entrepreneurial experience.

No answer

Rogier Minderhout is an individual angel investor based in Frankfurt, Germany. He is the Founder of myPension and has a Master’s degree in Economics from the University of Amsterdam and an MBA from Stanford Graduate School of Business. His investment focus areas include the European Union (EU) and Europe, Middle East, and Africa (EMEA) regions. Rogier has made 1 investment in the past, including be+. His professional career includes founding myPension, and he was recently involved in Insurtech Insights Europe 2018. Rogier Minderhout operates as an independent investor with a specific interest in the EU and EMEA regions.

Noor Abid is an Angel Investor with a background as a Contracting Counsel Manager at Accenture LLP and previous roles as Procurement Counsel at Kirkland & Ellis and Procurement Staff Attorney at Sidley Austin LLP. He designs and develops user-friendly and accessible web and mobile applications, focusing on UX/UI design. Noor Abid has over four years of experience in UX/UI design, working with Adobe Creative Suite, Figma, and Microsoft Office. His investments and partnership styles are not publicly available.

BELLE Capital is an early stage angel fund that focuses on women-led technology companies. They invest in companies where management shows the ability to execute, have a female founder or owner, operate in large/fast-growing markets, aim for $20+ million in revenues within 5 years, and solve urgent problems. Their investment check size ranges from $100k to $1.5 million, with up to 25% reserved for follow-on investments. The team includes General Partner Lauren Flanagan and various council members, focusing on different aspects of the investment process. Previous investments include Ocuphire Pharma, CardiaLen, Digsite, TO THE MARKET, and Vyv. BELLE Capital emphasizes partnership and collaboration, seeking companies with high capital efficiency and significant barriers to entry, among other criteria.

Kevin Mckim is the CEO of Creative Medical, LLC, where he specializes in the sale and full-service distribution of healthcare products for the animal market. He serves as the President at RecoverCare LLC and was the President/Founder of MedaSTAT USA. Kevin’s previous experience includes being the CEO of PharmaSTAT. His track record includes increasing company revenue, capturing market share, and leading national project teams to measurable results. In terms of investment, his focus areas include healthcare equipment solutions, therapeutic support surfaces, bariatric products, and more. Kevin McKim’s investment check sizes and partnership styles are tailored to the healthcare industry, with a hands-on approach to drive growth and innovation.

Ravi Berry is an Angel investor at Angel Physicians Fund, based in Cincinnati, Ohio. His investment thesis focuses on Therapeutics, Medical Devices, Pharmaceuticals, Marketplaces, BioTech, Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. Ravi’s investment range is $5K – $50K, with a sweet spot at $25K. His previous investments include startups in various healthcare sectors. Collaborates with scouts & angels like Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Altitude Ventures provides early-stage venture capital financing to healthcare services and technology startups that improve healthcare.

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

Estelle Botbol is a seasoned investor on the Speedinvest Health team, committed to identifying and supporting early-stage European healthtech and digital health startups. With a focus on the TechBio space, Estelle seeks out exciting companies in Digital Health. Her background includes working at Inkef, specializing in Life Sciences and MedTech. Estelle is known for her collaboration and partnership styles, leveraging her experience to forge strategic alliances. She holds a Master’s degree in Applied Biosciences and Biotechnology from Imperial College London and a Bachelor’s in Microbiology and Immunology from McGill University. Alongside her professional pursuits, Estelle is a talented songwriter, piano composer, and singer in a Funk & Disco band in Paris.

Frederic Truchot is a private investor, business angel, and adviser with a strong knowledge of international capital markets. His previous experience includes roles such as Managing Director at Crédit Agricole CIB, Head of Global Markets – Americas, and CEO of Credit Agricole Securities Japan. He has expertise in fixed-income sales, trading, debt capital markets, and securitisation. Frederic has a proven track record in developing businesses in emerging and developed markets, with a focus on regions like Europe, Asia, and the Americas. He excels in client relationship management and fund-raising initiatives. Specific details about his investment thesis, investment check size, previous investments, and partnership and collaboration styles were not available in the sources reviewed.

Marco Giunta is an experienced Private Equity Operating Partner & Chief Commercial at Oak Lane Partners. With a track record in various roles at companies like CompuCom, he brings a wealth of expertise to the table. His collaboration style emphasizes leveraging partnerships to drive revenue and fostering an openness to change for strategic success. Marco’s investment check size and specific focus areas are not explicitly mentioned, but his approach underscores the importance of psychology in pricing, customer engagement strategies, and the value of expanding product offerings for revenue diversification.

Health Velocity Capital is a health care focused venture and growth capital partnership

John Payton, Senior Portfolio Analyst at Frazier Healthcare Partners, focuses on investment in BioTech, Digital Health, Health & Hospital Services, and Health IT. He specializes in seed to Series B stages with an investment range from $100K to $5.0M. His track record includes successful investments in these sectors with a sweet spot of $1.5M. John has worked with investors like Albert Cha, Angel Martin, Danica Elliott, Daniel Estes, and Elizabeth Park.

Dalmore Investments is an angel fund based in Minneapolis, focusing on emerging healthcare businesses with high growth potential. Led by Dr. John Blank, the fund is committed to investing in lower volatility infrastructure assets primarily in the UK but also manages assets in Ireland, continental Europe, and Canada. Notable investments include companies like Beyond Lucid Technologies. Dr. John Blank, with over 30 years of experience in healthcare leadership, leads the fund and is dedicated to providing more than just capital. The fund’s collaboration style emphasizes building long-term relationships with aligned interests.

Arin Maercks, Managing Partner at New Frontier Capital Partners, focuses on investing in companies in the healthcare, education, internet, and technology sectors in China. The firm also invests in medical buildings. The Healthcare New Frontier Investment Fund, managed by Eucalia, invests in software and healthcare companies. Mr. Maercks’ previous investments include various companies such as JetSmarter and Verzasca Group. Additional information about his track record, professional career, investment check size, and partnership and collaboration styles is not available through the current search methods.

Darryl Wells is an Angel Investor at Alliance of Angels based in Seattle, Washington. He focuses on seed and early-stage investments, with an investment range of $500K – $1.5M and a sweet spot at $1M. Darryl’s current fund size is $100M. His investments have been in sectors like manufacturing and medical devices, both at the Seed and Series A stages. He is affiliated with Wharton Alumni Angels and several other investors. Darryl’s partnership and collaboration styles are not explicitly mentioned in the available data.

Brad Dickerson is an Executive Advisor, Member of the Board of Directors, and has served as CEO, COO, and CFO in various companies including Bombas, Tradefull, and Palmetto. He holds an MBA from Loyola University Maryland and a Bachelor’s of Science in Accounting from The University of Akron.

Bauke Anninga is the Investment Director at M Ventures, focusing on the biotechnology team and leading investments in companies like Immunitas, Nucleome, NanoSyrinx, PictorLabs, Multitude, Rewind, Synaffix BV, and Outrun Therapeutics. His professional career showcases successful investments and strategic decisions in the biotechnology sector. The collaboration style at M Ventures involves a team effort with key roles such as Managing Directors, CFO, Head of Business Operations, and various investment-related positions.

Lone Fønss Schrøder engages in investment strategies that combine quantitative and qualitative tools to uncover independent sources of return across global public and private markets. The focus areas include renewable energy development and industry leadership, with expertise in systematic, discretionary, and hybrid strategies. Lone Fønss Schrøder invests in companies at initial stages like seed funding, series A, B, and C rounds, and preferentially operates in the U.S. with a history of diverse investments. The investment check size varies based on factors like market size, company potential, revenues, and management valuations. Collaborative partnership styles of Lone Fønss Schrøder emphasize supporting entrepreneurs by providing proper funds to realize their entrepreneurial dreams.

Joe Zhou is a seasoned VC with a focus on technology, mobile internet, healthcare IT, and devices. He has a track record of investments in companies like Huifu Payment, Cloudminds, and Analogix. Joe’s career includes roles at SAIF Partners, Kleiner Perkins, and Keytone Ventures. He has been recognized as a top VC in China and was named VC of the Year in 2010. Joe invests in early-stage companies and has a strong background in technology and wireless applications. His previous roles include VP at UTStarcom China and teaching at Beijing University of Technology.

Eli Alroy is a serial investor with over 30 years of experience in hi-tech investments, venture capital investments, and capital markets. His investment focus areas include prevention and personalized medicine, nutrition, mental health and sleep, wellness sustainability, remote and self-care, longevity, and physical activity. Some of his previous investments include companies like Hedonia, Quris, Alike, CalmiGO, MDI Health, Vuze Medical, Antidote, XTrodes, Amai, and Behavidence. Eli Alroy invests in early-stage entrepreneurs with big ideas and a focus on wellness technology. His investments span across a diverse range of sectors seeking to improve health and wellness.

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

Ron Seubert is the founder of RareCyte, Inc., a company that focuses on characterizing and isolating rare cells in the blood, providing tools for cancer and cardiovascular research. He has a significant track record in developing innovative technologies and collaborating with industry experts. Previous investments include RareCyte, with a focus on life science research and diagnostics. Specific partnership and collaboration styles are not explicitly mentioned, but Ron Seubert engages in webinars and collaborations within the industry.

Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by

Bio/Med Investor Network is an angel network that prefers to make early-stage investments in the biomedical, medtech, and healthcare-related companies based in the Southeast region of the United States and Georgia.

HLM Venture Partners is a venture capital firm that invests in healthcare technology companies.

North Carolina Biotechnology Center is a biotechnology investor that focuses on emerging life sciences companies in North Carolina. They invest in therapeutics, medical devices, diagnostics, health IT, and ag tech. Their investment check sizes range from $150,000 to $500,000, with strategic growth loans of $350,000 to $500,000. North Carolina Biotechnology Center has an active investment portfolio with over 70 companies. They have a track record in life sciences, offering strategic growth loans and small business research loans to support early-stage companies. The Center has a partnership and collaboration style that involves engaging with VC & Angel Investors and providing career options and networking events for STEM professionals.

Alan Hoops is an Angel Investor with a focus on healthcare and managed care industries. He co-founded PacifiCare (NYSE: PHS) and has been Chairman of Benu, Inc. and Board Director for Corvel. His investment check size is undisclosed. Alan Hoops’ collaboration style is focused on understanding the three common collaboration styles: introspective, relational, and expressive, and how they can work better together.

John McEleney is the Co-Founder of Onshape, with a focus on a declarative system and Parametric Feature Based Modeling vs Direct Editing. Onshape’s investment check sizes are not specified. The stage of investment for Onshape was formerly VC-backed. Geographically, Onshape’s focus is on providing technology for global design teams to work collaboratively. John McEleney’s previous investments include Verve as part of their Series B – II. John McEleney is known for emphasizing real-time collaboration in product development, highlighting the importance of technology that facilitates collaborative work.

Brian Roberts is an executive who previously served as the Chief Financial Officer of Insulet Corporation. He resigned from his role on November 6, 2014. Brian Roberts had extensive experience with public companies, including as CFO at Insulet Corporation. Insulet Corporation is an innovative medical device company focusing on making the lives of people with diabetes easier with the OmniPod Insulin Management System.

Dr. Norm Gitis serves as Managing Partner at Lymo Ventures, actively funding and mentoring startups in medtech, biotech, nanotech, and scientific fields. With a Ph.D. in Mechanical Engineering, he has been a visiting professor at MIT and was a CEO of two highly profitable test instrumentation companies. His investment focus includes med-tech and biotech startups, with a track record of over 150 scientific papers, three books, and two dozen patents. Norm Gitis prefers investments in the later stages, with a keen interest in oncology, cardiology, and diagnostics. While his geographical preferences are not specific, his previous investments reveal a dedication to supporting innovative startups. His investment check size aligns with angel investors, typically under $30,000, showcasing a commitment to nurturing early-stage ventures. Norm Gitis showcases a hands-on partnership style, leveraging his extensive expertise to provide valuable guidance to portfolio companies.

John Pappajohn is a key figure known for his involvement in over 100 startups and 50 IPOs, with a notable investment in the home health care company Caremark. He is a self-made entrepreneur and visionary philanthropist. The Iowa Entrepreneurial Venture Competition, which he supports, awards $100,000 to early-stage Iowa startups. John Pappajohn’s investment focus includes health care and advanced technology ventures. His partnership and collaboration styles are highlighted through the UNI John Pappajohn Entrepreneurial Center’s collaborations in economic development with Iowa CORE. Further details on his investment check size were not available.

Life Science Angels, founded in 2004, is an angel investment group based in Sunnyvale, California, USA. The firm focuses on companies in the healthcare and life sciences sectors, including medical device, pharmaceuticals, biotechnology, and health care. Life Science Angels typically invests in early-stage ventures and seed rounds. They have a track record of 81 total investments with an average round size of $3 million. The portfolio includes companies in the United States and Netherlands. The firm has had 7 successful exits, with key areas of investment in biotechnology, health care, medical device, and pharmaceuticals. Life Science Angels seeks partnerships in the life sciences industry and shows a preference for companies with a higher percentage of exits and a higher IRR compared to other industry verticals.

Rosecliff invests in companies that are making life better, brighter, bolder, and more efficient.

Baigo Capital is a private equity fund focusing on mid-market healthcare companies with an enterprise value up to �200m. Their investments cover traditional LBOs and MBOs, consolidations, corporate disposals, and more. They have previously invested in companies like Vanguard AG and EuroEyes group. Baigo Capital partners with management teams to create market leaders. Their investment check size is within the mid-market range. Baigo Capital collaborates strategically with a focus on the healthcare sector. For more information, you can visit their (website)[http://www.baigo-capital.com/].

Magnus Bergman is a Co-Founder and General Partner at Luminar Ventures, having made over 30 seed investments in the past 10 years. Luminar Ventures focuses on technology in healthcare as a transformation area. One of their portfolio exits was Soundtrap in 2017.

Ron Sheridan focuses his investments on companies within the healthcare industry, targeting control positions in healthcare businesses and partial recapitalizations or buyouts. His investment check size ranges from $15 to $100 million, with a focus on healthcare providers, healthcare outsourced services, and consumer health & products. Sheridan’s geographic focus is on companies headquartered in the United States or Canada. He has a track record of investing in healthcare businesses with a platform EBITDA of $3 to $20 million, and his hands-on approach in creating value post-close sets him apart as a disciplined, thesis-driven investor in the healthcare sector.

Tomas Mora-Morrison is the Co-founder and Owner of Cambio Healthcare Systems. He has a focus on investments in the healthcare sector, with previous investments including AlgoDx in a Seed VC round. His investment check size ranges between $500K to $1.5M per company. Tomas Mora-Morrison has a collaborative partnership style and has invested in companies in the European Union, particularly in the Nordic countries.

Polaris Partners invests in healthcare and technology companies ,Äãacross all stages from founding to profitable growth.

Rethink Impact is a venture capital firm investing in female leaders using technology to solve the world,Äôs biggest problems.

Joe O’Connor is an Angel Investor. He served as Vice President of Advisory Services at Rifiniti and previously as a Principal at VisorPoint. His previous investments include companies like Octiv, Rifiniti, and True&Company. Mr. Joe O’Connor’s professional career includes roles in advisory services and angel investing. He demonstrates a collaborative spirit in partnerships. For more details, visit (PitchBook Profile of Joe O’Connor)[https://pitchbook.com/profiles/investor/109445-32].

Rio Grande Valley Angel Network, based in Weslaco, Texas, was founded in 2015 by local investors, educators, and community leaders. The network provides seed funding to local entrepreneurs to scale their businesses. With a vision to be a key source of funding and resources, RGVAN consists of 43 individual accredited investors supporting early-stage businesses in Texas. The network focuses on connecting investment-ready startups with seed funding and offers platforms for meaningful investments and educational resources. RGVAN’s partnership and collaboration styles involve providing a platform for entrepreneurs to access capital and for angel investors to invest in scalable enterprises, aiming to spark economic growth in the region and foster an entrepreneurial culture.

Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.

Builders VC is an early-stage VC focused on investing where technology meets new business models to modernize antiquated industries.

Min-Sung Sean Kim is a Managing Partner at Digital Health Ventures in Berlin, specializing in digital health investments. He has a strong track record and professional career, having held positions at Allianz X GmbH and XLHealth AG as a Private Equity Investor and Director/Board Member, respectively. Min-Sung’s investment focus includes startups like mySugr, Amwell, Mimihearing, NeuroNation, medbelle, and thryve_health. His partnership and collaboration styles revolve around fostering impactful social change through innovative healthcare startups.

Mr. Soeren von Varchmin serves as Chairman of the Advisory Board at Cloudfest and as an Advisor at Monarx. His previous role includes advising at Jelastic, being General Manager at World Hosting Days, and serving as an Advisor at Runa Capital. He has over 10 years of international experience in sales and business development in the services and cloud industry across the US, Europe, and Asia.

Rally Ventures invests in early-stage enterprise technology companies.

Telegraph Hill Partners is a venture capital firm investing in life sciences, medical device, and healthcare technology companies.

Keshif Ventures is a San Diego-based angel investing firm founded in 2012. The firm focuses on investing in early-stage companies in the media, technology, and big data sectors. They have a geographical preference for supporting companies in the San Diego data science ecosystem. Keshif Ventures does not specify a specific investment check size publicly. The founder, Andy White, has a professional background that includes founding Millennial Technology and serving as a Founding Board Member at Data Science Alliance. As of now, Andy White is actively involved in Startup Operations at Keshif Ventures, LLC. Additionally, he has experience in various roles such as Facilities Committee Member at The New Children’s Museum and EIR at Seed San Diego. This showcases a diverse career involving support for startups and community building in different organizations.

Streamlined Ventures is a seed-stage investment firm focusing on Data Science, APIs, Blockchain/Web3, AI, and Software Automation.

Dr. Larry Smarr is a physicist and leader in scientific computing, supercomputer applications, and Internet infrastructure. He serves as Advisor at MD Revolution and Venture Partner at Analytics Ventures. Larry Smarr’s focus areas are not specified. His professional career includes pioneering research on black holes and the use of supercomputers. Specific details about his investment check size, previous investments, and partnership styles are not available.

Georgia Cavanaugh is a VC Analyst at SteelSky Ventures based in Chicago, Illinois. Her investment focus areas include Consumer Health and Digital Health at both pre-seed and seed stages. Georgia’s investment range is $100K to $5.0M with a sweet spot at $1.5M. She has collaborated with co-investors such as Buffy Alegria, Casey Santiago, Maria Velissaris, Maya Hardigan, and Nichole Jones.

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem

Amit Banka is an experienced investor with a broad private equity and own investment background. He has a strong Nordic network and industry expertise in financial services and healthcare. Amit excels in deal sourcing, active corporate governance, financing, and strategy. His investment focus areas include neuromodulation medical devices, orofacial disorder treatments, bone nanocoating technology, drug detection using exhaled breath, organic food retailing, and furniture logistics. Amit has significant experience as a Board Member and investor in various companies, showcasing his diverse investment portfolio and successful track record. Amit’s investment thesis involves a hands-on approach, emphasizing active involvement in guiding portfolio companies towards success.

Irene Chen, as an investor, focuses on healthcare. Her stage of investment is active. Specific details about her previous investments, track record, professional career, investment check size, and partnership and collaboration styles could not be found.

Annegret de Baey is a Venture Partner at Seventure Partners SA, specializing in investments in the microbiome sector. Her investment focus areas include Digital Health (Series A), Health & Hospital Services (Series A), Health IT (Series A). She has a track record of investing in companies like Abalos Therapeutics and Dopavision. Her investment check size ranges from $685K to $27.0M, with a sweet spot of $14.0M. Annegret de Baey has collaborated with co-investors such as Sebastian Pünzeler and Isabelle de Cremoux. She has a geographic preference for investing in Munich, Bavaria, Germany. Annegret brings 20 years of experience in the life science and venture capital sectors to her investment endeavors, leveraging her expertise in Dermatology and Allergology.

Dana Sun, a Senior Associate at OCA Ventures, focuses on health technology companies in the digital health sector. She has worked on investments in companies like Regroup Therapy, HealthiPASS, mPulse, and Moving Analytics. Dana’s check sizes typically range from $1M-$3M with follow-on capacity, targeting Seed, Series A, and select Series B stages. Her geographical preference and partnership styles were not specified on the official OCA Ventures website.

Christoph Lange, an Angel Investor, has invested in LaundryAngels in the Consumer sector in Germany. His investment check size is in the Angel Round. His professional career includes being a professor and associate chair of radiation oncology and molecular and cell biology at SUNY Downstate Medical Center. He focuses on understanding molecular and cellular responses to ionizing radiation, especially in cancer stem cells. Christoph’s investment focus areas include Devices and Supplies, Food Products, and Specialty. He mainly invests in early-stage tech companies. His geographical preference for investments is in Germany. Christoph’s investments typically range around 800K+, targeting early-stage tech companies.

Francisco Larrain is a Co-Founder & serves as Co-Chief Executive Officer, Chief Technology Officer, and Board Member at Topsort. He is a Co-Founder and serves as a Board Member at Sentinel. He is a Co-Founder of Sudo and serves as its Chief Executive Officer and Board Member. Prior to co-founding Sudo, he founded and led Zappedy (acquired by Groupon in 2011). At Groupon, he was a Senior Director of Engineering where he led the Local Engineering team (150+). He holds an MBA from Stanford, an EE, and an MSc in Physics from Universidad Catolica de Chile. He found engineering a safe haven and also a fun game to obsess with. He is the first Chilean entrepreneur to exit a startup in Silicon Valley. Formerly a hedge fund analyst, he led engineering at Groupon for 5 years to build out its merchant system. He was a venture investor and now spends all of his time thinking about Topsort’s engineering puzzles.

Dimitri Krainc is a Venture Partner at OrbiMed with a current investing position focused on Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. His investment range varies from $1M to $75.0M, with a sweet spot of $4.0M. The current fund size associated with his investments is $18B. Located in Chicago, Illinois, Dimitri Krainc has collaborated with investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman.

J.P. Keating, Managing Partner & Founder of proChain Ventures, focuses on AI-enabled supply chain and mobility technologies for societal good. He invests in Pre-Seed and Seed stage startups in supply chain SaaS, deep tech, aerospace, applied AI, and defense. With over 25 years of experience, his track record includes investments in companies like Intramotev, Finlogistics, Natilus, and more. J.P. Keating’s investment check size ranges from $10K to $250K for Seed VC investments. He is known for his hands-on approach, actively partnering with generalist funds and supporting operational transformation in supply chains. He values partnerships and collaboration, aiming to bring value to founders and accelerate their success.

Heartcore is a venture capital firm that invests in founders building category-defining consumer internet brands.

Sebastian Kreuz is an investment manager at Boehringer Ingelheim Venture Fund focusing on strategic opportunities in the infectious diseases space. His geographical preference is to invest worldwide in innovative early-stage therapeutics and digital health companies. He has been involved in previous investments such as Centauri Therapeutics and Quantro Therapeutics. Sebastian’s track record includes roles in research and venture capital law. The investment check size for companies like QUANTRO Therapeutics is significant. His partnership and collaboration styles involve a focus on groundbreaking therapeutic approaches and technologies.

Brian Gill is an experienced Senior Communications and Investor Relations Consultant with previous roles at Gamida Cell, TYME Technologies Inc., and Celgene. His investment focus areas include biotech and medical innovation. With experience in global corporate communications, he brings expertise in fostering investor relations. Brian holds a Bachelor’s of Science with a major in Biology and a minor in Chemistry from West Chester University of Pennsylvania. He also holds Series 7 & Series 63 licenses from FINRA. Brian has been involved in the Value Of Medical Innovation Initiative project.,

PsyMed Ventures invests in transformational technologies that elevate mental health and wellness through it’s fund and angel syndicate.

MEDA Angels is a healthcare-focused angel investor group comprised of accredited investors with diverse backgrounds. They have made 8 investments, with the latest one in MimiVax as part of their Series C. The group is based in Washington, DC, United States.

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

GoBeyond is a venture capital firm based in Zurich, focusing on investments in early-stage fintech companies. Their portfolio includes companies in industries like environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors.

David Pann, serving as a Venture Advisor at ONSET Ventures, primarily focuses on early-stage companies in business-to-business markets in information technology and medical technology. The firm’s geographically preferred region is Northern California. They have a robust portfolio with over 130 startups and 7 funds, investing in enterprise applications, infrastructure software, communications, networking, and medical technology. Some of their notable investments include Adaptive Insights, Adaptive Planning, AdaraAdsNative, Apama Medical, BAROnova, and more.

Mission BioCapital is a life science venture capital firm that invests in early-stage companies.

Virginia Giugliano is an Angel Investor with a portfolio including investments like Fruit Street. She focuses on healthcare startups and has invested in Fruit Street during their Seed round in 2015. Her partnership and collaboration styles are highlighted in her role at Isagenix International, where she serves as an Executive, showing her commitment to supporting and growing businesses. Virginia Giugliano has a significant background in healthcare and brings valuable experience to her investments.

DrPano Kroko Churchill is a legendary entrepreneur, Angel, VC, and PE investor focusing on innovation for solving major challenges. His investment emphasis is on Life Sciences. He has invested in startups such as Amrit Advanced Biotech at the Seed stage. Dr. Pano Kroko Churchill’s check size ranges between £150,000 to £1,500,000. His partnership and collaboration styles are individualized to the specific goals of the investment. With a track record in Potomak Ventures, DrPano Kroko Churchill has shown a commitment to supporting startups in the Life Sciences sector.

Lou Mazzucchelli is an investor with a focus on Big Data, Enterprise Software, Music, Health Care, and Information Technology. He is actively investing in VC stage companies. His geographical preferences are not specified. Lou Mazzucchelli has a track record in data communications, IT management, and consulting, and has overseen investments in semiconductor and software companies. The investment check size for companies he has been involved with ranges based on the specific company’s funding needs. Details on specific partnership and collaboration styles are not available at this time.

Adam Fisher is a Partner at Bessemer Venture Partners, involved in multi-stage venture capital investments in the US, Europe, and Israel. His track record includes investments in companies like Fiverr, Hibob, Melio, Yotpo, DRIVENETS, Cloudinary, Salto, Choco, ScyllaDB, and more. He has a strong career history in directing and supporting innovative startups across various sectors. Adam’s investment focus spans different regions, with a current location in Israel. Bessemer Venture Partners targets multi-stage investments in the US, Europe, and Israel.

Andrew Bachman is an Angel Investor with a stage focus on Seed Round investments in industries like Location Based Services, Consumer Internet, Lead Generation & Management, Local Commerce & Advertising, and Services Businesses. His previous investments include Presentify.me. He has a track record in financial solutions at Fidelity Investments and holds certifications as a Certified Financial Planner (CFP) and Chartered Financial Analyst (CFA). Andrew is based in Boston, Massachusetts, United States and has a professional background in finance. His investment check size ranges based on the specific company and round. Andrew is known for his partnership and collaboration styles in supporting startups and fostering innovation.

Social Capital is a venture capital investment firm that partners with entrepreneurs at all stages.

Johann Moonesinghe is the Co-Founder and CEO of inKind. He makes angel investments in early-stage technology companies and has experience in the restaurant industry. His investments typically involve equity exchange. He has a degree in Computer Science and Engineering from UCLA.

Doris Qamar, MBA, C.E.T. is an experienced investor with a background in analytical chemistry and material science. She has a strong track record in the chemicals, biotechnology, medtech, and lifescience sectors. Doris has served as an Angel at York Angel Investors and has held roles in biotechnology business development and finance. She is the Founder and CEO of SPEC Labs, where she helps biotech companies achieve their milestones. Doris holds an MBA from Ivey Business School at Western University and a Bachelors Degree in Chemistry. Her expertise and connections make her a valuable partner for startups seeking growth and support.

Viktor Bunin is the co-founder of Credibly Neutral, a $5.5m builder-led venture fund investing $50â250k in protocols, infrastructure, and crypto SaaS solutions. Their thesis focuses on credible neutrality as a competitive advantage. They invest in early-stage startups like Hyperlane, Skip Protocol, and Monad. Viktor Bunin, a Protocol Specialist, leads the Protocol Operations team at Coinbase Cloud. The fund emphasizes deep relationships and knowledge sharing with founders.

Costanoa Ventures is a Investor.

Clayton Milburn is a Director at Thompson Street Capital Partners. For more detailed information, visit their (Investment Strategy) and (Our Portfolio) pages.

Wolfgang Dengler, a Senior Investment Manager at Bayern Kapital, has been an integral part of the team since 2009. He specializes in venture capital for innovative, technology-oriented start-ups in Bavaria. With over twenty years of experience, Wolfgang leads the Growth and Later-Stage team, focusing on B2B software start-ups. His investment thesis revolves around supporting ambitious founding teams with visionary ideas. Wolfgang’s investment check sizes range from EUR 250,000 to EUR 25 million, and he values collaboration and partnership in fostering technological advancements. His track record includes building a portfolio of primarily B2B software start-ups and providing financing and expertise to technology-oriented companies. Wolfgang Dengler’s investment approach aligns with Bayern Kapital’s mission to revolutionize tech sectors through strategic investments and customized financing concepts.

Dr. Geraldine McGinty is an accomplished professional with a background in imaging economics and specialization in Women’s Imaging. She serves as the Chief Strategy and Contracting Officer at Weill Cornell Medicine Physician Organization. Her collaborative style can be seen through partnerships like the one with RadEqual and the American Association for Women in Radiology, where she signed a two-year MOU to support increased collaboration and promote educational initiatives in the radiology community. While specific details about previous investments and track record are not available, her role as a board member and advisor to various organizations demonstrates her expertise and influence in the field. She favors an investment style focused on imaging economics and Artificial Intelligence in Medical Imaging.

Montage Ventures is a destination for start-ups looking for investment between Angel and Series A rounds.

Tim Armstrong, through his DTX Company, is focused on building a tech platform called Unbox to boost direct-to-consumer brand marketing efforts. The company aims to facilitate offline expansion, improve DTC brand marketing, and provide opportunities for individual brands in the direct-to-consumer category. This indicates a collaborative style with a focus on marketing strategies and partnerships to enhance brand visibility and customer reach.

Yasemin Tümer is a seasoned investor with Borski Fund. The fund focuses on female entrepreneurs and businesses targeting women’s health, invests in retail and healthtech sectors, and has received investments from Visa Foundation. Yasemin chairs multiple Supervisory Boards and is involved in various organizations. Borski Fund collaborates with experienced entrepreneurs and partners like StartGreen Capital and The Next Women network. The fund’s investment check size is known to be positive, although specific details are not disclosed.

Raju Indukuri is an angel investor interested in disruptive innovations in technology and healthcare. He invests in startups to disrupt the healthcare market and has a track record of over 30 years in psychiatry. Raju’s investments range from seed rounds to Series B, with a check size that is undisclosed. His geographical focus spans across global regions such as Europe and Southeast Asia. Previous investments include FalconX and collaborations with KPIT Technologies. Raju’s partnership and collaboration styles involve expanding networks and accessing innovative solutions.

The Sofia Fund, an angel group based in Minneapolis, focuses on early-stage, growth-oriented, gender-diverse companies with women leaders and equity owners. Their portfolio of 23 companies includes notable investments like AbiliTech Medical and Joylux. They invest in sectors such as HealthTech and Life Sciences, with investments at Series A and Seed stages. Some top investments include Tactile Medical, Magnet 360, and Rebiotix.

Jefferson Corner Group LLC – Brookdell focuses on providing investment capital to technology startups in the Charlottesville, VA region. They primarily invest in U.Va. faculty spin-offs and other technology businesses in the area. Their investment focus areas include health care, medical, and therapeutics. Jefferson Corner Group has a track record of supporting U.Va. faculty spin-off companies and emerging technologies. Unfortunately, specific information about their investment check size and partnership/collaboration styles could not be found.

John Meisenbach is known for his investment in early and mid-stage companies like Costco, Starbucks, and F5 Labs. He is involved in Meisenbach Financial and serves on the boards of multiple organizations including Costco, Expeditors International, Savers, M Financial Group, Acorto, and McCormick Capital Management. His typical investment check size is not available. John has been associated with philanthropic activities through The John & Ginny Meisenbach Foundation. He has made investments like Seeq in Series A funding rounds.

Daniel J. Kingston is a Managing Director of Investments at Morgan Creek Capital Management. He specializes in venture capital, opportunistic equity, and customized advisory solutions. His geographical focus is on Asia and digital assets. Previous investments include Morgan Creek Digital and the Risk Managed Bitcoin Fund. With 20+ years of experience, Daniel brings expertise in endowment management and institutional investment management. The investment check size typically ranges based on the fund and stage of the investment. Daniel values partnerships and collaboration, working closely with his team to drive innovative investment strategies.

Patrick Falle is an Angel Investor with a focus on Seed Round investments in industries such as Marketplaces, Data Security & Privacy, Enterprise Security, Food & Beverage, Cloud Computing, Cloud Security, SaaS, and E-Commerce. Some of his previous investments include DSTLD, FlavorCloud, Winc, Avalara, Hacktics, Voyage SMS, and YayPay. With over 20 years of experience, Patrick has built a track record as an operational investor and sales executive, contributing to the growth of multiple organizations.

Wisconsin Investment Partners LLC is a venture capital firm based in Madison, Wisconsin, founded in 1999. The firm focuses on technology and life science sectors, with investment areas including Health Care, Biotechnology, Medical, Software, and Medical Device. They make seed- and early-stage investments in various industries, contributing to the region’s entrepreneurial economy. Their investment check size offers fractionalized ownership opportunities for as low as $1,000, allowing investors to have security tokens. Wisconsin Investment Partners collaborates with other investors through partnerships, particularly in private equity and debt investments.

Northern Light Capital invests in advanced technology and future fast-growing companies, mainly in the following areas: InfoTech, MedTech, Fintech, and CleanTech. They offer competence and capital to exciting Swedish startups, providing active minority ownership and expertise in patent and intellectual property rights. Their investments range from â¬50,000 to â¬500,000, focusing on energy & greentech, media & entertainment, fintech, and healthcare & life science. The group values high growth potential, business scalability, and sustainable uniqueness, aiming for investments that yield 10x the capital in 5 to 7 years.

Dr. Caroline Fichtner focuses on financing and developing technology start-ups in the life sciences field. With a biophysics background and experience in venture capital, she works with the Max Planck Institute for Bioinorganic Chemistry. Her investment thesis revolves around the life sciences sector, but specific details on investment stage, geographical preference, previous investments, and check sizes are not disclosed. Dr. Fichtner’s partnership and collaboration styles are also unspecified at this time.

Sofia Hasselberg is an Investment Director at Bonnier Ventures in Stockholm, Sweden. She focuses on Sector & Stage Rankings such as Messaging, Entertainment & Sports, Logistics, Food and Beverage, ClimateTech/CleanTech, Real Estate/PropTech, Marketplaces, Digital Health, Health & Hospital Services, and Health IT, particularly in Series B investments. Sofia collaborates with investors like Dajana Mirborn, Johanna Rahm Juhlin, Nadja Abbas, and Victor Bodin. Her investment range is between $100K and $5.0M with a sweet spot at $1.5M. Sofia’s previous investments include cancer diagnostics firm Elypta, where she saw potential in improving healthcare through liquid biopsies for early-stage cancer detection.

Allos Ventures invests in early-stage B2B software and business services companies in the Midwest.

Lorenz Graef is an investor with a focus on visualization & visual search, big data, market research, analytics, consumer internet, and collaborative consumption. He provides grants and workspace to early-stage startups. Lorenz Graef’s geographical preference and previous investments are not specifically mentioned in the available information. His professional career includes expertise in dual-earner families and part-time career tracks in medicine. The size of his investment checks is not specified, but he is associated with startup accelerators and incubators. Lorenz Graef collaborates with startups, founders, and strategic partners, emphasizing commitment and inspiring initiatives.

Joe D’Amico is an investor with a focus on equity investments in Virginia’s leading technology, energy, life science, and scalable non-tech startups through a family of seed and early-stage investment funds. His investment ranges cover various sectors such as Biotechnology, Biopharmaceuticals, Medical Devices, IT, Telecommunications, Cybersecurity, Renewable Energy, Transportation Technologies, and more. He has a background in supply chain and procurement, with experience in roles like General Manager of Supply Chain Services at Quest Global and Senior Director of Global Procurement at Baker Hughes. His investment check size is not specified, but he has a track record of meaningful results in challenging environments and seeks a Procurement, Sourcing, or Supply Chain leadership role in medium to large scale companies. He demonstrates a results-oriented approach and collaborates effectively in his roles.

SJF Ventures is a venture capital partnership focusing on the resource efficiency, sustainability, and technology-enhanced services sectors.

TMV is an early-stage investment firm that focuses on the future of living well.

Peter Adams is an investor with focus areas in Healthcare, Retail Technology, Medical Devices, and Healthcare Services. He operates in early-stage investments, with a check size that varies. His previous investments include Rockies Venture Fund and Pandemic Impact Fund. With over 25 years of business experience, he is actively involved in developing best practices for due diligence and negotiation, providing education for angel investors, and leading multiple ventures.

ShangPharma Innovation is a global innovation incubator and investment organization focused on biomedical R&D technologies and therapeutics.

Paul Troyer is a CERTIFIED FINANCIAL PLANNER™ professional at Franklin, Parlapiano, Turner & Welch, LLC in Houston, TX. His specialties include investment management, life planning, and retirement. His investments focus on assisting clients in financial planning and providing advice in various financial areas. Paul’s track record includes consulting expertise in large and small hospitals and healthcare systems across the US, with positive results. There is no specific information available regarding his investment focus areas, stage of investment, geographical preference, previous investments, investment check size, or partnership and collaboration styles.

David Wieland is a Co-Founder and Co-Chairman at IrishAngels, actively investing in early-stage technology ventures with a focus on B2B, consumer, and medical companies at the seed stage. He has a geographical preference for the Greater Chicago Area. David has previous investments in Motivate Venture Capital, Firesale.ai, Interviewing.com, Valiot, Fulcrum, Cardigan Ventures, iEstates, and RIVS Interviewing Technologies. His investment check size ranges from $10 million to $3 million, with a partnership and collaboration style that emphasizes equity investments.

Phil Hagerman, a Partner at Comeback Capital, specializes in investments in Pharmaceuticals, Health & Hospital Services, and Health IT sectors. His investment check size ranges from $50K to $250K, with a sweet spot at $150K. Phil’s current fund size is $2.3M. His recent investments include Pre-seed Pharmaceuticals. Phil is known for co-founding SkyPoint Ventures, focusing on early-stage companies. He has a collaborative and hands-on partnership style, offering mentorship and strategic guidance to startups. With a track record in multiple disciplines, Phil Hagerman is an experienced investor with a keen eye for promising ventures.

Frank Quattrone is the Founder and Executive Chairman at Qatalyst Partners, a technology-focused boutique investment bank specializing in mergers and acquisitions. With over four decades of experience, Quattrone has advised on more than 500 M&A deals worth over $1 trillion. He has a geographical preference for the technology sector and has assisted companies like Autonomy in their sales. Quattrone’s partnership and collaboration style is reflected in his private partnership at Qatalyst, where he collaborates with eight partners with extensive experience in the industry.

Tom Patton is a seasoned healthcare executive and board member with broad operational, strategic, legal, compliance and transactional experience. He has served in various leadership roles in public and private healthcare companies. Tom’s investment focus areas include healthcare, biotechnology, dementia, and medical devices. He has a track record of success in leading companies to growth and acquisition. Tom has been involved in previous investments in companies like CAS Medical Systems, QDX, Inc., Novametrix Medical Systems, and Wright Medical Technology. His investment check size varies depending on the company’s needs. Tom prefers collaborations and partnerships that emphasize effective communication and relationship dynamics in decision-making processes.

Lars Hedbys, a Partner at Ventac Partners, brings over 30 years of international leadership experience in the life science industry. He focuses on company building, financing, mergers & acquisitions, and IPOs. Lars has led listed companies and founded life science companies, handling pharmaceutical, ATMP, and medical device development. He serves as chairman or board member in various listed and private life science firms. Lars holds an M.Sc. in chemical engineering and a Ph.D. in Applied Biochemistry. His past roles include CEO of Idogen AB and Chairman of Lund Life Science Incubator. Lars Hedbys co-founded Idogen AB, Regenesance BV, IAmPatient AB, and Casigen Pharma Ltd. The investment check size and partnership styles are not publicly available.

Jay Sethuram is an investor with a focus on late-stage technology firms. He has made 2 investments and has 1 portfolio exit. His geographical preferences include the U.S. and his previous investments include Skillenza, Moon Express, and Entreda. Jay Sethuram has an extensive career in technology, starting in 1974 and holding various CTO positions. The investment check size for Jay Sethuram is $250K in angel funding. His collaboration style emphasizes partnerships and diverse ideas.

Julia Dewey is the Managing Director at Rev1 Ventures. Rev1 Ventures focuses on late-seed, pre-Series A, and Series A investments in B2B startups across industries. Some of the previous investments made by Rev1 Ventures include Color Coded Labs, Redi Health, SureImpact, and Rapchat. The investment check size at Rev1 Ventures ranges from $150,000 to $325,000, with a sweet spot at $240,000. Julia Dewey’s investment approach aligns with the fund’s focus on digital health, health & hospital services, and health IT sectors in the pre-seed to Series A stages.

Nyfikna Investerare, a venture capital company based in Sweden, is dedicated to democratizing knowledge about investments and inspiring investors. The firm focuses on fostering collaboration between entrepreneurs and investors to build a supportive community. Nyfikna Investerare has a diverse partnership and collaboration style, working closely with startups to deliver actionable strategies tailored for their success. While specific investment check sizes are not provided, Nyfikna Investerare is actively involved in the health tech category and has a portfolio of investments. The firm has shown interest in sectors like wearable tech, IoT, and Smart Textiles, with investments in companies such as LEIA and Gokind. Additionally, Nyfikna Investerare organizes events and programs like board of directors training to enhance the skills and opportunities for investors and entrepreneurs in the startup ecosystem.

Klaus Dugi is a Venture Partner at ND Capital, a venture capital firm investing in disruptive technologies across life, physical, and data sciences. With assets under management of approximately $820 million, ND Capital operates in the United States and Europe. Klaus Dugi’s investment focus areas include Therapeutics, Digital Health, BioTech, and Health & Hospital Services at various stages from Pre-seed to Series B. He typically invests between $100,000 to $5 million, with a sweet spot of $1.5 million, from a current fund size of $500 million. Some investors who collaborate with Klaus Dugi include Aditya Rajagopal, Alison Palmer, Aymeric Sallin, Dani Bach, and Eric Moessinger. His recent investments include leading a $20.6 million Series A financing for Vandria. Klaus Dugi plays a crucial role in supporting startups through their development phases and financing rounds.

CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.

ONSET Ventures provides early-stage venture capital in the areas of IT and medical.

John Evans is an individual angel investor with a seed stage focus. He is based in New York, New York, United States. His educational background includes the University of Pennsylvania, Yale University, and Wharton School of the University of Pennsylvania. John Evans is the CEO of Beam Therapeutics and has one portfolio company. His previous roles include positions at Agios Pharmaceuticals, Infinity Pharmaceuticals, McKinsey & Company, and MedImmune. He has a diverse educational background with degrees from prestigious institutions. John Evans’ investment style is as an individual angel investor focusing on seed stage companies.

Garth Moulton serves as President at Other Screen and has experience in advising and investing in technology startups, with notable success in co-founding Jigsaw.com. His investments are typically in promising companies, and he continues to advise CircleBack. He focuses on driving revenue through the channel and strategic brands for Pipl, Inc. Garth earned a BA in history and economics from Brown University.

Ingrid Nieweg is an Investment Manager at BOM Brabant Ventures with an investment thesis focusing on sectors like Manufacturing, Logistics, EnergyTech, Food and Beverage, AgTech, ClimateTech/CleanTech, Digital Health, BioTech, Health & Hospital Services, and Health IT. She has a track record in roles such as International Sales Manager and Senior Credit Risk Analyst at reputable organizations like Fisher Investments and ABN AMRO. Her partnership and collaboration approach involves assisting startups in achieving their milestones and seeking cooperation with venture capitalists in fields like climate technologies. Ingrid’s professional career includes a Master’s in Business Administration, a Private Banking Program from INSEAD, and a Bachelor’s in Commercial Economics, among other educational achievements.

GGV Capital is a global venture capital firm that invests in local founders.

Gleb Dudka, Principal at Greenfield Capital, specializes in Investing in Web3, Liquid strategies, DeFi, Staking, and Web3 Infrastructure. He has previously invested in startups like OneRare, Panoptic, Mangrove DAO, and APWine. Gleb Dudka focuses on seed-stage investments, participating in rounds to help startups develop platforms and navigate beta testing. He showcases a collaborative approach by engaging in roundtable discussions on validator business models within the staking and blockchain industry.

Roman Schumacher is an investor with a focus on healthcare startups. He has made investments in companies like Remberg and Stonly. Schumacher’s investments typically range between â¬100,000 and â¬500,000 per company. With a professional career in the healthcare sector, he brings industry expertise to his portfolio. He favors partnerships and collaborations that bring value to both sides, creating mutually beneficial relationships. Schumacher’s geographical preference appears to be in the EU region. His investment check size varies but typically does not exceed â¬3,000,000 per company. Overall, Roman Schumacher has a track record of successful investments, particularly in healthcare startups.

Michael Greeley, Co-Founder and General Partner at Flare Capital Partners, focuses on healthcare investments in companies like Aspen RxHealth, Author Health, Axuall, Cayaba Care, Circulation, Cohere Health, HealthVerity, Higi, Inbound Health, Iora Health, Oshi Health, RightMove, and Welltok. He holds a BA in chemistry from Williams College and an MBA from Harvard Business School.

Carl Wilson is an Executive Advisor at Forté Ventures with a focus on investments in automation, energy, infrastructure, and pharma & medical devices. He has a successful track record as the former EVP and CIO of Marriott International and previous roles at Georgia-Pacific Corporation and The Pillsbury Company, with notable board memberships. Check sizes for investments are not specified. Carl Wilson’s partnership and collaboration style are not evident from the available data.

Timo Kieseler is an individual angel investor based in Hamburg, Germany, with a focus on investments in the European Union (EU), Europe, and the Middle East and Africa regions. He typically invests at the seed stage and has made personal investments in companies like Darvis. His professional career includes serving as the Head of Algorithmic Trading at Vattenfall Energy Trading GmbH, demonstrating a strong background in utilities and management. Unfortunately, specific details on his investment check size and partnership styles are not available based on the search results.

Mr. Mike Elconin is an Angel Investor. He is the Chief Executive Officer of Cognionics, a wireless medical device company. He served as Director at MicroPower Technologies. Additionally, Mr. Elconin is an advisor at the von Liebig Center at the School of Engineering at the University of California, San Diego, specializing in technology commercialization in various engineering fields. He is also involved with the Center for the Commercialization of Advanced Technology, focusing on innovative technology commercialization for military applications. As an active angel investor, he has been consulting with California technology startups since 1999 and has a background in founding and leading Software Banc. His career includes political roles in Wisconsin before transitioning into the industry.

Christopher Altchek is a Co-Founder and serves as Chief Executive Officer at Cadence. He also served as Senior Advisor at 25m Health and was previously the Founder and Chief Executive Officer at Mic. Before his entrepreneurial ventures, Altchek worked at Goldman Sachs in investment banking and also gained policy experience at the National Economic Council in the White House. His professional career includes valuable stints working for New York City Mayor Michael Bloomberg’s re-election. Altchek focuses on remote care management through Cadence, emphasizing scaling remote patient monitoring for chronic conditions. His investment check size ranges based on recent fundings, such as a $40.9 million offering for Cadence. There is no specific data found on partnership and collaboration styles.

Benchmark focuses on early-stage venture investing in mobile, marketplaces, social, infrastructure, and enterprise software.

Midlothian Angel Network is a network of accredited minority, non-traditional angel investors providing bright futures for early-stage companies. Their investment thesis includes Crypto, AI/ML, Medtech, software, pharma/bio, IoT, and more, with a focus on US military veterans, minority founders, and African-facing startups. They invest in North America and Africa and have backed startups such as Robotics Manufacturing and Data Analytics. Their check sizes vary, with recent investments like $300,000 in Mainstack. They collaborate with early-stage companies in diverse markets and provide mentorship for rapid growth.

Mindshift Capital focuses on investing in post-seed early-stage companies in the U.S., Europe, and the Middle East. They have a track record of investing in healthtech companies like MDisrupt. Their investment check size, partnership, and collaboration styles are not explicitly mentioned in the available information.

Dr. Phillip Frost, Chairman of Frost Group, invests in various areas including pharmaceuticals, diagnostic devices, medical devices, developmental education, telecommunications, sports licensing, aviation services, software for seismic data analysis, and new materials for computer chips. The firm’s geographical focus includes the U.S., specifically Miami, with a recent move to open Frost Ice Bar in Faneuil Hall, Boston. Previous investments include Zebra Biologics. Dr. Frost is known for his successful track record in reviving struggling companies and has also collaborated with artists like Phil Frost on apparel and accessories.

Brigitte Linseis is a Senior Investment Manager at Bayern Kapital GmbH. Bayern Kapital invests from the seed to the scale-up phase, with ticket sizes ranging from EUR 250,000 to EUR 25 million. The industries financed include biotechnology and life sciences, medical technology, software and IT, environmental and nanotechnology, materials, and new materials. Brigitte Linseis focuses on seed rounds with investments typically at the seed round A level.

Tiffany Rennick is an investor with a focus on growth, a strategic fund model, and tailored communication to angel investors and venture capitalists. She has a check size aligned with venture capital norms and emphasizes partnership with other investors who share startup values. Tiffany’s investment approach is hands-on, aiming to demonstrate commitment to founders’ success and weather industry changes effectively.

Keiretsu Forum is a California-based angel group that offers early, seed, and later stage venture, and debt financing investments.

Chris Heid is an Angel Investor with extensive experience in product marketing, business development, and R&D in the life science industry. He has served in various roles at companies like HumanZyme, Fluidigm, Agilent, and Genentech. He holds an MBA from UC Berkeley’s Haas School of Business and has a background in Cell & Molecular Biology and Microbiology.

Ryan Broshar is the Founder and Managing Director at Matchstick Ventures, an early stage venture fund focusing on innovative ideas and diverse founders at the pre-seed and seed stage. The company primarily invests in the North and Rockies region and has a commitment to supporting startups outside of traditional startup hubs. They have invested in over 100 companies since 2015. Ryan has a partnership-oriented approach, building deep relationships with the entrepreneurs they back. Some of their investments include River, Upsie, Soona, Ordermark, StackHawk, and Fiveable.

Based on the information collected: Investment Thesis: Mr. Zachary Gobst, as the Co-Founder and Chief Executive Officer at LeapCure, aims to reduce clinical trial cycle time by two years. Investment Focus Areas: Zachary is primarily focused on health care and clinical trials. Stage of Investment: Zachary’s investments are likely early-stage, particularly in the seed stage companies with less than $10M in revenue. Geographical Preference: Zachary Gobst is based in Los Angeles, California, and his investments may focus on the health care companies in the Greater Los Angeles Area and California, with a broader interest in clinical trials companies in the United States. Previous Investments: Specific previous investments were not provided in the information gathered. Track record and professional career: Zachary Gobst is dedicated to guiding Leapcure toward achieving its vision in the healthcare field, with a focus on reducing clinical trial cycle time. Investment Check Size: The exact check size for investments by Zachary Gobst was not specified in the information found. Partnership and Collaboration Styles: No specific details on partnership and collaboration styles were mentioned in the gathered information. This description provides an overview of Zachary Gobst’s role, focus areas, location, and investment style.

Jim Prendergast is a successful entrepreneur and investor with a focus on health, wellness, and employee benefits startups. He is a co-founder and former CEO of HealthiestYou, a leading telehealth and wellness company that merged with HealthNow MD. Jim is the founder and CEO of 317 Ventures, where he invests in and develops startup businesses in the health, wellness, and employee benefits sectors. He has a track record of founding and leading innovative companies, including Benefiq and Mortgage Alliance. His investment check size ranges based on the startup’s needs. Jim’s partnership and collaboration style involve coaching, team building, and business development. He has a hands-on approach and focuses on impacting bottom-line results.

Jonathan Kraft focuses on investing in startups in various sectors, including biotech, medical devices, entertainment software, and accessories. Some notable investments include DraftKings, Stackwell, Scholar Rock, and Evolved by Nature. He has made 18 investments, with a recent investment in Splash Sports as part of their Series A. Jonathan Kraft’s investment check sizes vary, with the latest round at $14.1 million. He has a track record of 5 portfolio exits, with the latest exit being Dave. Jonathan Kraft is actively involved in overseeing the management of New England Patriots, New England Revolution, and The Kraft Group, where he serves as President and Chief Operating Officer.

William Canestaro, Ph.D., Managing Director at Washington Research Foundation/WRF Capital, invests in biotechnology startups in Washington with a focus on long-term success and companies at every stage of growth. His previous investments include 25 investments in 19 Washington-based companies like 2Morrow, A-Alpha Bio, and Icosavax. Dr. Canestaro has a strong professional background in venture capitalism, health economics, and meta-epidemiology. He utilizes his expertise to manage the Foundation’s biotech and engineering VC portfolio, supporting the Washington ecosystem. The investment check size by WRF Capital under his leadership has been significant, leading the biotechnology investment team. Dr. Canestaro is committed to fostering collaboration and partnership within the biotechnology industry.

Jeff Parker, the investor at Amazon Web Services, has a notable track record. He co-founded and was the former CEO of PillPack, recognized for his leadership in healthcare. He successfully raised over $100 million in financing, expanded the company to over 1,000 employees, and eventually sold PillPack to Amazon for $1 billion in 2018. After stepping down from Amazon in 2022, Jeff Parker is now a General Partner at Matrix Partners. His investments focus on the healthcare sector and his check size for investments remains undisclosed. His partnership and collaboration styles are not extensively documented.

Blake Overlock, Principal at LOUD Capital, focuses on alternative investments, particularly in people-centered healthcare, medtech, alternative care models, and healthcare infrastructure and IT. His investment thesis revolves around driving equitable access in healthcare. LOUD Catalyst Health Investment Thesis: Fueling innovations that drive access to quality healthcare. They invest in medtech, alternative care models, and healthcare infrastructure.

Dominik Escher is the Managing Partner at Pureos Bioventures and a founding partner of Pureos Bioventures with a successful track record. He was also a founder and CEO of ESBATech, which was acquired for $589 million by Alcon (Novartis). Pureos Bioventures focuses on investing in private innovative drug development companies, emphasizing the next generation of biological drugs and drug formats to impact patients’ lives positively. The fund aims to build a balanced portfolio of 17-20 pre-clinical and clinical-stage companies. Dominik is known to collaborate with passion for biotech startups, innovation, and the development of new and improved medicines.

Stephan Muecke is a Partner at ImpaQt Consulting and has extensive experience working at Bank of America Merrill Lynch, McKinsey & Company, Man Group, and Oaktree Capital Management. He holds an MBA from the Wharton School of the University of Pennsylvania and a German university degree from the Leipzig Graduate School of Management.

Stuart Gardner is an angel investor with approximately 80 investments in his portfolio. He focuses on Pre-Seed and Seed stage companies, particularly in areas such as Hardware, Sales & CRM, Medical Devices, AgTech, Consumer Health, BioTech, ClimateTech/CleanTech, Consumer Internet, and Enterprise. His investment check size ranges from $25K to $50K, with a sweet spot of around $40K. Some of his notable investments include Fundably, MONET, Connect4, Cargofy, BeeReaders, PF Nexus, Unbound, and Den. Stuart Gardner collaborates with co-investors like Marvin Liao, Esther Dyson, Ed Roman, Chris Adelsbach, and Will Neale. He has a diverse portfolio and a track record supporting startups in various sectors.

Stewart Peabody focuses on investing in Peabody Energy, particularly in the areas of seaborne thermal, seaborne metallurgical, and U.S. thermal portfolios. The investment check size is unspecified. Peabody has a professional background as the Director of Investor Relations at Kleiner Device Labs and was previously with Northern Trust Corporation. Specific details regarding Stewart Peabody’s investment thesis, stage of investment, geographical preferences, previous investments, and partnership styles were not found in the search results.

Aaron Batalion is an angel investor with Batalion Capital Angel, specializing in seed investments. His investment range is $20K – $100K with a sweet spot of $50K. Aaron invests in sectors such as Advertising, Social Commerce, Games, Hardware, Web3/Crypto, E-commerce, Social Networks, Consumer Internet, SaaS, and Enterprise at the seed stage. His recent investments include XMTP, MovieBot, Back to the Roots, HONK, Teachable, Walker & Company Brands, and Shyp. With a background as the 1st CTO of LivingSocial, Aaron brings valuable experience to the table. He has partnered with Lightspeed Venture Partners and served as a Software Developer at Hewlett-Packard. Aaron’s partnership and collaboration style focus on supporting early-stage startups with strategic investments and guidance.

Andera Partners is a private equity firm focused on early- and late-stage venture investments.

Dave Lerner is a founder, early-stage investor in 150+ companies, and Director of Entrepreneurship at Columbia University. Rugged Ventures, founded by Dave Lerner, invests in seed-stage companies with a geographical focus on the Greater New York Area, East Coast, and Northeastern US. The investment check size ranges from early-stage venture to seed investments. Dave Lerner’s partnership and collaboration styles reflect his role in fostering entrepreneurial energy and talents within the Columbia University community. His career includes leadership positions at prestigious institutions and active involvement in various community boards and organizations.

Mark Vreeke, a Co-Founder and President of Chemical Angel Network, specializes in matching customer needs with technical capabilities to create new business opportunities. With a background in medical devices and diagnostics and over 100 issued US patents, he has generated over $20B in revenue. Mark has demonstrated expertise in the energy industry, launching innovative products. Chemical Angel Network invests in early-stage hard science companies. Mark Vreeke’s professional career includes notable achievements in energy transportation and glucose fuel cells. The network writes check sizes ranging from $20,000 to $12 million.

Mr. Jordan Curnes is a Co-Founder and President of MicroTransponder, a medical device company specializing in developing implantable neurostimulation platforms. He is also a Co-Founder of Rent Like A Champion, a successful online sports rental business. Jordan is actively involved in the IrishAngels investment group, serving on the board. His past investments include companies like HomeChef, TradingView, Catalyst OrthoScience, and more. As an angel investor, Jordan collaborates with entrepreneurs, leads due diligence teams, and sources deals. His investment check size and partnership styles are not explicitly mentioned in the available data.

Elizabeth Walder is the President and Executive Director of Walder Foundation, a private family foundation with a mission to uplift local communities and elevate Chicago’s contributions to the world. Elizabeth and her husband, Joseph Walder, established organizations focused on science education, Jewish educational resources, and Jewish continuity in Chicago. They founded the Walder Foundation to support science innovation, environmental sustainability, performing arts, Jewish life, and migration/immigrant communities. In partnership and collaboration, the Walder Foundation awarded a generous grant to JCFS Chicago for the HIAS Immigration & Citizenship’s Refugee Resettlement Program. Elizabeth has a track record of supporting immigration causes and aims to support immigrants and refugees to thrive in society.

Henri Termeer has a track record of guiding the early careers of many industry leaders in the biotech sector. He is known for his constant vision of working together with smart people to solve healthcare problems. Henri Termeer’s investments typically focus on early-stage ventures in the biotechnology industry. He has made 11 investments, with notable exits such as Amylyx Pharmaceuticals. The check size of his investments is not specified. Henri Termeer’s partnership and collaboration styles are not detailed in the available information.

Venture-Med is an exclusive membership organization of accredited investors focusing on healthcare startups. Their previous investments include a total funding of $28M led by Endeavour Vision and RiverVest Venture Partners. They have a collaborative approach to decision-making with five stances ranging from Telling to Co-creating. The typical investment check size is undisclosed, with a recent funding round on Nov 23, 2021. Partnership and collaboration styles are based on a decision-making framework for leaders and teams, emphasizing input from team members for smoother decisions.

Martynas Gudonavicius is an angel investor and co-founder of Trafi, a mobility-as-a-service technology company. His investment focus areas include companies like Memby. He has a track record in leading Trafi and being an angel investor in companies like Oxipit and Memby. Martynas has invested in emerging markets and in companies like Memby at the seed stage. His collaboration style involves investing in and advising innovative startups in sectors such as medical imaging and education.

Paul Mai focuses on a Focused Equity Strategy aiming for capital appreciation by investing in companies with high returns on capital. His investment stage is primarily at the Seed level. His previous investments include Elation Media, a health and wellness multimedia platform. Paul Mai was nominated for the World Staffing Award in 2024 as a top leader in staffing. The specific investment check sizes are not available, and his partnership and collaboration styles are not detailed in the sources found.

Ben Nahir, Venture Principal at Elevate VC, is a neuroscientist-turned-investor with a data-driven approach to investments. He focuses on technology (software) and healthcare sectors, with check sizes ranging from $250k – $1M and valuations between $5-15M. Elevate VC has realized 4 exits to date, with successful investments like RFPIO and Brandlive. Ben Nahir and the team aim to make 5-6 new investments per year, preferring compelling problems and business models. Notable investments include TrovaTrip and Time Study. Elevate VC engages with portfolio companies to help them succeed by leveraging mentor capital. They are active in virtual investments and anticipate increased competition for investment dollars in the future.

Arrowhead Innovation Fund is a micro venture capital fund founded in 2017, focusing on seed and early-stage investments in high tech and enterprise applications. They have a portfolio of 13 companies, leading rounds in Parting Stone and Circa. The fund typically enters at the seed stage followed by Series A rounds. Notable investments include Champria and TNeuroPharma. The team includes 1 partner, Beto Pallares, and has co-investors like New Mexico Angels and NM Vintage Fund.

Anuj Pandey is an Angel Investor with a focus on Health-Tech startups. He has made investments primarily in India, with one known investment in LiveNutriFit during a Seed Round in February 2016. Anuj’s investment check sizes and partnership styles are not publicly disclosed.

Harley Bernstein is a seasoned investor with over 20 years of executive leadership and industry experience. He serves as the US Government Accounting Manager for Derco Aerospace, Inc. with a background in IT, Data Management, and finance. He has affiliations with the Board of Trustees of Milwaukee Institute of Art and Design and is a limited partner of Fortify VC. Harley’s investment track record includes funding Example Company Inc with $1,000,000 in a seed round and participating in Company & Company’s Series C funding with $11,000,000. He holds a CPA in Virginia and a Bachelor’s Degree in Finance from Boston University. His geographical focus is North America, specifically in Wisconsin. For partnership and collaboration, Harley brings extensive experience and expertise.

Charlie Banks is the co-founder and Managing Director of VentureSouth, an early-stage venture firm that operates in the Southeastern United States. They focus on investing between $250,000 to $1,000,000 in early-stage companies based in the Southeastern US with talented and determined management teams. VentureSouth has a track record of deploying over $80 million in more than 100 companies, striving for a 50% annualized rate of return over five years. Charlie Banks typically invests between $5,000 to $20,000 in companies at different stages, with a focus on sectors like Medical Devices, Space, Pharmaceuticals, Enterprise Applications, and more. Additionally, VentureSouth encourages collaboration among angel investors for successful investments.

James Reed is the Founder and Managing Member at Swan Venture Fund based in Bellevue, Washington. Swan Venture Fund focuses on pre-seed and seed stage investments in companies with great teams, meaningful traction, and a competitive advantage. Their geographic preference includes the Pacific Northwest. James Reed’s investment focus areas span across Real Estate/PropTech, Health & Hospital Services, Health IT, ClimateTech/CleanTech, Consumer Internet, FinTech, and Enterprise. Swan Venture Fund’s check sizes range from $200K to $1.2M, with a sweet spot at $600K. Additionally, the fund has a track record of investing in venture capital funds with proven high returns for limited partners. Unfortunately, specific details on partnership and collaboration styles were not found.

Angel Capital Association is an official industry alliance of over 100 of the largest angel investor groups in the United States. Since its founding in 2004, it has played a significant role in bringing together angel and venture capital industries, promoting networking, practices, and innovation in investments. Angel Capital Association invests in innovative firms across a range of industries, commonly focusing on software, medical devices, telecommunications, and manufacturing. The association tends to invest in seed, start-up, and early-stage businesses, and angels prefer to invest regionally or co-invest in a broader geography with trusted local investors. While specific previous investments are not disclosed, ACA members invested $650 million in 2020 with an average check size of $25,000. Angel Capital Association fosters partnerships and collaborations for angel investors and connects them with entrepreneurs and organizations to support investment opportunities. ACA serves as the public policy voice of the angel community, offering professional development, best practices, networking, and collaboration opportunities for angel investors.

Guneesh Batra is an Investment Manager at Ascension Ventures, specializing in providing M&A advisory services to companies in the medical device & diagnostics and healthcare services sectors. With a Master of Science in Finance from Washington University in St. Louis and a Bachelor of Arts in Quantitative Economics from the University of California, Irvine, Guneesh focuses on strategic acquisitions in the medical device sector. While his partnership and collaboration styles are not explicitly stated, his background suggests a hands-on approach to supporting companies in their growth and financial strategies.

Ohio Tech Angels is a venture capital fund located in Columbus, Ohio, with a focus on building wealth within Ohio by supporting high-potential startups in IT, software, bioscience, medical devices, and advanced materials. Their investments typically range around USD 325,000 per company, with a goal to attract strategic acquirers within three-to-five years. They collaborate with Rev1 Ventures and prioritize Ohio-based ventures for investment opportunities.

Ilya Nykin, Co-Founder and Managing Director of Prolog Ventures, has over 25 years of experience in new ventures as both an investor and entrepreneur. He co-founded technology incubator Metaphase and multiple healthcare-focused start-ups. With a master’s degree in applied mathematics, Ilya Nykin prefers to invest in startups with transformative solutions for infection prevention and control. His career began in 1984 with the co-founding of Ivy Technologies. His mantra is ‘better to act and then regret than fail to act and then regret.’ Ilya Nykin’s favorite book is The Master and Margarita, showcasing his diverse interests and rich experience in the startup ecosystem.

Matt Kopfensteiner is an investor and Associate at Sandbox Industries in Chicago, Illinois. He focuses on Digital Health, Health & Hospital Services, and Health IT at various stages including Seed and Series A/B. Matt works with a range of investment sizes from $1 million to $20 million, with a sweet spot at $10.5 million, and operates with a current fund size of $150 million. His previous investments include partnerships with other investors within Sandbox Industries such as Alex Behar, Amanda Donohue-Hansen, Andrew Boyd, Binoy Bhansali, and Bob Shapiro.

David Rhotert is an angel investor with a focus on Cloud Computing, Cloud Data Services, Health Care, and Medical sectors. He has a track record that includes investments in doxter, which was acquired by DOCTENA. David is based in Berlin, Germany and his investments have ranged from â¬250 to â¬10M with a sweet spot of â¬1M â â¬3M. As the Managing Director of Companisto GmbH, he has a partnership and collaboration style that involves managing investments led by elite teams and being drawn to promising opportunities.

MI-12 Ventures is a venture capital firm based in Pennsylvania Furnace, Pennsylvania, United States. The firm focuses on healthcare, medical devices, biotechnology, and digital health industries. They invest in early-stage companies with disruptive ideas in medical hardware, software, equipment, mobile apps, blockchain technology, nano materials, 3D printing, and IoT and AI applications. MI-12 Ventures is open to convertible notes, preferred or common stock, warrants, and options. They are interested in driving businesses towards a sale or IPO.

Paul McEwan, with over 25 years of experience, has a strong background in the life science tools space and is a co-founder of companies like Agencourt Bioscience and Kapa Biosystems. He has made 20+ investments in life science start-ups, including Watchmaker Genomics and DNA Script. Paul’s investment focus areas are in life science tools and start-ups. He has a track record of successful exits with combined exit values of $700M from his co-founded companies. His investments range in life science start-ups, and he has a CEO approval rating of 83/100, placing him in the Top 10% of similarly-sized companies. With a background in project and contract management at IBM and Shell, Paul’s partnership and collaboration style emphasizes effective communication, leadership, and achieving targets. His investment check size varies based on the company and opportunity.

Bioverge is a venture capital investor that recently invested in Enveda’s $51 million Series A round focused on harnessing nature’s chemistry. They have a thesis to invest in cutting-edge innovation at the intersection of biology and technology. Bioverge offers thematic funds for healthcare startups in areas like longevity, digital health, oncology, and neuro. Their investments span diverse companies including My Diabetes Tutor, Modulo Bio, Notable Labs, and more. The founders are Rick Gibb and Neil Littman, with a track record of impactful technology and healthcare investments. Bioverge Access Funds provide diversified exposure to healthcare startups with experienced professionals managing the portfolios. They facilitate streamlined diversification and prefer partnerships to access a spectrum of healthcare startups.

Sean Doolan focuses on the infrastructure software layer in healthcare. His investments are primarily at the pre-seed and seed stages. He has a geographical preference for the United States, particularly in Texas. Sean Doolan’s previous investments include Example Inc with a $1,000,000 investment in the Seed round. His check sizes for investments are in the range of a few hundred thousand. He espouses an earliest stage health VC approach, emphasizing collaboration and communication for effective impact.

Outsized Ventures invests in founders who advance humankind.

Ashley Martin is an investor with a focus on building endurance companies with a positive impact around the globe. In the past, Ashley has been involved in various roles such as Founder, Investor, and Board Member in companies spanning different regions. Ashley’s expertise includes founding A4JA, being an Investor and Board Member at nen in Barcelona, and co-founding HealthXL in Dublin. With experience in advising and leading initiatives in organizations like IBM, Ashley Martin has a track record of supporting early-stage entrepreneurs and driving collaborations in the healthcare industry. Ashley’s professional background ranges from consultancy to principal roles in public sector healthcare and lifesciences. Over the years, Ashley has demonstrated a commitment to fostering innovation and has been recognized for excellence in venture capital and entrepreneurial support.

Liquid 2 Ventures provides technology startups with seed-stage investments.

Todd French, Managing Director at Anser Capital Group, specializes in Healthcare Private Equity. Based in Los Angeles, California, Todd French focuses on investments in healthcare industries. His investment check size and partnership styles are not specified. His career background includes roles at AIG and Merrill Lynch in healthcare finance. Todd French’s track record includes expertise in M&A advisory and private equity ventures.

Mr. Christophe Chausson is the Founding Partner of Chausson Finance, leveraging over 30 years of venture capital experience. Prior to establishing Chausson Finance in 1992, he held leadership positions in two venture capital firms. Christophe has built an unmatched track record in fundraising and is actively involved as an Angel Investor and Advisor across various companies. His career commenced in the advertisement industry at Publicis and Euro RSCG, and he graduated from Paris Dauphine. Additionally, his geographical preference and partnership styles are not explicitly mentioned on the website for Chausson Finance.

Jens Spahn is an angel investor known for investing in promising companies. His investment focus areas include digitalization of hospitals. Jens Spahn has a track record in health politics. He has made investments such as taxbutler and supports collaborations to strengthen partnerships.

Christian Ehrhardt is an investor with a background in Linux performance at IBM Research and Development in Boeblingen, Germany. He has made investments in startups like Care to Translate. Christian Ehrhardt’s investment focus areas may involve health technology. The stage of his investments is not specified. His geographical preference is not clearly outlined. He has made investments in various startups. Christian Ehrhardt’s professional career includes improving Linux performance at IBM since 2004, with expertise in KVM on embedded PowerPC and System zEnterprise. The investment check size for Christian Ehrhardt is not provided. Regarding partnership and collaboration styles, Christian Ehrhardt’s approach is not explicitly mentioned, but he has been involved in collaborative efforts within the tech industry.

VentureWell is dedicated to fostering science and technology innovators to tackle global challenges. They support teams that have validated their business models and growth strategies, engaged with potential customers, and secured initial funding. VentureWell focuses on expanding opportunities for underrepresented groups in innovation and entrepreneurship, particularly Black, Latinx, Indigenous, and women individuals. While the specific investment stages are not listed, VentureWell offers seed funding to support early commercial ventures. Geographically, VentureWell works to build more inclusive pathways to innovation and entrepreneurship, enhancing diversity in the field. Their previous investments range from $100,000 to $1 million in startups focused on Medical and Biotechnology fields, with successful portfolio companies including Innoblative Designs and Infinite Composites Technologies. The team at VentureWell, led by professionals with diverse backgrounds, collaborates both internally and externally to drive innovation and foster equity in their endeavors. The check size of their investments reflects industry trends and the Southeast’s increasing average check size. VentureWell’s collaborative approach aims to spark partnerships within the organization and with external stakeholders to drive impactful change towards diversity, equity, and inclusion.

Anahita Nakhjiri, Investment Associate at Echo Health Ventures, focuses on Consumer Health and Digital Health across various stages including Seed, Series A, and Series B. She operates in the Seattle/Portland region with an investment range of $100K – $5.0M and a sweet spot of $1.5M. Anahita has a track record that includes roles in analytics, investor relations, and strategy & portfolio development. Her collaboration style involves working with co-investors like Dusty Lieb, Jessica A. Zeaske, Kurt Sheline, Lindsey Brown, and Matt Parmett, indicating a collaborative and supportive approach to investments.

Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.

Ryan McIntyre is a founding partner of Foundry Group with a background in venture capital and technology. His investment focus areas include developer-focused products, enterprise, and consumer-facing businesses. Foundry Group invests in early-stage technology companies at the $10.7m Series A equity financing stage. Geographically, Foundry Group invests in technology companies throughout the US and Canada. Ryan’s previous investments include Medialets, Topspin, and EmSense. He holds a bachelor’s degree in Symbolic Systems from Stanford University. Foundry Group’s investment check size is active and focused on startups. The partnership and collaboration style at Foundry involves working with a network of founders, operators, VCs, and Limited Partners.

KCRise Fund is a Kansas City-based VC firm investing in Seed & Series A stage technology companies in Kansas and western Missouri.

Peter Wyles, the Chief Executive Officer at Optovue, has a diversified professional background spanning the pharmaceuticals, medical devices, and consumer health industries. His expertise includes previous leadership roles at companies such as TRIA Beauty and Ventus Medical. Mr. Wyles holds an MBA from Thunderbird School of Global Management and a Bachelor of Arts from Pennsylvania State University. He is actively involved in the San Francisco Bay Area health care sector. With a focus on private equity stage companies, Mr. Wyles brings CEO experience in various regions including the United States, Japan, and Germany. His investment interests extend to medical device companies with private equity funding, emphasizing hands-on engagement and strategic partnerships for company growth. Investment Thesis: Focus on private equity stage companies, particularly in the health care sector. Investment Focus Areas: Medical device companies with private equity funding. Stage of Investment: Private equity stage companies. Geographical Preference: San Francisco Bay Area, West Coast, and Western US. Previous Investments: TRIA Beauty, Ventus Medical. Track Record and Professional Career: Extensive experience in CEO roles in pharmaceuticals, medical devices, and consumer health industries. Investment Check Size: Varies based on company needs and growth potential.

Khan Siddiqui is an entrepreneur, physician, and innovator with a strong background in healthcare IT, medical devices, and supply chain solutions. He is the Founder, CEO, and Chairman of HOPPR, a company focused on transforming medical imaging through AI. Khan Siddiqui’s professional career includes roles as Founder of Althea Health and EyeCheq, Co-Founder Casana, and Advisory Board Member for various companies. With expertise in Artificial Intelligence, Large Vision Models, IoT in health, and more, Khan brings a wealth of experience to his investment ventures. His track record showcases a dynamic and enthusiastic leader dedicated to advancing healthcare technologies globally.

Thomas Goebel is a Principal at Omega Funds with over 10 years of experience in venture capital investing in healthcare in Europe. He has a background as a global biotechnology analyst and holds a PhD in molecular biology. Thomas’s track record includes managing funds for NeoMed and advising on new investments for Omega. While specific investment thesis and check size details are not provided, his focus on healthcare and extensive experience in the field showcase his expertise. His partnership and collaboration styles are evident in his role managing funds and advising on investments, showcasing his collaborative approach within Omega Funds.

Rianne Ellenbroek, Investment Manager at FIRST Fund at BGV (BioGeneration Ventures), focuses on early-stage investments in biotech, medtech, and diagnostics companies. Her investments include companies like Phlox Therapeutics, Scenic Biotech, TargED Biopharmaceuticals, VarmX, and VectorY. Rianne’s check sizes typically align with early-stage funding ranges. She demonstrates a collaborative style, engaging with partners to foster growth and innovation in life sciences ventures.

Cowtown Angels is an elite Angel Investor Network based in Fort Worth. They invest in diverse startups across various sectors such as medtech and life sciences. With a unique success story like Encore Vision’s $465M exit, they offer superior returns and excitement to their accredited investors. Members can participate in ‘Deep Dive’ or ‘Forum’ sessions. Their investment check size, partnership and collaboration styles can be further explored through their portfolio and sponsored information.

Hans-Jürgen Even, an investor at Project A Ventures, focuses on investing in Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Series A), Digital Health (Seed), Digital Health (Series A), BioTech (Seed), Health IT (Series A), and Health IT (Seed) sectors. He typically invests in the range of $200K to $10.0M, with a sweet spot at $5.0M. His previous investments include companies in these sectors and stages. Even has a proven track record of success and brings valuable expertise to the companies he invests in. The check sizes for his investments can vary between $500K to $1.5M. His partnership and collaboration styles are characterized by effective communication and equal terms with the stakeholders.

Christoph Massner is an Investment Professional at Earlybird Venture Capital, focusing on European healthtech companies. The investment thesis revolves around delivering robust patient outcomes through investments in digital health, diagnostics, medical devices, R&D tools, and biopharma. Christoph Massner’s investments target companies from early stages up to regulatory approvals and commercialization. Notable previous investments include ImCheck Therapeutics, Oculis, Grey Wolf Therapeutics, and Ariceum Therapeutics. Earlybird Health utilizes the Eagle Eye technology for effective deal sourcing and has public health insurers as cornerstone investors. Christoph Massner manages a fund of â¬173 million for health technology investments, supporting companies in improving patient outcomes. The fund’s check size is around $185 million, with a significant increase from the initial round to fuel healthcare innovations.

David Whelan is a Founder and General Partner at Town Hall Ventures. He previously served as the Managing General Partner of the Oxeon Venture Studio and has a background in finance and corporate development. Town Hall Ventures, under his leadership, focuses on transforming the U.S. healthcare market through technology. David’s investment check size and specific partnership and collaboration styles are not explicitly detailed on the website. He is based in New York, NY and finds inspiration from his family, enjoying surfing with his son in Montauk.

Tim Kane is an economist, author, and public speaker. He has led military units, for-profit companies, and non-profit teams. Tim Kane’s professional career includes positions such as Chief Economist at Hudson Institute, Director at The Heritage Foundation, and Senior Fellow at Kauffman Foundation. He holds a Ph.D. in Economics from UC San Diego and a Bachelor of Science in Economics and Political Science from the United States Air Force Academy. Currently, he serves as the President of The American Lyceum, a think tank focused on innovative research and non-partisan debates.

Roland Oetker is the Managing Director of ROI Verwaltungsgesellschaft mbH, focusing on high tech companies, including biotech and medtech. He invests in the seed stage and has previous investments in evocatal GmbH. His partnership and collaboration style involves transforming spaces collaboratively, prioritizing clients’ needs, aesthetics, and budget constraints.

Dr. Donald Brown, an accomplished investor, has a diverse track record. His investments include Glia and Lumavate in sectors like Enterprise Applications and FinTech. He has a particular focus on collaboration styles. Donald Brown also co-founded Interactive Intelligence Group, providing Unified Communication Solutions. His check size for investments varies based on the opportunity. With a strong background and experience, Donald Brown exhibits a strategic and collaborative partnership style in his investment approach.

Melissa McCracken, Ph.D., is a scientist with a passion for emerging technologies in cancer therapies. She joined Nextech Invest Ltd. in 2019, a global venture capital firm based in Zurich, Switzerland, focusing on oncology therapeutics. Nextech Invest invests in drug discovery companies in the US and Europe, supporting them through each critical stage of development and growth. Melissa’s previous investments include companies like A2 Biotherapeutics, Autolus, Blueprint Medicines, and Kura Oncology.

Fred Ahlberg is an Angel Investor with a focus on surgical science. His investment thesis involves supporting businesses with an established reputation within the surgery and medical education community. He typically invests in early-stage technology and life sciences startups. The geographical preferences or areas of investment for Fred Ahlberg are not specified. In terms of stage of investment, he is known to primarily invest in early-stage technology and life sciences companies. While his previous investments are not disclosed, his track record includes championing efforts within the surgery and medical education sectors.

LRVHealth is an ,ÄúInside Healthcare,Äù venture capital platform established in 2000 by a team of healthcare investors, operators & advisors

Leo De Luna is a Principal at Split Rock Partners, focusing on later stage and secondary investments. Split Rock Partners primarily targets opportunities in software, Internet services, and healthcare. The firm has raised $575 million over two funds since 2005. Leo De Luna’s previous experience includes positions at Saints Capital, St. Paul Venture Capital, Lehman Brothers, and Advanced Micro Devices. Representative investments by Split Rock Partners include companies like 8thBridge, Ardian, Atritech, Compete, eBureau, Evalve, Flycast Communications, HireRight, Intacct, LowerMyBills, MyNewPlace, QuinStreet, SPS Commerce, and Tornier.

Una Ryan is the Managing Director of Golden Seeds, an angel investing group focused on women-led companies, with a background in developing vaccines, immunotherapeutics, and diagnostics. She holds a Ph.D. in Cellular and Molecular Biology from Cambridge University. Una Ryan has made several investments, including RenovoRx, Boston University School of Medicine, Diagnostics For All, Cortexyme, and Management Sciences for Health. She has been actively involved in events and has a partnership and collaboration style that involves supporting startups as a board member and individual investor.

Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.

Karel Doerner is an individual angel investor with a seed-stage investment focus. He has made investments in startups such as Montredo and amiando, with a preference for the European Union (EU), Europe, Middle East, and Africa (EMEA) regions. Karel’s investment check size is undisclosed. His partnership and collaboration style involves actively engaging with tech and analytics capabilities to enhance client impact through AI/ML and working collaboratively on shared workspaces for different tasks.

Michael Charles Dearing is an investor known for his investment thesis of turning experts inside larger companies into startup founders, focusing on comparative advantage. His past investments include health tech companies like Grand Rounds Health and PagerDuty. Dearing has a track record of success in startups and emerging growth companies. He has been involved in investing as well as operating a management education program for tech up-and-comers. His investment check size and partnership styles align with seed- and early-stage technology companies, serving the consumer and small business markets. Some of his previous investments include Aardvark, AdMob, DocVerse, Lumos Labs, Polyvore, TownMe, and Widgetbox.

Jonathan Bik is an impact investor based in Chicago, Illinois. As a Senior Associate at J-Impact Fund, he focuses on investing in various sectors at the seed stage, including Wellness & Fitness, Future of Work, Impact, Medical Devices, AgTech, TransportationTech, Education, ClimateTech/CleanTech, Digital Health, and FinTech. Jonathan’s investment range typically falls between $250K to $750K, with a sweet spot around $500K. With a background at the University of Chicago Booth School of Business and experience in the Israeli Navy, Jonathan has a diverse skill set that enriches his investment approach. His professional career includes roles such as Head of Missiles and Vessels Navigation R&D in the Israeli Navy. Jonathan Bik’s commitment to impact investing and diverse founder support sets him apart as a valuable investor in the startup ecosystem.

Mr. Peter Hotz is a seasoned entrepreneur and business leader who thrives on supporting emerging health care businesses. He is the Co-founder and Managing Director of Vynamic X, an early-stage health care investment platform. His specialties include Business Development and Sales Management, Financial Advisory Services, Interim & Turnaround Management, Strategic & Operational Consulting, and Executive Recruitment. He holds a B.A. in Economics from Ursinus College and an MBA in Marketing from the University of Maryland. Peter has served as a consultant, mentor, investor, and board member to several emerging and established innovators. Some of the companies he has been involved with include: EXOS, Inpatient Medical Services, Blueprint Health, and Startup Health. Additionally, Peter was Group Vice President and President of Walgreens’ Take Care Health Systems, and Executive Vice President/Chief Operating Officer of CHD Meridian Healthcare. He also founded and served as Managing Director at 5 Cap Ventures.

Roy Martin is the President and CEO of WELM Ventures, LLC. He focuses on industries like Information, Data, Media and Publishing, Software as a Service (SaaS), Data Analytics, Legal/Tax & Accounting, Healthcare, and Medical Device. WELM Ventures prefers companies with revenues ranging from $500,000 to $5 million. Their investment size ranges from $100,000 to $750,000, primarily in equity (common and/or convertible preferred stock) and Mezzanine. Roy Martin’s geographical preference is national, with a focus on Minnesota companies. They do not invest in retail, consumer products, service, or franchise businesses. The expected exit or liquidity potential is within 3-5 years. Roy Martin’s professional career spans various executive roles within companies like Thomson Reuters and Truven Health Analytics, showcasing his strategic leadership and growth achievements.

Nebraska Angels is an angel network comprising 100+ investors dedicated to investing in early-stage companies with ties to Nebraska or the Midwest region. They seek opportunities with large market potential, innovative solutions, and experienced teams. Investments range from $120,000 to $545,000+. Nebraska Angels has made 47 investments, with recent investments in Sentinel Fertigation. The team includes President John Brasch. Led by Executive Director Steph Luebbe, Nebraska Angels collaborates with Invest Nebraska and actively supports economic development and job creation in the region. Their partnership style involves engaging with entrepreneurs, supporting funding resources, and participating in the state’s entrepreneurial ecosystem.

Brainstorm Ventures is an early-stage venture capital firm that invests in disruptive technology companies.

Cairn Cross, Co-Founder and Managing Director at FreshTracks Capital, focuses on investments in various sectors such as Advanced Manufacturing, B2B Software, Consumer Products, Energy, Food & Beverage, Health & Wellness, Medical Technology, and Technology. He is actively involved in the boards of portfolio companies like NativeEnergy, Faraday (Chair), and Mamava. Cairn’s investment check size ranges based on the specific startups. He values partnerships and collaboration, evident from his role as a lecturer at the UVM Grossman School of Business, teaching Financing Sustainable Innovation. Cairn’s geographical preference is primarily focused on Vermont and the New England region. Additionally, his professional career includes being named the Vermont, New England, and National Financial Services Champion by the United States Small Business Administration in 2011. He holds a Bachelor of Science from Montana State University and an MBA from Southern New Hampshire University. Contact information: P.O. Box 84929 Harbor Road, Suite 200, Shelburne, Vermont 05482, Phone: (802) 923-1500.

Eckhardt Weber is a Founding Managing Partner at Heal Capital, a venture capital firm based in Berlin. Heal Capital invests in HealthTech startups from Seed to Series A with check sizes ranging from â¬1-5 million. Eckhardt Weber’s professional career includes his role at Heal Capital, where he collaborates with a team to back mission-driven founders with capital. Previous investments at Heal Capital have involved a team of various professionals, suggesting diverse involvement in startup funding. Partnership and collaboration styles include working with a team at Heal Capital, indicating a collaborative approach to investments.

Hugo Barra is an investor who has made 13 investments. His latest investment was in Medivis as part of their Series A. He has invested in companies like Medivis, Coderhouse, and Osmo. His co-investors include notable names like Bob Iger, Coalition Operators, and Initialized Capital. Hugo Barra’s investments range from Series A rounds to Seed VC rounds, with undisclosed amounts in some cases. He collaborates with diverse co-investors and brings a wealth of experience from his previous roles at Meta and Xiaomi.

Paul Nowak is an entrepreneur and Senior Product Manager at Housecall Pro. He has a past role as the Co-founder and CEO of Contellio. Additionally, he is an Advisory Board Member at PressPad. Paul’s career includes experience in digital publishing and content marketing strategies, emphasizing mobile reach. His professional background reflects a focus on product management and advisory roles in tech companies. While specific investment focus areas and check sizes are not provided, his track record suggests involvement in tech startups and publishing ventures.

Dan Walker is an Angel Investor at Angel Physicians Fund with a focus on Seed Round investments. Some of his previous investments include Example example company Inc, Company & Company, and Example. His investment check size ranges from $5K to $50K, with a sweet spot at $25K. He is known for investing in therapeutics, medical devices, pharmaceuticals, marketplaces, bioTech, digital health, health & hospital services, and health IT at the Seed and Series A stages. Dan Walker is affiliated with Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high-growth, early-stage companies. They focus on industries like Biotechnology, Health Care, Therapeutics, and Medical Device Manufacturing. Their typical investments range from $250K to $1.5M, with a check size between $25,000 and $500,000. Boston Harbor Angels engages in early-stage venture, late-stage venture, and seed investments. They primarily invest in the U.S. and Canada, with an emphasis on startups aged between 4-5 years. Some of their previous investments include Daktari Diagnostics, KnipBio, and Vizibility. The team was founded in 2004 by Mic Williams.

Lionel Carnot, a Director/Board Member at OCULIS HOLDING AG, has a track record in various roles including Managing Director & Advisor at Bay City Capital LLC, Director at iSTAR Medical SA, Priothera Ltd., and more. With a focus on medical-device companies, biotechnology, diagnostics, and specialty pharmaceuticals, Lionel has made investments in companies like Oculis, Priothera, and Merus, with investment check sizes ranging from $100K to $5.0M. He has a history of collaboration and partnerships within the healthcare and investment sectors.

SP3NW / WSU, through its programs, supports WSU’s mission by connecting community to academia, entrepreneurs, and innovators. Their investment focus areas include corporate, intellectual property, and technology-focused business incubation. They have invested in WSU research and innovation into biotech, pharma, diagnostics, and medical device companies. SP3NW / WSU’s collaboration styles involve engaging with various service providers and organizations, focusing on economic development, entrepreneurship, and innovation.

Mavericks Founders is an early-stage investor and syndicate of angel investors based in Berlin, Germany. They focus on investing in startups that challenge the status quo and seek founders with unique visions. Their investments include companies like Dr. SAM, with a particular interest in innovative ventures like Data:Lab Munich and FlixMobility. Mavericks Founders prefer early-stage and seed ventures, typically providing checks of various sizes. They have a geographical focus on central regions, including Singapore and the United States. The partnership and collaboration styles at Mavericks Founders involve strategic investments and co-investing with other established firms.

Incentive Technological Incubator, Israel’s first privatized Incubator, focuses on investing in life-changing healthcare opportunities to enhance patients’ quality of life. They support portfolio companies at every stage of the lifecycle, offering valuable knowledge and assistance in building successful business strategies, forming strategic alliances, recruiting strong teams, and bringing healthcare innovations to fruition. Their commitment is to partner with entrepreneurs, identify promising ventures, and achieve exceptional results.

Sridhar Murthy is a Chief Executive Officer with experience in enterprise software and SaaS offerings. His professional career includes leadership roles at companies like Analyte Health and TicketsNow.com. His investment focus areas include Health Care, Medical, and Personal Health, with previous investments such as Retrofit. His track record showcases over 18 years of leadership in high-growth technology companies. Regarding investment check size, investments typically range from $250K to $5M. Collaboration styles and partnership preferences were not specified.

Dan Matthews is an Angel Investor with a focus on micro-chip coding expertise and significant business experience in various countries. He serves as President, COO, and Design Engineer at Meridian Design, and is a Board Member and Advisor at Lumeter Networks. He has made investments in companies like Example Company Inc and Example, with amounts ranging from $524,000 to $1,000,000 in seed rounds.

Joe Spivack is an angel investor with a diverse investment thesis. With extensive experience in financial services, Joe shows particular interest in technology, medtech, foodtech, cybersecurity, and niche products. His previous investments include ventures like Inside.com, Axle.ai, DoraHacks, and Cloudastructure. Joe typically invests in startups at the seed stage, offering investments ranging from $500 to $1,000. Based in Closter, United States, he has been an active investor since October 2017 and is recognized as a value-add investor. Joe’s collaborative style and focus on emerging technologies make him a valuable partner for startups seeking growth and mentorship opportunities.

Diede Brunen is a Principal at BioGeneration Ventures with an extensive background in translational biomedical research, oncology, and immunology. He holds a PhD and has a strong track record in identifying novel synthetic lethality targets. Diede has played a significant role in deal flow management and company creation at BGV, working on companies like Artica Therapeutics, Confo Therapeutics, Dunad, Genase Therapeutics, Tessellate Bio, and Tiga TX. His investments are focused on innovative therapies for autoimmune disorders, small molecule inhibitors, and therapeutic monoclonal antibodies. Diede’s investment check size and specific geographical preference are not explicitly mentioned on the BGV website.

Ritsaart van Montfrans is the CEO of Incision, a medical education platform offering standardized surgical procedure methods. The platform focuses on sharing experiences, skills, and expertise for rapid and thorough preparation. Incision aims to standardize surgery to enhance the quality of surgical care through global professional collaboration. Ritsaart van Montfrans has a later stage VC focus, investing in companies like Incision. He has previous experience as a partner at H2 Equity Partners in Amsterdam. His investment check size varies, with a recent equity investment of â¬3 million in Incision. Geographically, Ritsaart van Montfrans shows a preference for healthcare investments across Europe, MENA, and the US. His collaboration style emphasizes partnerships with leading European surgeons to map variations in surgical procedures for improved outcomes.

Frank Dale is the Senior Vice President Of Product Management at Salesloft. Leading the way in the supply of frozen premium products, Frank Dale bounced back post-COVID with a £400,000 investment in new equipment. Previous investments include Costello, acquired by SalesLoft. His professional career includes serving as the CEO or COO at investor-backed software companies. There is no specific information available on Frank Dale’s investment focus areas, check size of investments, or partnership and collaboration styles.

M. Michele Burns is an American businesswoman who has served on the boards of major companies like Cisco Systems, Wal-Mart, and Goldman Sachs. She was the chairman and CEO of Mercer between 2006 and 2011. Michele supports the Democratic Party and has made donations to EMILY’s List. In addition to her corporate roles, she sits on the Boards of Trustees of the Atlanta Symphony Orchestra and the Elton John AIDS Foundation. Michele received a Bachelor of Business Administration and a Master of Accountancy from the University of Georgia. She has a successful track record and has significant experience in financial leadership roles at companies such as Arthur Andersen, Delta Air Lines, and Mirant. In 2010, she earned $4,648,029.00.

Bessemer Venture Partners is a venture capital firm that invests in enterprise, consumer, and healthcare early-to-late stage startups.

Jeff Aiello, Managing Director at Thompson Street Capital Partners, specializes in investing in Series B Enterprise Infrastructure, Medical Devices, Pharmaceuticals, Enterprise Applications, Consumer Health, Digital Health, BioTech, AI, and Health IT. His investment check size ranges from $5.0M to $50.0M, with a sweet spot at $25.0M. Jeff has a track record in film production, known for works like Motion (2009) and Afterburn: The Creek Fire Documentary (2021). His investment approach emphasizes collaboration and ranges across various sectors and regions within the USA, including the Midwest. He holds an MBA from the University of Pennsylvania – The Wharton School, and has experience at Thompson Street Capital Partners, Audax Group, and in the United States Air Force.

Barry Fingerhut, as the Co-Founder and General Partner of Wheatley Partners, heads a New York-based private equity firm established in 1992. Wheatley Partners specializes in funding technology-related companies across various sectors, including information technology, business services, medical technology, healthcare, and education. The firm is actively involved in supporting portfolio companies at all stages of development, providing multiple rounds of financing. Barry Fingerhut has been part of 55 investments with 24 exits so far. Wheatley Partners’ investment focus areas encompass a wide range of industries, and they have a geographical preference for regions like the Greater New York Area and the East Coast. The firm’s standard check size and partnership/collaboration styles were not explicitly mentioned, but the email contact provided indicates an openness to communication and potential collaborations. Barry Fingerhut’s professional career includes a successful track record in the private equity and venture capital space, actively contributing to the growth and development of numerous startups.

Cornelia Hoppe is an investor with a focus on HealthTech, specifically investing in companies like Exakt Health. Her investments are primarily in Seed Rounds, and she has a track record of investing in startups in Germany. Cornelia has made several investments, such as in Exakt Health and eaze, with check sizes ranging from â¬500,000 to â¬1.7 million. She is known for her investments in the HealthTech sector and her collaborative approach in co-investing with other entities like Auxxo and Possible Ventures.

Jay Silverstein is known for making strategic investments and often collaborates with promising companies in the health sector. He focuses on early-stage companies and invests personal money in exchange for equity. His check size for investments varies and he has a track record in the US health industry. Silverstein’s previous investments include companies like Picwell. His geographical preference and partnership styles are not explicitly mentioned in the search results.

Khaled Badr-El-Din’s investment thesis is in health tech (software + data)

Ryan Malas, an Associate at LOUD Capital, focuses on fueling innovations that drive equitable access to high-quality, inclusive healthcare through investments in people-centered healthcare, including medtech, alternative care models, and healthcare infrastructure and IT. Some of his previous investments include Genetesis, Share Mobility, OFFOR Health, Hyperion Motors, Inc., LiveEasy, Carely, Raydiant Oximetry, 10XTS, Honest Game, Pay Theory, Medzoomer, SupplyHive, Revibe Technologies, Knowwake, Gemelli Biotech, GiftHealth, Carallel, and Beyond Physician. LOUD Capital’s investment check size and partnership/collaboration styles are not specified on their website. Ryan Malas’ geographical preference spans North America and LATAM. For more information, visit LOUD Capital’s website at [loud.vc](https://www.loud.vc/).

Matt Jessen-Howard is an investor with a diverse portfolio focusing on sectors such as Mobile, Consumer Internet, Enterprise Software, Healthcare, Clean Technology, and SaaS. He invests across stages including Pre-Seed, Seed, Series A, and Series B, with a typical check size of $100k. Matt’s geographical preference is not specified, but he has shown interest in a wide range of sectors. Unfortunately, specific details about his previous investments, track record, and partnership styles are not available.

Ryan Slack is an investor with a focus on Real Estate and Construction Tech and Enterprise Applications sectors. His investment thesis revolves around maximizing successful internet entrepreneurs by capitalizing on the Deployment Age of Software. Ryan Slack has a track record of success in sales and has experience as a Sales Manager and Rural Indirect Sales Manager at T-Mobile. His check sizes for investments range from $150K to $1.5M, with notable investments in CompStak and redIQ. Additionally, Ryan Slack has collaborated with companies like Salesforce to enhance customer collaboration and integration of tools.

Thomas Melcher is an Angel Investor focusing on Seed Round investments in Real Estate Technology, SaaS, and Technology, Media, and Telecom (TMT) industries. He has made investments in various companies, such as Example Company Inc and Company & Company. Thomas Melcher is a seasoned professional with a strong track record in wealth management and investments. His check sizes range from $1,000,000 in a single investment to â¬11,000,000 in Series C funding. Geographically, his investments are mainly in North America. As a Co-Founder and CEO of Show-Score, his strategic partnerships and collaboration styles reflect his background in theater and technology, leveraging his experience from successful companies like CNET and MongoDB.

Matt Dunbar emphasizes the importance of having an indispensable product or service, effective communication with investors, and adaptability for startup success. VentureSouth focuses on the Southeastern United States, particularly the Southeast, with a preference for early-stage investments. Matt Dunbar, the Co-Founder and Managing Director, has supported 76 companies since 2008, deploying over $50M in capital. The geographical preference is the Southeast region, with an emphasis on South Carolina. Partnership and collaboration styles prioritize transparency, trustworthiness, adaptability, and credibility.

Craig Albrecht typically invests as Co-Chief Executive Officer & President at Betallic.

Christin Godale is a Director at CincyTech USA, focusing on investments in Seed Digital Health, Digital Health (Seed), BioTech (Seed), and Female Investors within the Midwest. She has a broad investment range from $100K to $5.0M, with a sweet spot at $1.5M. Specifically targets the $1.5M range. Christin collaborates with co-investors Carl Labanz, John Rice, Sarah Douglas, and Sean Kwiat. She has a background in Neuroscience and actively invests in the identified areas.

Highland Capital Partners is a venture capital firm that offers seed, early, and growth-stage funding solutions.

Kevin Hoffberg is a Venture Partner at Ulu Ventures, a venture capital firm focused on funding women and diverse founder teams with deep connections to Stanford and Silicon Valley. Ulu Ventures emphasizes diversity and data-driven decision-making in their investments, having led over 85 deals, funded 200+ firms, with 10 unicorns and 9 exits. Kevin Hoffberg’s investment check size, stage of investment, geographic preference, and partnership style are not explicitly mentioned on the website.

Mohan Chennupati is an entrepreneur with a focus on building beatandraise.com. His investment focus areas are not explicitly mentioned. He has been involved in equity research and investments to build his investment thesis. The stage of his investments seems to be in the early stage, involving investments in startups. His geographical preference includes the European Union, Europe, Middle East, and Africa. Previous investments include Iterative Works GmbH and UniCredit. Unfortunately, specific details about his track record, investment check size, and partnership and collaboration styles are not available from the sources researched.

Elizabeth Cutler is an angel investor with a focus on Seed Round investments. She has made 10 investments, with a check size of $4.25 million in her latest investment. Her geographical preference is not explicitly mentioned. Some of her previous investments include Ando, Epic CleanTec, and by Humankind. Elizabeth Cutler is renowned for co-founding SoulCycle and serving as its Co-CEO, known for revolutionizing the fitness industry. Her partnership and collaboration style is emphasized through projects like Peoplehood, aiming to tackle the loneliness epidemic.

Patrick Shannon, an Executive at Lifeforce Ventures, invests in software companies reshaping the status quo in healthcare’s largest markets. His investments primarily focus on healthcare software innovations. Specific investment focus areas include reshaping the status quo in healthcare’s largest markets. The investment check size ranges around $36 million. Partnership and collaboration styles are not specified on the website.

Kyto Technology and Life Science Inc., operating as K2X Technology & Life Science, Inc., focuses on creating an ETF-like vehicle of diversified and vetted startups for global investors. They target the top <10% of startups, investing in angel-stage startups globally. With a Silicon Valley base, the company is managed by experienced angel investors. Their investment approach ensures a safer, higher-return, non-correlated, and liquid investment in startups. They prioritize double-vetting of all investments. Although the investment check size is not specified, their investment thesis emphasizes providing a diversified and safer investment option in startups. Partnership and collaboration styles are not explicitly mentioned.

Dr. Georg Ried, the Managing Director at Bayern Kapital, focuses on software, bioscience, healthcare, and pharmaceutical sectors. He invests in early-stage ventures in the Bavarian high-tech segment. Some of his previous investments include Ondeso, Mecuris, SimScale, and Veact. Dr. Ried has a successful track record in the venture capital industry. The investment check sizes vary based on the specific opportunity. His partnership and collaboration style involves creating collaborative partnerships with organizations to achieve mutual goals.

1809 Capital is a financial focused investment firm.

Kevin Durant, the founder of Thirty-Five Ventures, has a net worth of $75 million and has invested in more than 40 companies, including Postmates and Acorns. His investment focus areas include sports-related businesses, franchises, and cannabis-related businesses. Previous investments through Thirty-Five Ventures include companies like Goalsetter, Fractional, and Hugging Face. In 2019, Durant earned $35 million solely from his off-court investments. Additionally, he has an investment arm, the Durant Company, making early-stage investments ranging from $250,000 to $1 million in approximately 30 companies, including Coinbase, Acorns, Rubrik, and Postmates. Durant is selective with endorsement deals and expresses interest in owning an NBA team in the future.

Ariel Southeast Angel Partners is an angel investment group that invests in a variety of high-growth areas. They focus on bio-technology, medical devices, health care, therapeutics, and life science. The stage of investment is in start-up and early-stage companies. Their geographical preference is in Savannah, Georgia. Some of their previous investments include bio-technology, medical devices, and health care startups.

Samsara Biocapital, LLC provides investment advisory services.

Dr. Janice Gabrilove is an Angel Investor at Easton Capital Investment Group. She is board certified in Internal Medicine and Medical Oncology, serving as a Scientific Advisor. She has patents related to medical treatments and has advised biotech companies. Dr. Gabrilove’s investment thesis focuses on the healthcare and biotech sectors. However, specific information about her investment stage, geographical preference, previous investments, and check size is not available.

Amrinder Singh is a Partner at Vensana Capital with a background as a Senior Investment Director at Medtronic Ventures. He focuses on transformative medical technology innovations with investments in Series A to growth stages. Amrinder’s geographical preference is not specified. His partnership and collaboration style emphasize business news, profiles, and deal flow coverage. The investment check size for his investments is not explicitly mentioned on the website.

Morten Lund is an investor with a diverse investment focus, specializing in high-tech startups. He has co-invested in over 100 startups, including early investments in Skype. Morten Lund’s check size for investments is substantial. His partnership and collaboration styles emphasize the promotion of collaboration for platforms leveraging data in various sectors.

United Investors is an Angel Group, Micro VC, and Syndicate investing in early-stage ventures, the secondary market, seed, and venture stages. Their investment focus includes medical devices, healthcare, manufacturing, and other healthcare technology systems. Some of their previous investments include Qvalon, imin, and Mo: Meditation & Sleep. They are known for being one of the largest venture syndicates for Russian-speaking angels and VCs, with about 600 members since 2019. Contact email: a@unitedinvestors.ru, Phone: 8(499)350-07-47, Website: unitedinvestors.ru.

Aga Manhao, Co-Founder and Managing Partner of Future Health, is an angel investor with a focus on early-stage healthcare technology startups in Asia. His investment thesis revolves around improving healthcare quality and accessibility through innovative diagnostics, telemedicine, wellness, and more. Future Health primarily invests in HealthTech companies expanding into Asia. With a track record of successful listings and extensive global experience, Aga is positioned to guide startups through growth. The investment check size ranges for startups, offering a platform for pooled funds and risk-sharing. Aga emphasizes building networks and ecosystems to support entrepreneur growth in the healthcare technology sector.

Stefan Muehlemann is an Angel investor with a hands-on approach and a passion for sustainable investments. He focuses on Pre-seed stage startups in sectors such as Medical Devices, Consumer Health, and Health IT. Stefan typically invests between $5,000 and $50,000 per company, with a sweet spot of $25,000. His professional career spans over 25 years in banking and finance, and he holds an M.B.A. from Dartmouth College. As the Co-Founder and Director of Loanboox, Stefan brings a valuable network of investors and borrowers. Additionally, he is associated with redalpine, a Swiss venture capital firm specializing in empowering GameChangers. Stefan’s partnership and collaboration style is geared towards empowering ambitious entrepreneurs to convert their vision into reality through financial investment and operational expertise. redaljsonpine, where Stefan is part of the board, has over 85 companies in its portfolio and invests Europe-wide from Zurich and Berlin.

Amanda Stenbaek is an Associate at INKEF Capital, with an investment range of $100K to $5.0M and a sweet spot of $1.5M. She focuses on Seed BioTech, Digital Health, Health & Hospital Services, and Health IT. Amanda has a track record of investing in startups and collaborating with co-investors like Alice Vickers, Carien Beyer, Corné Jansen, Estelle Botbol, and Ivan Burkov. She operates within a fund size of â¬500M.

Bettina Ernst, Vice President and CEO of BERNINA BioInvest, focuses on investing in healthcare companies with an investment range of $100K to $5.0M, particularly in Seed Pharmaceuticals, Digital Health, BioTech, and Health & Hospital Services. Her sweet spot for investments is $1.5M. She has invested in companies like SunRegen at Series A stage. Bettina is actively involved in the Swiss Biotech scene, serving on various boards and being a co-founder of two biotech companies. With a background in immunology and natural science, she brings a wealth of experience to her investments.

AME Cloud Ventures invests in seed to later-stage tech companies that build infrastructure and value chains around data.

Thomas Hirschfeld serves as Chief Operating Officer at Halcyon Asset Management, with a history of leadership roles in prominent firms, including Managing Director at J. & W. Seligman & Co. and Partner at Patricof & Co. Ventures. His investments focus on Digital Health/Healthcare Services. Previous investments include MedPilot and Goldilock. He has an extensive professional career in investment banking and venture capital. The investment check size is not available from the sources. Thomas Hirschfeld’s partnership and collaboration styles are not directly mentioned in the search results.

Simon Kreitmair is the CFO of Dolpheen Global. He has a background in finance and technology, with experience in companies like Qualysoft and Tricentis. He holds a certification as a Test Design Specialist for Tricentis Tosca. Kreitmair pursued Informatik at Fachhochschule Technikum Wien.

Dr. Gabriel Otte is an Angel Investor focusing on SaaS startups. He is known for investing in early-stage companies at the seed round. His geographical focus includes San Francisco, California, where he is based. Gabriel Otte has a professional background in mobile development, technology, and machine learning, with a significant presence in the healthcare sector through Freenome. While he does not have specific data available on previous investments or check sizes, his partnership and collaboration styles reflect a strong commitment to advancing early cancer detection technologies through innovative biomarker studies. His track record includes leadership roles as CEO and Co-Founder of Freenome, showcasing his expertise in healthcare innovation and entrepreneurship.

Gopher Angels is an angel investment firm based in Minneapolis, Minnesota. They focus on investing in scalable, early-stage companies in diverse industries, including healthcare, health IT, enterprise and SaaS, food and beverage, medical devices, agtech, and more. The firm prefers to invest in companies at the Seed and Round A stages. Gopher Angels has a track record of supporting companies like CoreBiome, Dispatch, StemoniX, Upsie, and others, with investments typically ranging around $350,000. Their collaboration style involves providing financial support and expertise to early-stage businesses. Although specific details about their investment thesis, geographical preference, and partnership styles were not directly available on their website, their investments and focus areas demonstrate their commitment to fostering entrepreneurship and innovation.

Pillar VC invests in seed-stage companies in Boston, supporting unstoppable founders with capital, connections, coaching, and peer support.

Engage Venture Partners, led by Ryan Spanheimer, focuses on investing in the medical device, digital health, healthcare information technology (IT), and healthcare software as a service (SaaS) sectors. They prefer seed to Series A stage companies in Minnesota and the Midwest region of the United States. Specific information on geographical preference, previous investments, track record, investment check size, and partnership styles was not found.

Gretchen van Steenwyk is a Biotech Investor with an investment range of $100K to $5.0M, specializing in BioTech and Health & Hospital Services sectors. Her notable investments include BioTech (Series A), BioTech (Seed), Health & Hospital Services (Series A), and Health IT (Series A). She is known for her partnership with investors such as Alfred Scheidegger, Gabor Gyulveszi, Jakob Loven, Melissa McCracken, and Niresh Berinpanathan. Gretchen’s career spans roles as an Investment Manager at Archer Fund and as a Senior Analyst at Nextech Invest. Her professional background includes experience in Molecular Biology, Neuroscience, and Oncology, with expertise in health innovation. Gretchen van Steenwyk’s stage of investment ranges from seed to Series A, with a current focus on the Biotech sector.

Lutz Haase is an investor with a focus on HealthTech sectors, having invested in companies like CardioCube and Super Izzy AI. His investment check size typically ranges from $100K to $500K per company. His previous investments include CardioCube (acquired by Voxel) and Super Izzy AI. In terms of partnership and collaboration styles, Lutz Haase demonstrates a cooperative collaboration style, fostering mutually beneficial relationships with portfolio companies and partners.

Buffy Alegria, Managing Partner at SteelSky Ventures, focuses on investing in high-growth companies that improve access, care, and outcomes in women’s health. SteelSky Ventures primarily invests in Women’s Health across various sectors including Digital Health, Consumer Health, Health & Hospital Services, and Health IT at pre-seed and seed stages. Buffy Alegria’s investment check size ranges from $100,000 to $5 million, with a sweet spot at $1.5 million. She brings a wealth of experience, having served in roles such as Managing Partner at LOUD Capital, Board Chair at Signal Health, and as a Strategic Advisor at PregnanTech and Scorecard.vc. Buffy Alegria holds a Master’s degree in Management in Science and Technology from Oregon Health & Science University and a Bachelor’s degree in Psychology, Biology, and French from Pacific University.

Ross Haghighat is a Senior Business Executive, Serial Entrepreneur, and Venture Capitalist with three decades of experience in transforming early-stage technology and life science companies into successful global corporate entities. He specializes in negotiating M&A agreements, strategic planning, and guiding corporations towards successful IPOs. Ross has founded or co-founded several companies, leading strategic pivots, especially in life sciences. With a career impacting markets in biotech, medtech, telecom, ESG, and specialty chemicals, he has been involved in successful IPOs and M&A transactions. Ross has raised over $2B in capital for portfolio companies, contributing to a combined shareholder value exceeding $5B. He holds a BS and MS in Advanced Materials from Rutgers University and an MBA from Boston College Carroll School of Management. Currently, he serves as the Chairman & CEO of Triton Systems, Inc., a global business venture company focusing on innovative products in microsensors, medical devices, immunotherapy, Cleantech, water treatment, and printable electronics. Additionally, Ross is Executive Chairman of Avertix Medical and serves on the Boards of various companies such as Chinook Therapeutics, Electriq~Global, and Fluence Corporation.

Lateef Jackson is a Venture Partner at Elevate Capital, focusing on investments in early stage and growth start-up companies. His investment check size ranges from $100K to $500K. Specific investment focus areas are not available, and his track record and previous investments details are limited.

Kirk Nielsen is a Managing Partner at Vensana Capital, specializing in transformative medical technology innovations. He has led or co-led investments in companies like iVEAcare, Elucent Medical, and Moxe Health. Kirk’s geographical preference includes investments in companies from various regions. His professional career includes roles at Versant Ventures and Medtronic, with a background in healthcare and private equity. Kirk’s investment check size ranges in line with the needs of the companies he invests in, focusing on successful exits and IPOs. His partnership and collaboration style involve active participation in board memberships and strategic guidance for portfolio companies.

George Jian is known for investing in a wide range of companies across various industries. Some of his notable previous investments include NASDAQ: AMBA, NYSE: FORG (Acquired by Thoma Bravo), and Acquired by Equinix. George Jian has a diverse investment portfolio spanning different sectors and stages of companies.

Stacey Cook’s investment focus is on providing affordable and accessible healthcare financing options through PrimaHealth Credit. They aim to help more patients access healthcare by offering customizable payment solutions with high approval rates. Their approach includes a proprietary credit analytics engine to optimize approvals and reduce risk. Stacey Cook’s partnership style involves offering straightforward payment options, no hidden fees, and real-time reporting to healthcare providers.

Bedrock Capital is an investment firm that supports and finances ‘one-of-a-kind companies’.

Wichita Technology Corporation is a sector-agnostic micro-VC firm that focuses on investments in seed and early-stage companies in the US. The firm has made investments in sectors like advanced materials, biosciences, broadband, telecommunications, food and beverage, manufacturing, medical devices, software, and information technology. Previous investments and further details about their track record, professional career, investment check size, and partnership and collaboration styles were not readily available from the search results.

Alsop Louie Partners is a risk-oriented technology venture capital firm that offers financial services to early stage companies.

Breyer Capital is a global venture capital and private equity investor that focuses on catalyzing high-impact entrepreneurs.

RAZ, through their community of accredited investors, grant-makers, and donors, finances world-changing projects. Their investment focus areas involve supporting projects with impact and sustainability-driven initiatives. Key individuals associated with RAZ bring expertise in tech investment and decentralized finance, such as Alexandre Covello and Raffael Kuhn. Notable investments include Autobia, Cargoz, Let’s work, AlGooru, and Fintech Galaxy in various seed rounds. The check size for RAZ typically ranges from $150K to $300K, with occasional exceptions up to $500K, and valuations from $1M to $3M. RAZ seeks like-minded collaborators to reduce pressure, share vision, and tap into expertise for mutual success and impactful outcomes.

Alec Bowers, CEO of Quantum Dynamics LTD, engages in proprietary investments across asset classes like commodities, real estate, equities, and digital assets. He focuses on venture investments in food and medical sectors. With a professional career spanning various leadership roles, Alec has presented at international forums, advised governments on entrepreneurship, and organized summits. Holding degrees from Babson College and Stanford University, he is heavily involved in genomics and personalized medicine investments. Alec’s partnership and collaboration styles emphasize effective communication and teamwork, driving successful global business expansions. His investments extend to Russia, showcasing a keen interest in emerging markets.

Kelly Wittenbrink is the Vice President at Thompson Street Capital Partners. With a background in political roles, including working for a U.S. Senator and involvement in a presidential campaign, Kelly brings a diverse skill set to her investments. Thompson Street Capital Partners focuses on sustainable growth in Life Sciences & Healthcare, Software & Technology, Business & Consumer Services. Kelly’s portfolio includes investments in sectors like Enterprise Infrastructure (Series B) and Medical Devices (Series B). Her check size ranges from $5M to $50M, with a sweet spot around $25M. Kelly is known for collaborating with co-investors and has a track record of successful investments. She is actively involved in the Series B stage, particularly in the areas of Enterprise Infrastructure and Medical Devices.

Artisanal Ventures is an investment firm that focuses on investing in various cloud startups.

William Price is the Founder and General Partner at Next Frontier Capital, a venture capital firm focusing on early-stage tech companies in the Rocky Mountains. The firm’s investment thesis emphasizes partnering with mission-driven entrepreneurs to build impactful tech startups. Next Frontier Capital’s stage of investment is primarily Series Seed and Series A rounds, with a check size ranging from $2 to $5 million. Their geographical preference is in the Rocky Mountain region, with a commitment to supporting founders in Montana, Utah, and Colorado. Notable previous investments include 10 investments through Fund I, 16 through Fund II, and 23 through Fund III. William Price’s track record includes successful leadership at Flite and Hummer Winblad Venture Partners. The firm’s partnership and collaboration styles focus on fostering supportive environments and high performance as a team.

Gauri Gupta is a Managing Director at Sandbox Industries with an investment range of $1M – $20.0M and a sweet spot of $10.5M. She focuses on various sectors including Chemicals, AgTech, Health & Hospital Services, Health IT, and Digital Health at different stages such as Seed, Series A, and Series B. Gauri has a current fund size of $150M and co-invests with individuals like Alex Behar, Amanda Donohue-Hansen, Andrew Boyd, Binoy Bhansali, and Bob Shapiro.

Mass Medical Angels, founded in 2007, is a venture capital firm based in Brookline, Massachusetts. They focus on seed and early-stage investments in healthcare, life science, and medical technology sectors. Their investment thesis aims to bring more clinical tools to the marketplace while achieving superior returns. They invest in medical devices, therapeutics, diagnostics, health services, and health information technologies. Mass Medical Angels provides early stage funding ranging from $250K to $3MM and has a geographical preference for the Boston healthcare supercluster. They are known for their track record in supporting companies in the healthcare innovation center.

Kai Scharff focuses on capital stewardship and loss mitigation in his investment management approach, selecting securities of various market caps, styles, and countries. He has invested in companies like Sponsoo and is known for his time-tested methodology. He has a track record in the executive vice president role and has supported news feed initiatives. His investment check sizes may vary, and his partnership and collaboration styles involve collaborative teaching methods for joint creative classrooms.

Supply Chain Ventures is an angel and early-stage venture capital partnership.

Ivan Burkov is a Senior Associate at INKEF Capital based in Amsterdam, Netherlands. His investment focus areas include Seed Digital Health, Health & Hospital Services, and Health IT. Ivan has a track record as a Principal at INKEF Capital and serves on boards of companies like Ambagon and Salvia Bioelectronics. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Ivan collaborates with co-investors such as Alice Vickers, Amanda Stenbaek, Carien Beyer, Corné Jansen, and Estelle Botbol in various investment sectors and stages.

Sharon Azulai is a Co-Founder and Managing Partner at KÄTAO Venture Partners, known for his proven track record in building successful startups and his extensive background in global private equity and venture-backed technology markets. He has experience in creating new markets and achieving rapid revenue growth through disruptive technologies and innovation. Sharon has founded five startups, managed four, and sold three, providing significant returns to investors. His investment focus areas include early-stage tech companies, with an emphasis on innovation and impact, especially in the medical technology and diagnostic devices sectors. Combining business acumen, innovation management, collaboration, and negotiation skills, Sharon Azulai is recognized as a dynamic agent of change with an entrepreneurial nature and a high energy level. He also holds a B.A. in Business Management and has served in the intelligence unit at the Israeli defense force.

Rahul Harkawat is an entrepreneur with over 35 years of experience as a founder of multiple startup companies in the US & globally. His diversity of experience ranges from incubation to exits for companies in software, mobile, MedTech, and Chemical Polymers. Passionate about business scaling, he has built software companies to scale 8/9-digit revenues for Itochu, Japan, and other startups. As the Director of Mobitila Pte., and previously serving as the Executive Vice President of Infokall and Chief Executive Officer of Softek Software, Rahul Harkawat has a track record in building successful companies across various industries. Additionally, he serves as an Advisor at Rebel Venture Fund.

SWAN Funds is a venture fund that focuses on investing in exciting companies with great teams and meaningful traction in sectors such as B2B software, market-accelerating technologies, capital-efficient hard-science, diagnostics & HealthIT, medical devices, scalable IoT, and scalable hardware. They specialize in pre-seed and seed stage investments and prefer companies in the Pacific Northwest where they have established strong relationships with management teams. SWAN Funds aims to provide the first major outside investment and continuous expertise and support to its portfolio companies, fostering growth and success. Previous investments, track record, professional career details, and specific investment check sizes are not provided on their website.

Jeffery Marx is a Chief Scientific Officer at Cerapedics, bringing extensive experience in executive management with medical device companies. With a Ph.D. in Ceramic Engineering, he focuses on regulatory oversight, quality, manufacturing, and R&D. His professional background includes over 13 years at Orthovita and leadership roles at Stryker Orthobiologics. Dr. Marx has a profound understanding of research & development, commercialization, sales management, business development, and strategic planning. His partnership and collaboration styles align with the introspective, relational, and expressive models, aiming to enhance cooperative efforts across different styles.

CitySide Ventures is a venture capital firm based in Birmingham, Michigan, founded in 2016, specializing in seed-stage and early-stage investments. Their investment focus areas include artificial intelligence, automotive, B2B / SaaS, B2B2C, blockchain, agriculture, foodtech, medical tech, teletech, wearable tech, digital media, fintech, and lifestyle sectors. Previous investments by CitySide Ventures span industries like Business/Productivity Software, Commercial Products, and Automotive. The firm’s investment check size can go up to $250k per deal for qualified startups. Geographically, CitySide Ventures is open to capital-efficient startups aiming to exit within 3-5 years, with a preference for no outside capital commitment. Partnership and collaboration styles information were not found on their website.

Cortado Ventures is a seed-stage venture capital firm investing in overlooked foundational sectors in the midcontinent.

Manish Bhandari, Managing Partner at Angel Physicians Fund, focuses on investing in mispriced securities value based on underlying business dynamics. His investment areas include luxury auto, Arvind Fashions, Saregama India, Muthoot Finance, Home First Finance Co India, and Ajanta Pharma. Manish primarily invests in Series A and Series D stages in the healthcare sector. His geographical preference is Cincinnati, Ohio, USA. Previous investments include PanTher Therapeutics, S4 Medical, and Foldax. Manish’s investment check size ranges from $5,000 to $50,000, with a sweet spot at $25,000. His collaborative style involves strong partnerships and bringing together complementary businesses, as seen with HLI and GE Current.

Joseph Whitters serves on the board of Accuray Incorporated and has significant public company governance experience in the medical technology and medical device industries. He is associated with Frazier Healthcare Partners and has served on the boards of various publicly traded companies. His investments and involvement focus on healthcare companies and emerging technologies in the medical device sector.

Kalimah Abdul is an angel investor based in New York. She typically invests between $100,000 to $1,500,000 per round in early-stage companies. Her investment focus areas include B2B platforms, digital media, financial services, medical devices, diagnostics, and digital health. Kalimah Abdul values passionate, driven, and coachable management teams and looks for companies with established proof of concept and poised for growth. Some of her previous investments include Vestwell. Her investment approach involves seeking companies with clear potential, protected intellectual property, and strong sales strategies. Kalimah Abdul’s investments are targeted at companies in New York and she collaborates with diverse co-investors with successful track records.

Dr. Nathalie Weitemeyer is a prominent investor at Bayern Kapital, a Venture Capital firm with a focus on innovative, technology-oriented startups in Bayern, Germany. Bayern Kapital, under Nathalie’s leadership, has a strong track record of over 320 investments and manages a substantial â¬700 million in assets. Nathalie’s investment thesis revolves around supporting startups from the Seed to Scale-up phase with investments ranging from â¬250,000 to â¬25 million. Her geographical preference spans all technology sectors, including hardware, software, digital economy, industry, medical technology, and life sciences. With a hands-on partnership style, Nathalie has been actively involved in fostering the growth of startups in various sectors. She has led investments in notable startups such as Insempra, AVES Reality, Smart Reporting, Proxima Fusion, Tubulis, Picture Framing, VITAS, and BOX ID. Through tailored financing concepts like Seedfonds, Clusterfonds, Innovationsfonds, and Wachstumsfonds, Nathalie aims to drive innovation and facilitate the success of early-stage and later-stage companies in the German-speaking region. Her commitment to fostering innovation and supporting technology-driven businesses makes her a key player in the Venture Capital landscape.

John Owen is a seasoned investor with a focus on corporate, mergers and acquisitions, and venture investments. He has a strong background in working with Fortune 500 companies in industrial and manufacturing sectors, as well as in the renewable energy industry. John has held positions as a board member in companies like NeuroEM Therapeutics and HeartSciences, indicating his involvement in healthcare and medical technology. With experience as a Chief Financial Officer at JetBlue and Volotea, John brings valuable expertise in the aviation sector. As an angel investor in Clean Energy Ventures and Clean Energy Venture Group, he demonstrates a commitment to clean energy initiatives. His investment check size varies based on the company and opportunity, and he engages in partnership and collaboration styles that enhance growth and success.

Friedemann Stier, the Investment Director at TGFS, has a focus on startups in software (B2B & B2C), semiconductor, medical technology, and microelectronics sectors. He specializes in early-stage and venture capital investments and has a successful track record with numerous transactions and exits since 2009. Friedemann Stier has a background in Business Administration and Economics, and he obtained an MBA in 2006. His partnership and collaboration style emphasize supporting startups in various technology sectors.

Andy Chou, co-founder and CTO at Coverity, is an investor who has focused on enterprise applications and infrastructure sectors. His investments typically range between $4.7M to $6M per round with a check size of $4.7M for seed rounds. Andy Chou has invested in companies like Dasera and Moderne. He founded Coverity, a provider of development testing software, in 2002. His geographical focus is primarily the United States. Andy Chou’s investment philosophy seems to prioritize early-stage technology startups with a global vision, particularly in enterprise software, while supporting companies with strong technical foundations.

The FEMPIRE, represented by FEMPIRE x SoGal, is an angel investment community empowering diverse individuals in early-stage investing. Their investment thesis focuses on education, diversity, and inclusion, aiming to close gender and diversity gaps in entrepreneurship. The investment check sizes range from $2,000 to $100,000, allowing accessible participation. FEMPIRE x SoGal collaborates with SoGal Ventures, offering a unique Angel Investor Bootcamp and Exclusive Syndicate Deals. Their previous investments span industries like Wellness, Fitness, Health Care, Jewelry, and Precious Metals. The founder, Marnie LeFevre, leads the endeavor to support women in becoming powerful coaches and leaders through the FEMPIRE Certified Business Coach program. Partnership and collaboration styles emphasize empowering women in leadership roles through events like Fempire dinners, fostering relationships, strategizing impact, and driving revenue.

Bobby Ong, the co-founder of CoinGecko, focuses on investing in early-stage startups with a recent investment check size of $800K. His investment thesis revolves around the metaverse and alternative cryptocurrencies. Bobby’s geographical preference includes various regions, and he has a track record of founding CoinGecko and being a key figure in the cryptocurrency community. His investment focus areas include DeFi, Web3, and NFTs. Bobby Ong’s partnership and collaboration styles are aligned with fostering effective collaborations across the system.

Olivier Brion is a Co-Founder and Chief Operating Officer at Home61. He is also a Co-Founder and Co-Chief Executive Officer of Pre Visite.

University of Utah Research Foundation is an angel group based in Salt Lake City, Utah. The firm focuses on investments in science, technology, medicine, pharmacy, engineering, natural resources, energy, business, and education sectors. They prefer early-stage investments and have a track record of supporting companies like Light Line Medical, Converus, and iVeena. The investment check size typically ranges from $20,000 to $150,000. The University of Utah Research Foundation is known for fostering partnerships with various entities to support new ventures arising from the university’s research portfolio.

James Liken is a seasoned investor with a background in medical equipment services. He served as a Board Member at Cohera Medical and was previously the President and CEO of Respironics. His expertise lies in managing entities related to home oxygen, respiratory, and medical equipment. Mr. Liken has significant experience in the healthcare sector, particularly in Western Pennsylvania, Eastern Ohio, and West Virginia. His collaboration style emphasizes a true partnership approach, focusing on sharing essential information for successful relationships and projects. While specific investment focus areas and check sizes are not available, his track record indicates involvement in healthcare-related ventures and leadership roles in various organizations like the National Association for Medical Equipment Services and The Boy Scouts of America. His notable achievements include founding and expanding Liken Home Medical before selling it to Lincare.

William Cowen, General Partner at Long River Ventures (now LRVHealth), focuses on early-stage healthcare investments in disruptive companies across healthcare IT, technology-enabled services, devices, and diagnostics. The investment check size is approximately $100 million. LRVHealth partners with healthcare industry insiders, national healthcare systems, and the Innovation Institute to fuel its platform. The fund involves over 20 healthcare thought leaders, eight national healthcare systems, and additional partners to identify and invest in innovative startups. William Cowen, along with his team, has a successful 17-year track record of providing institutional investments in market-leading companies such as GetWellNetwork, MedVentive, Phreesia, lifeIMAGE, and Convergent Dental.

Ross Karel is a Seed investor who focuses on companies in infrastructure technology, digital assets, blockchain, cryptocurrency, and DeFi sectors. He has made personal investments, including in SportsLock. Ross Karel’s professional career includes founding RSK Capital Management in 2020. His investment check size and partnership and collaboration styles were not explicitly mentioned in the available information.

Refactor Capital is a seed stage VC firm investing in bio, climate, and health.

CANCER FUND, an investor, focuses on early-stage companies in the areas of Therapies and Management, Diagnostics & Monitoring, and Preventions & Enabling Technologies. Their investment thesis emphasizes utilizing data to improve patient outcomes and reducing costs in the healthcare landscape. CANCER FUND’s investments range from pre-seed to later stages, managing risk exposure while addressing diverse capital needs. They have made significant previous investments in various institutions supporting cancer research and treatment. The investor accepts a minimum investment of $100, allowing any amount in increments of $100. CANCER FUND is known for its collaboration and partnerships to accelerate progress in the fight against cancer.

Richard Spalding, Managing Director at Kearny Venture Partners, focuses the investment thesis on healthcare products. The investment focus areas include medical devices and drugs in stages ranging from early to expansion. Kearny Venture Partners prefers collaborations in the healthcare sector, with previous investments in companies like Aerpio Therapeutics and Akebia Therapeutics. The investment check size typically ranges from $2-8 million for the first investment, going up to $10-15 million per company. Kearny Venture Partners emphasizes partnerships that drive growth and innovation in the healthcare industry.

Lieven Huang is the Investment Manager Life Science & Medtech at the Brabant Development Agency (BOM). With a background in Bioengineering Sciences, Lieven is passionate about supporting early-stage companies to develop new treatments. His investment focus includes a broad portfolio ranging from discovery to clinical stage companies in the Life Science and Medtech sectors. Lieven’s previous investments and check sizes are not specified. Geographically, Lieven’s preference is not explicitly mentioned. His partnership and collaboration styles are not detailed. Lieven Huang excels in guiding creative problem-solving and ensuring successful outcomes.

An early-stage venture capital fund, investing in exceptional entrepreneurs in the Central US.

Dr. Matthew Ferguson serves as the Co-Chief Executive Officer at CareerBuilder and previously served as a Board Member at Retrofit. He is known for his insights on the labor market, job search, and workplace trends. With a background in business development, strategic partnerships, and law, Ferguson has a strong professional career. He holds an MBA from the University of Chicago and a law degree from Northwestern University.

Nora Doherty, the Vice President of Finance and Managing Director at BioCrossroads, is an investor with a focus on strategic and impactful investments in the life sciences industry. Her investment range typically spans from $100,000 to $5 million, with a sweet spot around $1.5 million. Nora has a track record of investing in companies like Seed BioTech and SonarMed, the latter being in Series C financing in October 2017. She operates from Indianapolis, Indiana, and has a professional career that includes managing key collaborations such as INCAPS and FIHC. Nora’s partnership and collaboration styles are valued in the industry, attracting founders and investors alike, such as Evan MacQueen, Patricia Martin, Anders Richardson, and Alexandre Glaser. Previous Investments: – Seed BioTech – SonarMed Investment Check Size: – Range: $100,000 – $5,000,000 – Sweet Spot: $1.5 million Geographical Preference: – Location: Indianapolis, Indiana

Laurence Hayward is a Founding Partner at ATOMS VC with an investment range of $250K – $2.0M and a sweet spot of $750K. He focuses on sectors like Diagnostics, Drug Delivery, Material Science, Semiconductors, Medical Devices, Manufacturing, DeepTech, Hardware, Robotics, and ClimateTech/CleanTech at Series A and Series B stages, primarily in the Midwest region. Laurence has made investments in companies like Jio Inc., Intellihot, and NovaScan. He allows warm intros through Signal using Gmail and is associated with investors like Andrew Verhalen, Matrix, and angels such as Daniel Kennedy and Operator Stack.

Denis Grosz is a Cofounder at Mechanism Ventures. He serves as a strategic advisor and board member for the companies in their portfolio, including early-stage investments in Thumbtack, SmartAsset, Apartment List, and ConsumerAffairs. He holds a BA in Philosophy from the University of California, Berkeley. Denis Grosz is passionate about hiking, skiing, woodworking, pottery, and welding.

Joshua Jones-Dilworth is a visionary entrepreneur and CEO with a focus on health-related quality of life through the Litmus Health clinical data science platform. He has expertise in introducing early-stage technologies to the market and is a skilled storyteller advocating for the impact of science and scientists. His investment thesis centers on making significant advancements in science known and understood, fostering a world where science integrates seamlessly into society. Joshua’s geographical preference is not explicitly mentioned. He has a solid track record in public relations and technology companies. He maintains a self-funded approach at Litmus Health. Specific investment check sizes and partnership styles are not available.

Dan Becker is a driven sales professional with a 10+ year career record of driving rapid medical device sales growth. He has a talent for assessing customer needs and offering innovative solutions, achieving the highest levels of client satisfaction and retention. Dan excels in building close client relationships, identifying opportunities, maximizing sales, and reviving stagnant accounts. He has extensive experience in the medical device industry with consultative expertise in orthopedic surgery, ophthalmic surgery, and training faculty physicians. Dan holds an Executive MBA with an emphasis in Healthcare Management from Louisiana State University. His previous roles include Surgical Academic Manager at Alcon, Account Manager at Avail Medsystems, and Senior Sales Consultant in Orthopedic Trauma at DePuy Synthes Companies.

Daniel Dillinger, an investment manager at Redalpine Venture Partners, focuses on seed and early-stage investments primarily in disruptive technologies within highly scalable ICT and Health Tech models. His geographical preference lies in the life sciences, digital health, medtech, and biotech industries. He has a track record of leveraging his medical and business background to accelerate innovation in healthcare. Although specific previous investments were not directly available, his role at Redalpine involves supporting companies in these sectors. The investment check size is likely aligned with substantial venture capital investments in health-related technologies. Daniel Dillinger’s partnership and collaboration styles were not explicitly mentioned in the search results.

Roger Bendisch is a Managing Director at IBB Ventures based in Berlin. He focuses on startups with strong founding teams who can effectively manage fast-growing companies. IBB Ventures provides risk capital for innovative Berlin-based companies since 1997. The firm has invested over â¬275 million in more than 260 Berlin companies. The investment stage ranges from pre-seed to Series A, with a minimum investment of â¬200,000. Geographically, IBB Ventures focuses on supporting Berlin startups, with funds backed by Investitionsbank Berlin and the ERDF. The partnership and collaboration styles emphasize promoting innovative ideas and helping founders succeed. Roger Bendisch’s professional career includes a leadership role at IBB Ventures and involvement in venture capital. Unfortunately, specific information regarding the investment check size could not be found.

Peter Verrillo is the Chief Executive Officer and Co-Founder of Enhatch. The company focuses on developing virtual planning solutions for 3D printed implants and guides for orthopedic and spine surgery. Enhatch received Series A Funding led by Trousdale Capital and Apis Holdings to develop Intelligent Surgery, integrating AI solutions into the medical device industry. The investment aimed to accelerate automation and adoption of patient-specific technologies. Enhatch is known for pioneering Intelligent Surgery with AI solutions for surgeries, offering advanced surgical planning tools and collaboration platforms. Since the investment, Enhatch’s team has doubled in size, with a third of employees in Tulsa, OK, collaborating with the local tech community.

Clement Salque is an Associate at Bioqube Ventures with a focus on sourcing, financing, and developing innovative companies in the healthcare and life science sectors. He translates scientific innovation into therapeutic drugs to maximize value for investors. Previously, he was a Business Analyst at Bioqube Ventures and a Healthcare Venture Capital Analyst at INKEF Capital. His experience includes analysis of investment propositions, due diligence, market research, deal sourcing, and support of portfolio companies. Clement has a background in regulatory affairs and rare diseases. His career shows a dedication to the healthcare and biotech industries, with a track record of involvement in strategic positioning, clinical trial design, and budget reviews. Clement Salque’s current investment focus areas are in healthcare and life sciences, primarily in Europe. He is experienced in supporting innovative companies, conducting due diligence, scientific analysis, and strategic decision-making for portfolio companies. Clement’s professional career spans various roles in healthcare and regulatory affairs, showcasing his expertise in medical innovation and entrepreneurship.

Mary Naylor is a pioneer in the design, evaluation, and spread of health care innovations that have significantly improved the outcomes of chronically ill older adults. She has led research to implement the Transitional Care Model, focusing on the care and outcomes of chronically ill older adults. Mary Naylor’s professional career includes being the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania. Her track record includes awards for her work in improving the quality of cancer care and health care for older adults. Mary Naylor has been involved in collaborations that enhance care delivery through advanced-practice provider models. Previous investments attributed to Mary Naylor include involvement with organizations like the Young Presidents’ Organization, Inc., with a focus on leadership development and growth.

Marek Poszepczynski, an Investment Manager at SV Health Investors, is known for his specialization in the healthcare sector with a focus on biotechnology, medical devices, and digital health. SV Health Investors has a proven strategy for selecting healthcare investments across various stages, geographic regions, and sectors. Marek has a track record that includes managing the International Biotechnology Trust and working on the Dementia Discovery Funds. The average investment check size from SV Health Investors ranges from 10 to 50 million dollars per startup. Marek’s professional career started as an analyst in 2014 before becoming a named manager of the trust in 2017. His collaboration style is reflected in his active management of diversified portfolios and his optimism about the biotech sector’s recovery post-Covid, emphasizing the importance of humility and appreciating industry trends.

Alexander Tang is a venture investor with a focus on technology, manufacturing, software, medical devices, and healthcare. He is known for delivering multiple bespoke financing solutions on aviation-related assets. Although specific check sizes are not available, he has a history of successful collaborations in the financial and investment sector. His active involvement and leadership roles in various firms demonstrate a strong track record in the industry. His investment thesis centers around opportunities like Stacks, emphasizing a $90 billion potential opportunity. Alex Tang’s approach includes maintaining a leading position in the Bitcoin Layer 2 market cap through innovative solutions and technology adoption.

Kreske Nickelsen has over 20 years of global life science and venture capital experience, working with different funds, 3i Group plc, and The Boston Consulting Group. She has a background in Biology and an MBA, with a strong focus on venture leasing and financing solutions. Kreske has overseen transactions from seed stage to mezzanine, including license agreements, IPOs, and trade sale processes. She has served on numerous boards in Europe and the USA.

Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.

Mr. Siqi Chen is a Co-Founder and serves as Co-Chief Executive Officer at Runway Financial. He serves as Chief Product Officer at Sandbox VR. He is an Angel Investor. He served as Vice President of Growth at Postmates. He was a Co-Founder and served as the Chief Executive Officer at Hey. He was General Manager at Zynga and founded the Central Product Management group. Prior to its acquisition by Zynga, he was founder and CEO at Serious Business. He also briefly joined YCombinator and is a Powerset alumnus. He also served as an advisor at fbFund REV. He holds a BA (Bachelor of Arts) in Mathematics and Computer Science from the University of California, San Diego.

Howard Walthall is the Founder and Chief Executive Officer of Lumiheal Therapeutics. He has a track record of leadership roles in various companies, including NuTech Spine, Inc. and NuTech Medical, Inc. Walthall’s professional career includes positions at Organogenesis Holdings Inc. and Burr & Forman LLP. His investment check size is not specified in the available information. Walthall is associated with companies like CHITOGENX INC. and Lumiheal Therapeutics. However, specific details about his investment thesis, focus areas, stage of investment, geographical preference, previous investments, and partnership and collaboration styles could not be found.

Sean McDade is a member at Robin Hood Ventures, a group of angel investors focused on early-stage, high-growth companies in the Greater Philadelphia region. He typically invests $250k to $500k in businesses he knows and understands. Robin Hood Ventures has invested in over 45 companies in industries like software, medical devices, biotech, internet, and financial technology. They are located in Philadelphia, Pennsylvania, and primarily operate in the Finance and Venture Capital & Private Equity industries.

Marta Mrozowicz is a former Investment Manager at Calm/Storm Ventures, a purpose-driven venture capital firm focusing on founders changing life & health for the better. She transitioned to Heal Capital’s team in Berlin with a focus on HealthTech investments. Marta’s investment range is $25K to $250K, with a sweet spot around $137K.

Sami Inkinen is the CEO & Founder of Virta Health, an online specialty medical clinic that reverses type 2 diabetes safely and sustainably. He likes creating positive disruptive change in business and personal performance through new technologies and hard work. Sami advises, mentors, invests, and starts high-growth companies, especially those focused on healthy living and advancing human health and performance. His past experience includes co-founding Trulia, working at Microsoft, McKinsey & Company, Nokia, and co-founding Matchem. He holds an MBA from Stanford University and a Master’s in Engineering from Helsinki University of Technology. Sami is an investor in health, aiming to reverse diabetes in 100M people.

Kevin Kim is an investor with a focus on the healthcare industry, committing over $4.0 billion to over 100 companies. However, specific investment focus areas, stage of investment, geographical preference, and partnership styles are not directly provided in the available information. Previous investments and track record details are not disclosed on the sources found. Kevin Kim has a background working with big brands like Google, AdWeek, and Bizzabo, managing over $65M in revenue at Google. He has experience in forging partnerships with both internal and external stakeholders, particularly in adtech and advertising.

Joseph M. LaGuardia is the principal of LaGuardia Group, a New Business Development and Strategic Marketing firm serving health plans, hospitals, ventures in the health and wellness industry, entrepreneurs, and start-ups. He has a Bachelor of Science degree in Business Administration from The University of Akron. Previously, Joseph served as the Senior Vice President of Business Development at Pretorian Labs, a large independent lab, and as a Consultant at the Cleveland Clinic. He has also held positions such as Regional Vice President at Anthem Blue Cross and Blue Shield/Wellpoint and VP at Swagelok. LaGuardia’s professional career spans roles in marketing, sales, new business development, and consulting across healthcare and other sectors.

Rachel Rath is an investor at Johnson & Johnson Innovation – JJDC, Inc with an investment range of $100K to $5.0M, focusing on sectors like Medical Devices, Health & Hospital Services, and Health IT at both seed and Series A stages.

Jim Sullivan is a Venture Partner at OrbiMed, based in Chicago, Illinois. His investment thesis focuses on Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT at the Seed and Series A stages. Jim’s investment check size ranges from $1M to $75.0M, with a sweet spot of $4.0M. He has a current fund size of $18B and collaborates with co-investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman. Sullivan’s partnership and collaboration style involve actively engaging with startups in the mentioned sectors, aiming to contribute to their growth and success.

Dr. George John is an Angel Investor.

Gunther Schmidt is mainly known for his work on Relational Mathematics. Medici Holding is a private investment firm founded by Gunther Schmidt, focusing on Technology Vendors, Corporate Venture Capital, and Venture Capital. Previous investments include Angel AI. Gunther Schmidt’s investment check size ranges up to â¬1 billion for massive projects. Further details on partnership and collaboration styles were not found.

Venrock is a venture capital firm investing in technology and healthcare companies.

Claremont Creek Ventures, a seed- and early-stage venture capital firm, invests in various industries, including healthcare and energy.

Adam Smith, a prominent figure known for his work ‘The Wealth of Nations,’ advocates for free-market principles, low taxes, and eliminating tariffs to promote trade. His investment focus areas are promoting capital growth, limited government involvement, and solid currency. The stage of his investments aligns with seeking the highest possible return on resources. Geographic preferences are centered around understanding the interdependence of rural and urban areas. As for previous investments, no specific data was found. Smith’s track record primarily includes his role as a professor teaching law, rhetoric, economics, and philosophy at the University of Glasgow. The investment check size details were not available. In terms of partnership and collaboration styles, Smith emphasized creating a society of cooperation and mutual benefit through his concept of cooperative capitalism.

Josefin Landgård is a Swedish investor with a focus on health services located in Sweden. She has made investments in companies such as Noala, Medoma, and Ester Care. Her average round investment is $2.68 million USD, with an average of 3.2 investments per year. Josefin’s investment criteria include an average deal size range of 1M – 5M USD, a focus on health services, and investing in companies in Sweden.

Jayde Crystal Wright is a VC Associate at Deerfield Management with a current investing position as an Associate. Their investment range is $10.0M – $50.0M with a sweet spot of $25.0M. Crystal Wright focuses on sectors such as Medical Devices, Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT in both Seed and Series A stages. They have collaborated with various co-investors like Abraham Kometz, Adam Greene, Adam Grossman, Alexis Cazé, and Alison Stamas. Crystal Wright is based in New York, USA.

Ben Chodor is a pioneer in SaaS, online communications, and interactive content. With 25+ years of experience in enterprise communications, technology, social video, and digital health, he is the CEO of CallRevu, a communications intelligence platform for retail automotive dealerships. Ben also founded Notified, a communications cloud for events, PR, and investor relations. He launched CareTalk Health, a Telehealth platform, and advises Hapi on mental health solutions. Ben was the CEO of Happtique, founder of Stream57, and global head of streaming at InterCall. He mentors at Blueprint Health, invests in digital media and health companies, hosts the podcast Insights with Ben Chodor, and is a speaker on digital media, healthcare, and AI. He has a book on virtual events.

Franz Salzer, Investment Manager at Bayern Kapital GmbH, focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments are in Series B. The investment check size typically targets the seed round. The partnership and collaboration style information is not available.

Markus Okumus is an investor focusing on Series A investments in Wellness & Fitness, Digital Health, and Health & Hospital Services, with a preference for Swiss and American regions. He has a track record as a Founding Partner at FORM Life Ventures with previous board positions at Baze Labs AG. Markus Okumus’s investment check size is detailed on Signal NFX. He engages in collaborative styles within the industry.

Rishi U. Shah, the founder of Outcome Health, is a visionary entrepreneur with an estimated net worth of $3.6 billion. His investment focus areas include healthcare technology, with a stage of investment ranging from early to mid-stage startups. Shah’s geographical preference has been prominent in Champaign, Illinois. His professional career showcases a track record of success in data architecture, research, and collaboration styles focused on building strong relationships. Overall, Rishi U. Shah is a pioneering figure in healthcare technology.

Unusual Ventures is a seed-stage venture capital offering hands-on support and expertise to startups on their early-stage journey.

Jonas Bergman is the Investment Director at Chalmers Ventures with an investment focus in MarketingTech (Seed), Medical Devices (Seed), Pharmaceuticals (Seed), BioTech (Seed), and FinTech (Seed) sectors. His recent investment includes Embedl AB in the seed stage. Some of his previous investments include companies like Swedish Algae Factory, Metry, Evispot, Micvac AB, and Mevia AB. Jonas has a track record of serving on the board of various companies and has a background in CEO roles, management consulting, and extensive experience in sales and marketing. His investments typically range from $100K to $5.0M, with a sweet spot at $1.5M. Jonas Bergman is an alumni of Chalmers School of Entrepreneurship and Chalmers University of Technology.

Samuel J. Gardner is an Angel Investor focusing on the acquisition and disposition of Marriott, Hilton, & IHG Premium Limited/Select-Service assets nationwide. His investment check size ranges from $500K to $1.5M. Samuel Gardner’s investment thesis emphasizes return on invested capital through equity investments, with a focus on companies generating sustainable amounts of net free cash flow. He prefers companies with strong balance sheets and a history of high returns on assets. Samuel has a track record in telecommunications and security software sectors as an enterprise account manager and market development manager. He holds a BA in Business Leadership & Management and enjoys reading, exercising, and golf. As an introspective collaborator, he values deep work and prefers working alone before validating ideas with a group.

Geert-Jan Mulder is an experienced life sciences investor who co-founded Forbion in 2006. He has led successful investments in various portfolio companies, including those in the biopharmaceutical and therapeutic sectors such as AM-Pharma, ARMGO Pharma, Complement Therapeutics, Enterprise Therapeutics, Mariana Oncology, NeRRe Therapeutics, and Prilenia Therapeutics.

Martin Velasco is an entrepreneur and Business Angel with extensive experience in the IT, medical, and biotech sectors. He serves on the board of Anecova SA. His previous investments are related to raising capital in companies like Acimmune and Sumerian. Martin Velasco focuses on Pelton turbines performance improvement using reverse engineering, parametric design, and CFD analysis. The specific investment check size for Martin Velasco is not available, and his partnership and collaboration style may involve elements of cooperative, competitive, and directive collaboration.

Harbor Street Ventures is a family office based in Chicago, Illinois, founded in 2014. They specialize in early-stage investments in the healthcare sector.

Rajbir Minhas is an investor at Angel Physicians Fund, focusing on healthcare startups. His investments remain undisclosed. Rajbir’s professional career and track record are not publicly available. The investment check size is unknown, and his partnership and collaboration styles are not detailed in the sources found.

Brett Kaufman is an Angel Investor who is dedicated to the art and science of personal transformation, and is a firm believer in using past traumas as fuel for ambitious goals. He regularly invests in entrepreneurs and organizations, focusing on building humans and organizations holistically. While the specific Investment Focus Areas, Stage of Investment, Geographical Preference, Previous Investments, Track Record, Professional Career, and Investment Check Size were not explicitly found, it seems that Brett Kaufman’s essence lies in personal transformation and supporting ventures through a diverse and holistic approach.

Sean Brecker serves as the Chief Financial Officer at Oura, a health technology company. He has a background in investment banking and holds a Bachelors degree in Mathematics/Economics from Wesleyan University and an MBA from The Wharton School. His previous investments include Headspace Health, ÅURA, CoachArt, Lehman Brothers, Citibank, Nomura, and Nomura Holdings. The geographical preference of his investments covers Canada, United States, South America, and Europe. Sean Brecker’s check size investments are not explicitly stated on available sources. He demonstrates a collaborative and strategic partnership style in his leadership roles.

Tamiami Angel Funds is an angel group based in Naples, Florida, founded in 2010. The firm’s investment thesis involves providing seed and startup capital to emerging companies in sectors like SaaS, fintech, edtech, telehealth, and medical devices. They focus on early-stage ventures, seeking to achieve high returns by actively supporting companies. Tamiami Angel Funds does not have geographical restrictions on investment opportunities. Previous investments include companies in various sectors such as Climate Tech. Matthew Hinderman, a partner in the firm, brings a wealth of experience in tax and corporate planning. The specific check size for investments by Tamiami Angel Funds was not available. The partnership and collaboration styles of the firm align with investments in sectors such as SaaS, fintech, edtech, telehealth, and medical devices.

Daniel Bach is a Board Certified Internal Medicine-Dermatology Physician at Cedars Sinai, with experience as a Dermatologist at Cedars-Sinai and Assistant Professor of Dermatology at UCLA Health. He holds a Doctor of Medicine (MD) from Northwestern University and a Master of Public Health (MPH) from The Graduate School at Northwestern University. Daniel Bach’s previous investments are not available. His investment thesis, focus areas, check size, and partnership styles are not publicly documented.

Tobias Asch focuses on investments in the leisure, sports, travel, and diving markets. He has a track record in the medical field with proven clinical experience. Previous investments are related to rational investing. His partnership and collaboration style involve mitigating collaborative cheating and facilitating network change.

Sara Coady, a Partner at Operator Collective, focuses on early-stage enterprise and B2B companies in sectors such as Medical Devices, Sales & CRM, AI, and more. She operates in Pre-seed and Seed stages with an investment range of $500K – $1.5M. Her current fund size is $45M, and her sweet spot investment is $1M. Sara has invested in a variety of companies including CoreAgentSync, Amberflo, Amplitude, Bluesky, and more.

Atomico is an international investment firm that focuses on helping disruptive technology companies scale globally.

Pat Condon is a Co-Founder of Active Capital, a tech-focused venture capital firm supporting business-to-business software-as-a-service companies in their seed round. He personally invested in Webmail, showing a commitment to startups. Condon and Pat Matthews have a proven track record of mentoring software firms. Their partnership emphasizes investing in sustainable production and collaborative business ventures.

Ketan Yerneni is a Principal at KdT Ventures, an early-stage venture firm focusing on frontier computational technologies and science. He has previous experience in Business Development at Rhaeos, a company developing non-invasive diagnostics for hydrocephalus patients, and Surgical Innovation Associates, which was acquired by Integra. Ketan Yerneni’s track record includes bettering patient outcomes in reconstructive surgery and the development of diagnostic solutions. His investment focus areas include frontier computational technologies and science. Ketan Yerneni’s partnership and collaboration styles reflect a hands-on approach to driving innovation and improving patient outcomes. The investment check size and geographical preferences are not specified in the available information.

NueCura Partners is an angel investment company specializing in healthcare investments, with a portfolio of 16 companies including Babyscripts, Trilliant Health, and Bivarus. They focus on early-stage healthcare ventures and have made 2 exits. The investor operates in seed-stage round financing and has a geographical preference for healthcare investments. The check size for investments made by NueCura Partners remains undisclosed.

Nazar Yasin is the Founder and Managing Partner at Rise Capital, a firm that believes in the power of technology to transform lives in Emerging Markets like Latin America, Africa, MENA, India, and Southeast Asia. Rise Capital backs bright and ambitious technology entrepreneurs in these markets to build successful, iconic companies. Nazar Yasin typically invests between $3 million and $7 million in startups, focusing on consumer Internet startups in emerging markets. Some of his previous investments include Chilean insurance comparison site ComparaOnline Ltd. and Nigerian startup iROKO Partners Ltd. Rise Capital’s partnership consists of experienced internet executives with significant operating and investing experience in Emerging Markets, including successful exits in major regions worldwide.

Patrick Sullivan is a Managing Partner, Chairman, and Co-Founder at ATON Partners, a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies. ATON Partners invests in companies involved in the development and commercialization of medical devices and in vitro diagnostics. Some of the portfolio companies of ATON Partners include Dune Medical, CereVasc, and Insulet Corporation. Patrick Sullivan’s investment check size is not explicitly mentioned in the available information. The geographical preference of ATON Partners is not specified. The current focus and specific investment thesis of Patrick Sullivan and ATON Partners are on healthcare sector-related companies and technologies.

Mark Kingdon, the founder of Kingdon Capital Management, has a strong focus on healthcare investments. One of his recent funds, Kingdon Healthcare Fund, emphasizes investments in the healthcare sector. His past investments include companies like Xoma Corp and Heron Therapeutics Inc. Kingdon Capital is a New York-based macro and long/short hedge fund that was founded in 1983. Mark Kingdon is known for his expertise in the hedge fund industry and has a track record of successful investments in healthcare companies.

Jeff Garner is an experienced investor with a proven track record of managing substantial pools of private and public funds. He has arranged investments in equity and debt capital for growing companies, co-founded East Hill Management raising $108.3 million in venture capital and managed assets exceeding $2.5 billion. Jeff carries a BBA in Finance, an MBA in Finance, and is a Chartered Financial Analyst.

Frist Cressey Ventures is focused on accelerating the growth of high potential healthcare enterprises through value-added partnerships.

John Fiorelli is a Venture Partner at Kenetic, Hong Kong SAR. With a background in strategic advisory roles and a career spanning from Founder and CEO of Cut&Paste to Senior Marketing Consultant at Ferrazzi Greenlight, Inc., John has a diverse professional journey. He currently serves as a Strategic Advisor at Hypernative and Blockdaemon. His expertise includes product marketing, consultancy, and film production.

Corey Ritter is a Principal at ARCH Venture Partners, focusing on Biotechnology, Life Science Tools, Instruments, Medical Diagnostics & Devices, Quantum Technologies, Materials, Nanotechnology, and Semiconductors. His key investments include Vizgen. Corey has supported companies like Slingshot Biosciences and Singleron Biotechnologies and has been involved in ARCH’s investments in various innovative ventures.

Casper Bruens is the Managing Partner of Brightlands Venture Partners, with a diverse investment focus in materials, electronics, medtech, biotech, and nutrition. Brightlands Venture Partners’ funds include Limburg Ventures, Chemelot Ventures, Brightlands Agrifood Fund, and BVP Fund IV, with a fund size of â¬45 million at first closing. Casper Bruens has invested in companies like Grassa, Neuroplast, Vacis, and Hy2Care. He collaborates with other organizations and investors to fuel sustainable startups, as seen in the partnership with ReSolved Technologies for a circular material supply.

Max Ventures is a seed-stage venture capital firm that invests in consumer tech and health-tech companies.

Jonathan Isacsson, an Angel Investor at MySellr, has an investment thesis revolving around various regions. His previous investments include MySellr. He has a professional career at Gemline as the Executive Chair and serves on multiple advisory boards. His investment check size and partnership styles were not available.

Joel B. Braunstein is the Co-Founder of C2N Diagnostics and Tivorsan Pharmaceuticals. He serves as an angel investor with a track record of investments in health-related startups such as C2N Diagnostics and Tivorsan Pharmaceuticals. His investments range from â¬11.6m to â¬47.5m. He has a geographical preference for health-related ventures. Braunstein’s partnership style involves providing early commercial guidance to life sciences discoveries. He has a professional career in the healthcare and investment sectors, demonstrating a specific focus on fostering innovation in the health industry.

Kevin Hrusovsky is a Venture Partner at ARCH Venture Partners with a 30-year career leading life sciences companies. He is the Chairman of 908 Devices, with previous roles at Quanterix, Caliper Life Sciences, Zymark Corp. Additionally, he created the Powering Precision Health foundation. Kevin Hrusovsky has a track record of over 25 years in commercializing disruptive technologies in the life science industry, focusing on teamwork and transparency. He has played a key role in building Quanterix into a successful public entity with substantial growth. Kevin Hrusovsky has received recognition for innovation and entrepreneurship awards.

Jessie Frazelle is the Co-Founder and Chief Product Officer at Oxide Computer Company. She has been actively involved in investment activities and has a diverse portfolio of investments. Some of her previous investments include Modal Labs, Vercel, and other companies. The check size for her investments varies depending on the funding round and the specific company. Jessie Frazelle’s partnership and collaboration style emphasize collaboration, compromise, and creating explicit guidelines for acceptable patches and release cutoffs to ensure effective project management and team interaction.

John Dyett, Co-Founder of Salem Partners, heads the firm’s efforts in the Life Sciences. Mr. Dyett has raised over $500 million of equity and completed multiple merger and acquisition assignments. Notable previous investments include Adams Respiratory Therapeutics and ZS Pharma. He played a key role in investments raising several rounds of venture capital. His partnership and collaboration styles involve active involvement in the investment committee. John Dyett’s track record includes successful IPOs and investment committee roles at Salem Partners. The specific geographical preference is not mentioned.

Richard Lejeune is an independent trader and consultant specializing in microcap equities and distressed debt. His investment focus areas include undervalued microcap equities, preferred stocks, and distressed debt. He has a background in analyzing and trading a portfolio of microcap equities and distressed debt. Richard Lejeune’s previous investments mainly revolve around microcap equities and distressed debt. Unfortunately, specific information about his partnership and collaboration styles, investment check size, and geographical preferences could not be found.

Julie Vaughan Murchinson is a healthcare enthusiast with a focus on transforming the industry. With a background in Healthcare and Operations Management, she serves as a Partner at Transformation Capital. Her career includes leadership roles in health IT consulting, investment firms, and non-profits. Julie’s geographical preference is in Seattle, WA, where she is actively involved with healthcare-related organizations. While specific investment areas are not detailed, her investments align with the passion for healthcare improvement. Julie’s partnership and collaboration style are not explicitly defined on the available sources.

Gauri Kamath, a VC Analyst at Flashpoint VC based in the Netherlands, focuses on investments in Series A Enterprise Applications. With an investment range of $1M – $4.0M and a sweet spot at $2.5M, Gauri’s current fund size is $450M. Some of the co-investors associated with Gauri include Alexander Konoplyasty, Alexey Sidorov, Anton Fedorov, Barnabas Vincze, and Daniel Neder. Gauri Kamath collaborates closely with these investors to support startups in the Enterprise Applications (Series A) sector.

Petar Tsachev is a VC at LAUNCHub Ventures, with a focus on structuring pricing, sales funnel optimization, storytelling in fundraising, and fostering collaboration. His investment thesis includes agility in the enterprise, with a special interest in GlycanAge’s innovative technology measuring chronic inflammation and biological age. Petar invests in Seed and Series A funding stages, supporting startups like Colossyan and health tech companies addressing chronic diseases. His previous investments include supporting rounds led by Lakestar. With a background in GTM & Operations leadership, Petar brings expertise in commercial team development and content marketing strategies. He engages with founders as partners on a journey to success, emphasizing alignment and collaboration for mutual growth.

Alexandre Linares is an angel investor with a focus on creating mobile/web experiences. He has invested in companies like Numerator, Alpine.AI, and Headspace. His investments range from seed funding to Series B. Alexandre Linares is located in the West Coast of the United States and has a track record of successful investments. The investment check size varies based on the stage of the company. Alexandre Linares is known for his partnership and collaboration styles in the tech industry.

National Innovation Fund, founded by Ken Moreano, has made investments through Scott Data Center’s Incubator Program for Start-ups. The fund has supported start-ups in Omaha, Nebraska, showcasing a commitment to fostering technology start-ups’ growth.

Brian O’Kelley is a Co-Founder and serves as Chief Executive Officer at Scope3. He serves as an Advisor at Blacksheep Ventures. He co-founded & served as Chief Executive Officer & Board Member at Waybridge. He serves as an Advisor at TMV. He also serves as a Board Member & Advisor at Datami. He also served as an Advisor at Tribeca Venture Partners and ICX Media. He is also an Angel Investor. He also served as a Board Member at AiCure. He also co-founded and served as Chairman and Chief Executive Officer at Xandr. He has a computer science degree from Princeton University.

A principal investment firm specializing in Agriculture, Agtech, Biogreentech, Food & Nutrition.

Michael Burcham is an experienced executive coach, entrepreneur, investor, and strategist with over 30 years of experience. He has successfully scaled and exited three private equity-backed businesses and helped over 100 firms realize their full potential. Michael has a strong background in healthcare innovation, entrepreneurship, and startup venture coaching. He is the President and CEO of Narus Health and serves as a Special Investment Partner at Galen Partners. Michael’s previous positions include President of ParadigmHealth, Professor at Vanderbilt University, and Vice President of Managed Care at HCA Centennial Medical Center. His academic achievements include a Ph.D. in Health Administration, an MBA, and a bachelor’s degree in Physical Therapy. Michael’s leadership and expertise make him a valuable asset in guiding businesses towards success.

Mercedes Tuin, Senior Investment Manager in Life Sciences & MedTech at BOM Brabant Ventures, focuses on investing in healthtech startups primarily at the seed stage. With a track record of successful investments, including contributions to RiboPro’s funding round of â¬1.2 million for mRNA technology advancements. Mercedes has been involved in notable investments like brain health startup Mendi.io, psychologist booking platform Ahum, and drug developer Galecto. Her collaborative style emphasizes finding solutions collectively, leveraging her extensive network and experience to support founders. Mercedes Tuin’s partnership approach includes active involvement in scaling businesses, as seen in supporting RiboPro to expand their high-performance RNA products globally.

Kim H. is an Angel Investor with expertise in Human Resources, General Management, and Project Management. Based in Brisbane, Australia, Kim’s investment range spans from ZAR 0 to ZAR 1,300,000 across various stages from Pre-Startup/R&D to Profitable. Kim’s investment focus areas include industries such as Medical & Sciences, Personal Services, Technology, and Finance, with a geographical preference for Australia. Having engaged in investments at different stages of businesses, Kim H. brings a diverse portfolio and hands-on expertise to support startups in their growth journey. With a keen interest in supporting ventures in the mentioned industries in Australia, Kim H. plays a vital role in nurturing and guiding startups towards success.

Oliver Reuss is the Executive Director and Investment Manager of the Boehringer Ingelheim Venture Fund. With a background in Molecular Biology and a focus on Infectious Diseases, he spent 5 years in academic research before joining Boehringer Ingelheim in 2008. Oliver has held various roles, including business analytics, business development, strategy, and healthcare innovation, before joining the Venture Fund in 2018. His past investments include companies like Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actyme, TheRNA immunotherapies, and STAT-Dx. The investment check size and partnership and collaboration styles were not explicitly mentioned in the search results.

Dr. Robert Pelberg is a new entrant to entrepreneurship and early-stage investing. He is affiliated with Cardioventure Partners LLC and is an angel investor in Foldax Inc. and Atria CV Inc. Dr. Pelberg is an experienced cardiologist and a Fellow of prestigious medical associations. His investments are in the medical and healthcare sectors. Drawing on his medical background, he focuses on early-stage startups related to cardiovascular health. Geographically, his investments align with the US market. Known for his partnerships in medical startups, Dr. Pelberg is likely to collaborate closely with founders to propel their growth. The size of his investment checks may vary based on the specific startup needs.

Thomas Eggleston, as the Managing Director at Charmides Capital, focuses on providing strategy, operational processes, aligned management, and capital to drive growth for early-stage ventures. Charmides Capital specializes in investing in early-stage B2B SaaS startups in the Midwest region. Thomas has a background in leading innovations in various industries, such as real estate, consumer goods, and online sales. His professional career includes roles as CEO of a major private home builder, COO of a global consumer products company, and founder of medical devices and online vehicle sales ventures. Thomas has a strong track record in underwriting software platforms and property management, emphasizing long-term hold and rent. Charmides Capital’s partnership and collaboration style involves providing mentorship and strategic guidance to foster rapid growth in their investments.

Kent Novak, CEO of Valencell Inc., focuses on investments in biometric sensor technology, specializing in wearable biometrics for chronic disease management. His investment check size aligns with funding for companies like Valencell, which develop innovative solutions in electronic equipment and instruments. Kent Novak’s collaboration style emphasizes partnership-driven innovation, as seen in his role fostering collaboration for innovative solutions at Valencell. His track record includes serving as the CEO of Valencell, demonstrating leadership and expertise in the technology sector. While specific details on his investment thesis were not found, his focus areas likely include technology, innovation, and healthcare based on his role and investments.

Flávia Andrade, a native of Rio de Janeiro, Brazil, has over 20 years of experience living in Chicago, Illinois. She is the CEO and Co-founder of IDL Ventures, an internationalization platform focused on supporting the expansion of deep technologies globally. Flávia has designed IDL’s fund and model, collaborating with various stakeholders to make the internationalization process sustainable and beneficial to all ecosystems involved. Her career highlights include strategies for national and international pilots, curriculum expansions, technology co-creations, and digital transformations. Before IDL, Flávia was a Professor at DeVry University, where she contributed significantly to curriculum design and pioneered international exchange programs. She also played a key role in the CS4ALL program, promoting STEM education in Chicago Public Schools. Flávia Andrade’s professional journey is characterized by a passion for innovation, venture capital investment strategies, business internationalization, and higher education management.

Dreamers VC is a venture capital fund for startups that are addressing social problems.

Manuel Grossmann is a Partner at Amino Collective with a current investing position. His investment range is $5.0M to $10.0M, with a sweet spot at $7.5M. He has 18 investments on record across various sectors and stages, including Pre-seed Digital Health, BioTech, Health IT, and Health & Hospital Services. Manuel collaborates with co-investors like Friedrich A. Neuman, Peter Thiel, Christian Reber, Filip Dames, and Florian Otto.

Kris Lichter is an Angel Investor with a focus on strategic business consulting. He is a Co-founder and Managing Director at DuMonde Ventures, with a track record that includes roles as the Chief Executive Officer of Ardica Technologies, COO at Originate, and Director of Marketing and Communications at IBM Global Smarter Cities and Public Sector programs. Kris’s investments are typically in the Series A range, with collaborative and diverse problem-solving styles, emphasizing alliances for improved success.

Martin R. Felsenthal is a venture capital and growth-stage investor who focuses exclusively on innovative healthcare software and services businesses. His previous investments include the healthcare sector, and he has a track record as a professional journalist. The check size of his investments can be further explored through the PitchBook Platform. Collaboration and partnership styles are not explicitly mentioned, but he focuses on investing in healthcare, suggesting a collaborative approach within the health tech industry.

Robin Borg, with a Bachelor of Arts in Communications from the University of Minnesota and SPHR Certification, has over 30 years of experience in human capital management. As part of Transformation Capital, she focuses on building strong leadership teams and fostering company cultures to drive growth. Her dedication lies in improving the healthcare industry, emphasizing women’s issues and children’s health. Noteworthy companies in her portfolio include DexCare, Galileo, Bind, PeopleServe, Optum, Boston Scientific, and Abbott. Located in Minneapolis, Minnesota, Robin is committed to evolving the healthcare sector. While specific details on investment focus areas, check sizes, geographical preferences, and partnership styles are not readily available, her track record showcases a passion for supporting companies in achieving their goals.

Andrew Ferguson is the Managing Director at Webster’s Wealth Partners. He focuses on investments in wealth creation, estate planning, tax implications, and retirement planning. The check size for investments has been observed to be around $3 million. Unfortunately, specific details regarding previous investments, track record, stage of investment, and partnership styles were not found.

Felix von Laffert is passionate about exchanging ideas with founders and topics that will shape the future. He focuses on investing in companies that create real value, become established employers, and values analyzing business models. His career background includes previous positions at Bencis Capital Partners, Digital+ Partners, Henkel Tech Ventures, FTI-Andersch, and Hermes-OTTO International. Felix has a BSc. in International Business Administration from WHU – Otto Beisheim School of Management and The University of British Columbia (UBC).

Julianne Roseman is currently a Senior Associate at Plug and Play Tech Center focusing on Health & Hospital Services (Seed) and Health IT (Seed) investments in the Midwest region. Some of her previous investments include Helium Health and Rapicare. She has a track record in leadership, commercial litigation, market research, and analysis. Julianne has experience from previous roles at Plug and Play Tech Center and Harrington Discovery Institute at University Hospitals. Her partnership and collaboration style involve contributing valuable insights to the industry, with a keen focus on innovative healthcare solutions.

Cheryl Zimberlin, Investment Director at M Ventures (Merck), is known for her focus on Digital Health, BioTech, Health & Hospital Services, and Health IT sectors. She typically invests in the Seed to Series B stages with an investment range of $100K to $5.0M and a sweet spot of $1.5M. Her recent investments include ImmuneBridge in the Seed stage, with a total of $12M raised. Cheryl collaborates with co-investors such as Dylan Morris from Insight Partners and other investors like Anique ter Braake, Bauke Anninga, Christian Patze, Christian Uhrich, and Daniel Franke. Her track record showcases a strategic approach to biopharmaceutical investments within these sectors.

Ondrej Smolek is an investor with a focus on Material Science (Series B), SMB Software (Series B), BioTech (Series B), and Health IT (Series B). He typically invests between $100K to $5.0M with a sweet spot at $1.5M. His geographical preference and partnership and collaboration styles are not specifically mentioned in the available data. Ondrej Smolek’s current fund size is â¬24M, reflecting a successful track record in investing.

Norbert Dawalibi is an Angel Investor with a distinguished career, including 24 years at IBM. He serves as President and CEO at GlassHouse Systems and Chairman at Clairvoyant Technology. His previous role was as CEO at Sirit Technologies, sold to Federal Signal in 2010. His track record includes leading companies to successful achievements. Geographic focus and investment check size are not specified publicly. His partnership style likely involves active contribution, aligning teams, and fostering creativity for value creation in collaborative environments.

Matthew Keiser is the Founder and CEO of LiveIntent, known for his dyslexia, which he credits for his entrepreneurial success. His investment focus areas include ad tech, data, and communications. He has a diverse portfolio and has participated in investments in companies like Sourcepoint and Fanbridge. Keiser has a track record of successful investments. He operates in New York, NY, and is actively involved in collaborative partnerships to advance the benefits of higher education and promote the game of golf. The size of his investments varies, with notable deals in the range of millions. Keiser’s stage of investment typically ranges from Series A to later stages.

Jakob Loven, Ph.D., a Managing Partner at Nextech Invest Ltd, is an accomplished oncology-focused entrepreneur with extensive experience in creating, launching, and building early-stage therapeutic-based platform biotechnology companies. His previous board seats include A2 Biotherapeutics, Arrakis, IconOVir, Hexagon, Boundless, Laronde, and Scorpion Therapeutics. With a Ph.D. in medical sciences focused on oncology, Jakob has a multicultural background and a successful track record in the life sciences sector. His investment focus areas include creating early-stage therapeutic companies. Check size and partnership style details are not available on the website.

Michael L. Mark is a successful entrepreneur with a background in technology companies. He has a strategic focus on investments in the biopharmaceutical and medical device sectors. Michael prefers late-stage growth investments in market-leading companies. His geographical preference spans North America, Europe, and Southeast Asia. Some of his previous entrepreneurial ventures include American Energy Services, Inc., Intercomp USA, Inc., and Cadmus Computer Systems, Inc. Michael’s investment check sizes vary, and he is known for his partnership and collaboration styles that focus on strategic alignment and mutual trust.

Bolt is a pre-seed venture firm investing where the digital and physical world intersect.

Bernhard Koehler is a Senior Investment Manager at Bayern Kapital, involved in funding startups in sectors like Medical Devices (Series B) and SMB Software (Series B). His investment range typically falls between $100K and $5.0M, with a sweet spot at $1.5M. Currently, he operates within a fund size of â¬24M, collaborating with other investors to support ventures at various stages. Bernhard’s investment approach seems focused on specific sectors and stages, indicating a strategic and diversified portfolio.

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Jacopo Leonardi is a Partner at Agent Capital, a biopharmaceutical investment firm. With a 25-year track record, his expertise lies in global commercial operations, focusing on orphan and rare diseases, immunology, and neurology, aligning with Agent Capital’s investment focus. The firm supports disruptive healthcare companies with novel therapeutics, aiming for high returns. Jacopo’s career spans roles at prominent companies like Baxter and Baxalta. Agent Capital’s previous investments include 14 healthcare companies, with four going public. Jacopo’s track record showcases sustainable growth in new ventures. Though specific check sizes are not listed, collaborations align with diverse management teams for superior returns and fostering healthcare innovations.

Vita Advisors, founded by Kevin Roche and Michael Kessler in 2008, provides research-grounded strategic advisory services to select healthcare companies.

Todd Katz is a Partner at Round One Capital, focusing on providing seed capital to firms in pre-seed and seed stages across areas like Insurance, Consumer Health, Digital Health, Health IT, and Consumer Internet. He has a track record of successful entrepreneurship, including founding a medical company and acquiring Bell-Horn for orthopedic manufacturing. Katz’s investment check size ranges from $100K to $5.0M, with a sweet spot of $1.5M. His collaboration style is known to involve active advisory roles and board membership in addition to providing seed capital.

Ilya Oskolkov-Tsentsiper, an angel investor, has previously invested in Building Maintenance, Home Renovation, Real Estate, and Sdelano acquired by Kismet Capital Group (KCG) markets. He is known for his achievements as the Founder of Afisha magazine and as the President of the Strelka Institute for Media, Architecture, and Design. Ilya’s investment check size and partnership style are not specifically mentioned in the available information.

Erwin Arkema, Co-Founder of TradeCast, has invested in Series E – Carbon and iCasting, focusing on media & enterprise software. Erwin Arkema’s partnership and collaboration style involves open innovation initiatives and participation in scientific and industrial partnerships with universities, start-ups, and public agencies. His investment check size and investment thesis were not specifically available. Erwin Arkema has a diverse background as the Founder & CEO at iCasting and the General Manager at IQ-Media. His previous investments include notable ventures like iCasting. Erwin Arkema’s geographic focus and stage of investment were not specified.

Miles Beckett is an investor with a focus on healthcare, specifically in the dental care industry through Flossy. His investment check size typically ranges from $5,000 to $25,000 per company. His geographical preference includes locations in San Francisco and Los Angeles. Some of his previous investments include Silversheet, Ringadoc, Tradesy, and Chromatik. Miles Beckett’s professional career includes founding and leading companies such as Flossy, EQAL, Silversheet Credentialing Solutions, and LG15 Studios. He holds a BS in Neuroscience from the University of California, Berkeley, and an MD from UC San Diego School of Medicine.

Gil Penchina is a seasoned investor with a strong track record in angel investing. He has founded and been involved in various companies including Flight Ventures, Pryze, and Fastly. Gil Penchina’s investment check size varies depending on the opportunity, and he has made investments in sectors like Enterprise Applications and Blockchain Technology. He has a diverse portfolio with notable companies such as happn, Origin Protocol, Orion, Nuzzel, and Contactually. With extensive experience in the industry, Gil Penchina brings valuable insights and expertise to the ventures he supports.

Halle Tecco is a healthcare investor with a focus on D2C and patient-centered healthcare innovation. She has made investments in companies like Natalist and Rock Health. Halle Tecco’s investment check size ranges from $10,000 to $250,000. Some of her previous investments include Natalist and Marley Medical. She collaborates with celebrities like Jennifer Lopez, Mark Cuban, and Ashton Kutcher in the healthcare sector.

The Angel Capital Group is an angel investor and venture capital firm investing in seed/startup and early growth stage companies, focusing on social media, medical devices, and movies/entertainment. The firm does not have a specified geographical preference and invests domestically. They have a track record of successful achievements and the CEO job announcement indicates a distinguished professional career. The investment check size varies between $500,000 to $2 million per round. The partnership and collaboration style involve keeping the angel investor updated on the company’s progress to maximize the partnership.

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

Sapan Shah is a Managing Partner at Alera Group, Inc., and a Board Director at HPA. He has been involved in various board director roles and has a background in healthcare acquisitions. Sapan Shah’s career showcases experience in healthcare and investment roles, with a focus on board memberships in Chicago-based organizations.

Pradeep Bekal is an Angel Investor at Angel Physicians Fund, a venture capital firm based in Powell, Ohio. The fund focuses on life science and healthcare investments at the seed stage. While specific investment thesis or partnership styles were not found, the fund’s investment check size and stage indicate a focus on supporting early-stage companies in those industries. The geographical preference and track record of previous investments are not available. Pradeep Bekal is associated with medical centers in Cincinnati, Ohio, and is known for his work in treating GI issues.

Farzad Nazem is an angel investor focused on pre-seed investments in areas such as Hardware, Medical Devices, Analytics, Education, BioTech, Marketplaces, Health & Hospital Services, Health IT, AI, and SaaS. He is based in the San Francisco Bay Area. His investment check size ranges and geographical preference are not specified. Farzad Nazem has a strong track record with 54 investments recorded, including companies like Ceevra, Inc., TigerGraph, Emailage, Luminist, and Tubi. With a background as the former CTO of Yahoo!, he brings extensive experience to his investments. His partnership and collaboration style involves engagement through partnerships and collaborations to drive innovation.

Gregory D. Wasson is the Co-Founder of Wasson Enterprise, a family office that partners to build sustainable, high-growth businesses aiming to do well by doing good. He collaborates to create disruptive businesses with a lasting impact in industries such as healthcare data analysis platforms, medical waste management, therapies, e-commerce, money transfers, and energy storage systems. Wasson’s investments align with his focus on sustainability and purpose-driven entrepreneurship. He has a wealth of experience in leadership, operations, and governance, contributing to the success of ventures he supports. Wasson’s partnership and collaboration styles involve building legacy businesses, and he serves in leadership roles across various organizations, including the board member at Cooler Screens, Performance Health Systems, and Innovation Associates, among others.

Daniel Cane is the co-founder of Modernizing Medicine, a healthcare IT company known for creating an electronic medical record system. His previous company was acquired for $1.6B. Daniel Cane’s investments include companies like Honorlock and SocialRadar primarily in the Enterprise Applications and EdTech sectors. He has a track record of entrepreneurial success and community involvement, winning awards like the Florida Business Ambassador Award. His investment check size and partnership styles are not explicitly mentioned, but he founded Cane Investment Partners in 2014, focusing on growth equity in sectors like healthcare, specialty finance, energy, real estate, and services.

Roman Huber is the Managing Director of Bayern Kapital, a venture capital firm that focuses on deep tech startups in the software, bioscience, healthcare, and pharmaceutical sectors. The firm invests from â¬250,000 to â¬25 million Euro and partners with startups offering new technical developments. Bayern Kapital’s investments in software startups include Wealthpilot, Daypaio, and Cliniserve. They emphasize on B2B business models with a clearly defined benefit for customers and require a comprehensive business plan with a technical roadmap. Roman Huber predicts growth in machine learning, AI, AR, robotics, and green technology.

Clint Nelsen is a Co-Founder and Managing Director at Startup Labs. He is an Angel Investor and invests in promising companies. Based in Seattle, Clint is passionate about startups and has a finance background from the University of Wisconsin. Clint has been featured in various publications worldwide and serves on the board of “The Common Good” organization. He has a track record in startups, co-founding Tomato Battle and being involved in projects like Startup Weekend and Ticketbase. While specific information about his investment focus areas, geographical preferences, previous investments, investment check size, and partnership styles could not be found, Clint Nelsen’s career showcases his dedication to nurturing startups and entrepreneurship.

Christian Schuetz is a Partner at b2venture, one of the most active investors in Europe, passionate about venture investing in life sciences, medtech, and health-AI sectors. His investment focus areas include managing the firm’s Industrial Technologies Fund, biotech, and health-related investments. Christian works with angel investors and has a track record of previous investments in various sectors.

RRE Ventures is a Venture Capital Firm.

Joe Schmidt is the Chief Executive Officer of WalkFree.org and Co-Founder of CustomerHD. He is an angel investor and serves as Advisor and Investor at Cofounders Capital. He co-founded Canvas on Demand and the Audacity Factory. Joe has a background in Entrepreneurship and holds an MBA from Boston College.

Brad Charchut is a Partner in the Private Credit Group at Bain Capital, based in the Chicago office. He is responsible for capital markets and originations in North America. He joined Bain Capital in 2011 and previously worked at Cerberus and Heller Financial. Brad Charchut’s previous investments include acquiring Merchants Fleet, a high-growth fleet management company, alongside the Merchants leadership team.

Digital Health Angels is a prominent investor in the Digital Health sector, focusing on seed-stage investments in companies with live MVPs or products in the market. Their investment strategy emphasizes technologies that drive healthcare innovation and transformation. While specific details about their investment thesis, focus areas, check size, geographical preference, and partnership style are not available, Digital Health Angels has a track record of consistent investments in digital health ventures over the years. Their investments are strategically aimed at supporting startups in the Digital Health space, contributing to the advancement of healthcare technologies. The precise size of their investments, previous investment portfolio, and partnership approaches remain undisclosed. This investor plays a vital role in fostering innovation and growth in the Digital Health industry.

Alison Schulte is the Vice President at Thompson Street Capital Partners, with an investment range of $5.0M – $50.0M and a sweet spot of $25.0M. She focuses on various sectors including Medical Devices, Pharmaceuticals, Consumer Health, and AI at Series B stage. Alison Schulte’s recent investments include roles at Thompson Street Capital Partners and Panera Bread. She collaborates with investors from Thompson Street Capital Partners such as Alex Mace, Bob Dunn, Bradley Strahorn, Brian Kornmann, and Cathy Bowers.

Ted Lachowicz is an Angel Investor who serves as a Board Member at IMAJION and has made investments in VIMOC Technologies. He is a member of the Advisory Board for the Whitman School of Management and Athletic Policy Board at Syracuse University. Ted Lachowicz holds a B.S. in Accounting from Syracuse University and is a non-active CPA in Florida and California.

Toba Spiegel is an Investment Manager at Trill Impact focusing on Impact Ventures. His investment focus areas include Digital Health, Health IT, and Health & Hospital Services for both Series A and Seed stages. Toba Spiegel’s previous investments include companies like Open Cosmos and Autovio. He maintains partnerships and collaborates with investors such as Christian Schulte, Felix von Laffert, and others. Unfortunately, details on Toba Spiegel’s track record, geographical preference, stage of investment, and investment check size were not found.

Chase Petrie, Principal at LOUD Capital, based in Columbus, Ohio, focuses on alternative investments. LOUD Capital’s investment thesis includes fueling innovations for equitable access to quality healthcare. Their investment areas cover medtech, alternative care models, healthcare infrastructure, and IT. LOUD Capital invests in a mix of traditional and alternative assets to reduce risk and enhance returns. Chase Petrie’s investment check size ranges from $100K to $5M, with a sweet spot at $1.5M. He has a track record of investments in sectors like Messaging, AutoTech, Payments, and FinTech at different stages. LOUD Capital’s partnership style is to empower healthcare ventures through resources and advisory support. Their collaboration emphasizes stakeholders’ understanding of healthcare complexities to drive successful ventures.

Will Bricker is a Principal at Hustle Fund specializing in investing in Pre-seed and Seed startups focusing on areas like Future of Work, SMB Software, Data Services, Developer Tools, Analytics, Cloud Infrastructure, AI, Enterprise, FinTech, and SaaS. Some of his previous investments include Pre-seed North American software startups. His professional career includes roles at Hustle Fund, Bridgewater Associates, and J.P. Morgan Asset Management. Will Bricker’s investment check sizes are detailed in articles he has published regarding portfolio management. For partnership and collaboration styles, specific data was not available on the website.

Quinto Van Peborgh is a venture capitalist with a focus on the e-commerce sector. He emphasizes the importance of aligning with venture capital funds’ priorities and demanding profitability from startups. Quinto has demonstrated an interest in B2B marketplaces and currently invests through the platform “rintin.” His investment strategies concentrate on seed-stage companies, contributing to their success post-investment. While his geographical preferences are not explicitly stated, his professional career showcases his involvement as a Co-Founder and CEO at rintin. The specific investment check sizes or partnership styles for Quinto Van Peborgh were not explicitly mentioned in the search results.

William Tay’s investment check size is not explicitly mentioned on the Equilar ExecAtlas page.

Michael Berman is a Venture Partner at RiverVest Ventures, specializing in medical device investments. His investment focus is on pre-seed to Series B stages, with a range from $100K to $5.0M and a sweet spot at $1.5M. Berman has a track record of investing in companies like BridgePoint Medical, Apnex Medical, and Prospex Medical. His geographical preference includes Israel and the Midwest region. With a current fund size of $184.4M, Berman collaborates with co-investors such as Brian Chee (Polaris Partners). His professional career includes roles as a Board Member at multiple medical device companies, Chairman at Rebiotix, and President at Boston Scientific Cardiology. Berman’s investing strategy involves partnerships with investors like Andrew Kleiboeker, Derek Rapp, Isaac Zike, Jay Schmelter, and John McKearn.

Kamran Shamsavari is the Chief Executive Officer and President at Xandex Investments, providing seed and early stage funding for ventures in Mobile Digital Technology, Healthy and Sustainable Lifestyles, and Medical Devices. The geographical focus includes North America, Asia, and the EU. Some of the previous investments include companies like Apple Inc., Amazon.com Inc., and Tesla, Inc. Shamsavari holds an M.S. degree in Mechanical Engineering from MIT, an MBA from Harvard Business School, and a B.S. in Mechanical Engineering from Cornell University.

Martin Redl is the Investment Director at Bayern Kapital, overseeing the early-stage sector since 2007. He focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments include Shore GmbH, United Maps, and casavi GmbH. Martin holds a track record of successful early-stage investments. His check sizes vary based on the project. With a collaborative and hands-on approach, he positions Bayern Kapital at the forefront of innovative funding strategies.

John Prendergass is an investor who focuses on early-stage digital health, biotech, and medical device companies in the greater Philadelphia area. He seeks solutions that fill unmet medical needs, with investments ranging from $50K to $500K and a sweet spot of $300K. His previous investments include OneForty in a Series A funding round. John Prendergass’s partnership and collaboration style involve investing in startups with specific healthcare objectives and avoiding basic R&D or cost-increasing solutions in the healthcare system.

Btov Partners is a venture capital firm focused on early-stage investments in digital and industrial technology companies.

Michael Nicastro is an individual angel investor with a focus on seed-stage investments. He operates primarily in the East Coast, New England, and Northeastern US regions. His investment check size and previous investments are not publicly available. Michael Nicastro has a diverse professional career, serving as an Executive Chairman at FinTron, CEO & Principal at Coppermine Advisors, LLC, Associate Professor and Entrepreneur in Residence at Central Connecticut State University, and Adjunct Professor at Western New England University School of Law. He also holds various board positions and volunteering roles, showcasing his active engagement in partnerships and collaborations across different sectors.

Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.

Christian Faes is the founder of Faes & Co, an investment firm focusing on real estate bridging finance in the US. The firm’s flagship private credit fund invests in technology-enabled direct lending businesses, primarily in the real estate bridging finance sector. Faes & Co has extensive experience managing over $5 billion in Funds under Management and employs over 200 people. Christian Faes has invested in early-stage tech companies such as Hubble and Volume. The investment check sizes range from $150K to $800K per company. Regarding partnership and collaboration styles, Faes seeks partnerships that advance its mission to support biomedical science through training, educational programming, networking, and career development, with a focus on promoting FAES as a valued organization.

Shaheen Shamsavari serves as Principal at Xandex Ventures and is also an Angel Investor. He has expertise in business development in Xandex’s Semiconductor, Solar, and Investment Divisions, with a focus on managing Xandex Investments’ portfolio. He is a member and active investor at the Life Science Angels, Keiretsu Forum, North Bay Angels, and HealthTech Capital. Previously, he worked at Gilead Sciences in Formulations and Process Development, specializing in HIV and Hepatitis C therapeutics. Shaheen is a graduate of the University of California at Berkeley in Molecular and Cell Biology with a Neurobiology emphasis. Additionally, he is the Founding member at HealthTech Capital.

Craig Pearlman, Managing Partner at VentureDNA, is focused on investing in innovative technologies and sustainable real estate redevelopment. He targets Technology Innovation and Real Estate Substantial Redevelopment as key investment areas. With an investment range from $100K to $5.0M, VentureDNA’s sweet spot is around $1.5M. Craig’s recent investments include sectors like Manufacturing, Retail, Digital Health, Health & Hospital Services, and Health IT, both in the Seed stage and Series A. His collaboration style involves key co-investors like Joe Brickman, Mark Hahs, Stewart Dixon, and Tom Ramar. Operating out of Chicago, Illinois, Craig Pearlman brings expertise and a track record in nurturing startups in these sectors, providing guidance and strategic input to foster growth and success.

Flatley Venture Capital focuses on investing in medical companies, particularly in areas related to cystic fibrosis. Their investment stages may include seed funding, startup capital, early stage, expansion, and later stage. Previous investments include Illumina. The check sizes of their investments vary, possibly ranging from under $300,000 to under $10,000,000. Their partnership and collaboration styles may involve setting up joint ventures and launching companies around interesting technologies.

Robert Kocher serves as a Partner at Venrock specializing in healthcare IT and services investments. His geographical focus includes North America and LATAM. Previous investments include companies like Devoted Health and Aledade. Dr. Kocher has a distinguished professional career leading him to roles in the Obama Administration and McKinsey & Company. The investment check size at Venrock ranges based on the stage of the startup. Partnership and collaboration styles reflect a focus on health tech and services investments.

Huseyin Karayagiz is a Co-Founder of TRAngels and Founder Partner of TÁRKKEP. With over 20 years of experience, he specializes in developing and selling internet, mobile, and cloud-based solutions. His investment focus areas include Marketing & Sales, and Investment & Fundraising. Huseyin’s previous investments include companies like Batron Enerji. He has a strong track record as an angel investor and typically invests in early-stage startups. His investment check size varies based on the opportunity. Huseyin Karayagiz is known for providing capital and advice to startups and portfolio companies, demonstrating a collaborative and supportive partnership style.

Grant Silow is a Managing Director at 25madison with a background in corporate development, venture investing, sales, go-to-market activities, and growth equity investing. He holds an MBA from Yale School of Management and a BA in International Studies from Johns Hopkins University. Silow has a keen interest in connecting with entrepreneurs solving significant challenges in innovative ways. His geographical experience includes Philadelphia, Baltimore, San Francisco, New Haven, and he currently resides in New York. In his role, Silow focuses on seed, pre-seed, and incubation in software technologies. He is actively involved in finding the white space in areas of interest to the company. Grant Silow’s investment style reflects a passion for financial inclusion and aging, aligning with his commitment to supporting startups tackling societal issues through innovative solutions.

Jaffray Woodriff, the Co-founder and CEO of Quantitative Investment Management, has a clear investment philosophy: “Embrace Simplicity, Beware Complexity.” His focus areas include investing in early-stage startups through The Felton Group and supporting entrepreneurs through the CODE Building in Charlottesville. Woodriff has made 9 investments, with recent ones like Yogi in Series A. His portfolio exit includes VividCortex. Woodriff’s investments range from early-stage ventures. He has a strong connection to his hometown of Charlottesville, showing a dedication to nurturing the entrepreneurial ecosystem there. Woodriff’s investment check size varies based on the investment stage and company needs.

Nick Ganju is a Co-Founder at ZocDoc with investments in ZocDoc, LearnStreet, and CK-12 Foundation. His investment check size is aligned with ZocDoc’s $130m funding round. His professional career includes roles as the Chief Technology Officer at ZocDoc and prior experience in startups like Mixonic. His geographical preference is not explicitly stated. However, his investments indicate a focus on technology vendors, corporate strategy, venture capital, and IT sectors. Nick’s partnership and collaboration style involve strategic initiatives and addressing impactful opportunities.

Brian Belsky is the Principal at Ascension Ventures, specializing in investments in Consumer Health, Digital Health, Health & Hospital Services, and Health IT. His investment range is $3.0M – $15.0M with a sweet spot at $8.0M. He has a current fund size of $255M. Brian has made notable investments like Strive Health and collaborates with co-investors such as Mohamad Makhzoumi, Sumi Das, and Vijay Patel. His investment style involves partnering with investors like Evan Stoff, Guneesh Batra, and others.

Ijeoma Agulanna@yahoo.com is a Pathologist with a background in various medical fields such as Thoracic Pathology, Anatomic and Clinical Pathology, and Polycystic Kidney Disease. They have pursued degrees in Pathology, Medical Science, Surgery, and Urology Residency, graduating from institutions like New York University and Yale School of Medicine. Ijeoma’s education includes a Doctor of Medicine (M.D.) degree and a Master’s degree. Their career spans roles like Attending Physician and Research Fellowship at esteemed medical institutions in the United States and Brazil.

Hatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.

Christopher Drake is an Angel investor with a background in founding and serving as CEO at Armor. His previous investments include Quantum Security, Defendry, Valify, and Ryver. He holds a BBA in Marketing from the University of North Texas, Denton, and a Business Degree from the University of California, Berkeley. Christopher Drake’s partnership and collaboration styles involve corporate structuring, start-ups, joint ventures, and M&A. He is known for his expertise in aviation funding structures, crisis management, and litigation support services. For inquiries, contact Chris Drake at +81 90 7400 3059 or [email protected].

Merel Keereweer is an investor at Borski Fund, specializing in Health & Hospital Services (Seed) and Health IT (Seed). Their investment range is $100K – $5.0M, with a sweet spot at $1.5M. Some of the investors who collaborate with Merel Keereweer include Aletta Stas-Bax, Bertrand van Leersum, Dagmar van Ravenswaay Claasen, Hannah van Goor, and Laura Rooseboom. Previous investments include projects related to the Future of Healthcare Committee.

Thomas Andrae focuses on investing in tech-forward healthcare entrepreneurs and innovators who are leading the way in biological engineering.

Jonathan Bush is the Chief Executive Officer at Zus Health, serving as an Advisory Board Member at Innovaccer and Sana Capital. He co-founded and was the Chairman of Athenahealth. His expertise covers various areas including care delivery redesign, community-focused health, mental & behavioral health, payment redesign, and organizational transformation. Jonathan Bush’s investments typically target later stage ventures with deal size information not disclosed. He has made previous investments in a variety of healthcare startups. His professional career includes roles as a medic in the U.S. Army, a management consultant at Booz Allen Hamilton, and a founder of Zus Health and Athenahealth.

Philip Vecht is an entrepreneur, business angel, and investor with a diverse portfolio. His investments include companies like Baboo Gelato Ltd, Selectika, Zinc Work, Skarper, Xapien, Rotor Videos, Heights, Fix Radio, among others. Philip has experience in various positions in investment, private equity, property investment, and development. He is an Entrepreneur in Residence at Queen Mary University of London and holds a LLB Hons degree in Law. Philip Vecht’s investments span across different sectors and technologies, focusing on startups in the UK and beyond.

Jonathan Greenfield is an Angel Investor. He served as Executive at Life Science Angels.

Grand Ventures is an early stage venture fund investing in seed stage B2B SaaS companies in emerging regions of the US and Canada.

Johanna Liebner is a Senior Investment Manager at Bayern Kapital, with over 20 years of experience in taking care of investments. She is committed to managing investments for the company. Contact email: liebner@bayernkapital.de, Phone: +49 871 92325 – 29.

ISA Ventures is an Iowa’s first multi-stage venture capital studio.

Joshua Bogart is a seed and early-stage startup angel investor. He is the Founder of Intrigued – Stealth Mode Matchmaking Startup and Co-owner of Catapult Consultants, Inc. He has a track record of being part of Inc. 500 companies in the past. Unfortunately, specific details about his investment focus areas, stage of investment, geographical preference, previous investments, investment check size, and partnership style could not be found.

Joseph Whitters is a seasoned investor with extensive experience. He serves as a Board Member at Higher Learning Technologies. Joseph Whitters brings notable public company governance experience in the medical technology and device industries. He is associated with leading healthcare providers like PRGX Global, Inc. and InfuSystem Holdings, Inc. Joseph has a background in venture and growth equity capital, contributing to emerging healthcare companies’ growth. His expertise and experience enhance shareholder value. Known for his public company board roles, Joseph Whitters has prior board experience with various reputable organizations. Recent SEC filings mention his engagements up to 2021-08-30. Mr. Whitters’ collaboration style aligns well with the introspective, relational, and expressive types, with strategies in place to ensure effective collaboration among these styles.

Simon Whitfield is a Co-Founder at Relentless Pursuits Partners, focusing on investments in health, activity, and longevity. He has a commitment to preventive healthcare, disease risk mitigation, and chronic disease management. Simon’s previous investments include a Sport Technology Company called TritonWear. The investment check size for Simon Whitfield at Relentless Pursuits Partners is not specified. His partnership and collaboration styles involve co-founding an angel investment group dedicated to healthy, active living, as well as working with non-profit organizations and receiving awards for his advocacy and mentorship in sport and health.

Landmark Angels actively seeks out investment opportunities ranging from $100K to $2M, with a focus on key industry contacts and conferences. They provide valuable advice and resources beyond capital. The firm has a broad investment thesis focusing on effective scaling companies with exit potential. Landmark Angels accepts applications from all geographic regions and was established in 2008 with substantial investment expertise. Previous investments information is not readily available. The average check size of investments can vary from $100K to $2M. Partnership and collaboration styles are focused on providing entrepreneurs with advice and resources beyond funding.

Joseph Speiser is a Seed investor with a focus on investments in the Greater New York Area, East Coast, and Northeastern US. His previous investments include The Fascination, Paytient, and The Hustle. Joseph’s investment check size typically ranges from seed funding to angel rounds. He seems to align well with task-oriented collaboration, prioritizing tasks, objectives, and deadlines to drive productivity.

Scott Moore is a Co-Founder and Chief Financial Officer at Boltive. He serves as a Board Member at Ad Lightning and has over 20 years of leadership experience in digital media. Moore has held positions such as Senior Vice President of Media at Yahoo!, General Manager at MSN, and President at MSNBC.com. He is a graduate of Harvard College and the University of Washington Foster School of Business (MBA).

Jim Bullock is the President and CEO of Zyga Technology. Prior to joining Zyga, he was the President and CEO of Atritech, Inc. and Endocardial Solutions, Inc. He has a strong background in the medical device industry and a track record of creating value for startup companies. Jim’s focus at Zyga is on clinically validated products addressing clinicians’ needs such as the SImmetry™ Sacroiliac Joint Fusion System and GLYDER™ Facet Resurfacing System. His expertise and commitment contribute to the company’s growth.

Franz Wocheslander is a Senior Investment Manager at Bayern Kapital. His investment focus areas include technology for stroke prevention. He invests in early-stage startups and prefers cooperative collaboration. Franz has invested in Curefab and has successfully managed a diverse fund portfolio. His check size ranges based on the startup requirements.

Mahendra Matta is an angel investor at Angel Physicians Fund, passionate about advancing healthcare through advanced technology. He has invested in startups such as Foldax and Aria CV. Dr. Matta focuses on healthcare advancements and has a track record of supporting innovative healthcare startups.

Joanna Soroka is a Principal at Hitachi Ventures with a focus on investing in Smart Cities/UrbanTech, Security, Robotics, Cybersecurity, EnergyTech, TransportationTech, IoT, Data Services, and more at Series A stage. She has a current fund size of $150M and a typical investment range of $100K to $5.0M. Her sweet spot investment is around $1.5M. Joanna has a track record of managing technology conglomerate ventures and corporate funds, primarily in the DACH region, providing strategic support to startups and collaborating with other top investors such as Ankesh Madan, Galina Rachenkova, Jan Marchewski, Pete Bastien, and Stefan Gabriel.

Paul Sethi is a seasoned investor with a focus on AI, digital bioprocessing, and health technologies. His previous investments include UniKey, SmarterX, and Mealco in the Business/Productivity Software and Media sectors. Dr. Sethi is a prominent orthopedic surgeon known for his sports medicine expertise, serving in various medical societies. His investment check size ranges from $300K to $600K, with a sweet spot at $450K. Dr. Sethi’s collaborative style aligns with introspective and relational approaches, emphasizing deep work, human connections, and visual engagement.

Rex Burgdorfer is a Managing Director at Juniper Advisory, specializing in non-profit health system mergers and acquisitions. He focuses on executing mergers and acquisitions transactions. Rex’s investment focus areas are in non-profit health system mergers and acquisitions. He has a professional career spanning over a decade in this market. Unfortunately, specific details about his stage of investment, geographical preferences, previous investments, investment check size, and partnership and collaboration styles were not found in the available information.

Ozan Polat is an investor with Vine Ventures, focusing on novel approaches to conscious health & wellness. He co-founded Dezentrum, a think tank researching positive future scenarios for a digitized society. With a passion for innovative societal approaches, he joined Vine Ventures. Vine donates 50% of profits to mental health and collaborates with Othership, a mental health community. Representative companies include Ryan Zurrer. Ozan’s investment check size, stage of investment, and partnership style were not explicitly mentioned on the website.

Mark Carthy is the Managing Partner of Orion Equity Partners, LLC, a healthcare venture capital firm co-founded by him. Orion focuses on investments in companies developing products addressing major medical or healthcare industry needs. The firm’s geographical preference is not specified. Orion Healthcare Equity Management primarily invests in health-related ventures. The stage of investment by Orion is early, with a focus on the health sector. Previous investments by the firm include companies such as Solexa and PowderMed. However, specific investment check size and partnership and collaboration styles are not readily available.

Anja Konig, as the Global Head of Novartis Venture Fund, focuses on developing novel therapeutics and platforms, with particular interest in patient solutions and life sciences opportunities. Her investment check size involves rounds for companies like Epsilogen and Splice Bio. Anja Konig’s previous investments span pharmaceuticals, biotech, and medical devices. With a background at McKinsey, she has facilitated successful exits for companies like Heptares Therapeutics and Covagen. Anja Konig collaborates through entrepreneurship, venture philanthropy, and impact finance, aiming to create innovative solutions for societal challenges and promote market-led sustainable development.

White Star Capital is an international venture and early growth-stage investment platform in technology.

Brett Crosby is the Co-Founder and Chief Operating Officer at PeerStreet, a platform for investing in real estate debt. He has a track record of success, having co-founded Google Analytics and Urchin Software Corporation. Crosby’s investment thesis focuses on transforming mortgage finance through PeerStreet, with a strategic emphasis on real estate debt. His investments typically range across sectors like Enterprise Applications and Consumer, with notable investments in Xola, Cord, and Triggit. Crosby’s investment check sizes vary, with most recent investments made in Cord during a Seed Round. He has a collaborative style, as evidenced by PeerStreet’s mission-driven approach and emphasis on real estate debt solutions. Previous portfolio companies include Xola, Cord, and Triggit among others.

Stephanie Jin is an investor at Avestria Ventures with a focus on early-stage women’s health and life science companies. Her investment thesis centers around impact investing in female-driven startups. Stephanie prefers to invest in companies prioritizing women’s health, aiming to create a positive impact through entrepreneurship. While her geographical preference is not specified, she is actively involved in the innovation and funding of medical startups that prioritize women’s health. Stephanie Jin’s track record includes cofounding Avestria Ventures to support startups in the digital health sector. She seeks to provide impact-driven investments, with check sizes that can range based on individual funds raised. In terms of partnership and collaboration styles, she is known for her strong support for female entrepreneurs and digital health initiatives.

Rajit Malhotra is an investor with a deep expertise in healthcare and experience in industries like Biopharma, Artificial Intelligence, Energy, and Real Estate. He has a background in advising Fortune 500 companies, specializing in healthcare, public sector, and EPNG practices. Rajit is the Executive Chairman of AmperSand Biopharmaceuticals and Tour Engine. His investments are focused on advanced technologies in therapeutics, medical devices/diagnostics, and digital health, with a funding range of $50-$150k per project. He is actively involved in organizations like UCLA Technology Development Corporation and the CAFAM Museum, displaying a commitment to civic and charitable projects. Rajit Malhotra’s approach involves supporting projects with significant commercial potential, promoting collaboration and the commercialization of UCLA-owned technologies.

Mariejo Johnson is an angel investor who focuses on investing in promising companies. Her professional career includes being an entrepreneur with a dedication to serving others. She has a track record of success and has been recognized as a Top Workplace. Mariejo’s investment style involves investing personal funds in exchange for equity in companies. She follows a consistent check size approach to negotiate better deals and ensure diversification. Collaboration and partnership styles are aligned with providing early-stage research funding, seed funding, equity investments, and licensing opportunities to support innovative ventures.

Chris Ash is an Angel Investor based in London, United Kingdom. He specializes in seed round investments with a focus on digital media, social games, gambling, mobile games, casual games, consumer internet, tablets, and mobile technology. Chris is particularly interested in early-stage tech product development for mobile and tablet applications across various sectors and is known for being a gaming specialist. His investment check sizes vary and include examples like $1 million for a company, â¬11 million for Series C funding, and $524,000 for a seed round. Chris Ash has a track record of investing in companies across different stages and is actively involved in the startup ecosystem, providing valuable support to budding entrepreneurs.

Tom Nicholson is a Founding Member at ARC Angel Fund, an angel fund focusing on early-stage and seed investments in Software, IT, Internet, Tech-Enabled Services, Business Services, Digital Media, Mobile, and Healthcare IT. The fund’s investments typically range from $50,000 to $150,000 per company. Tom Nicholson has a professional career as a CEO/President at Nicholson NY, providing capital and advisory services for early-stage companies. He has also served as an advisor at Art.sy and in leadership roles at LBi International AB and IconNicholson. Tom Nicholson holds an MFA from Cranbrook Academy of Art and a B.A. from the University of Detroit Mercy. As for his partnership and collaboration style, there was no specific information available on his LinkedIn profile regarding this aspect.

LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.

Clemens Raemy is a healthcare investor focused on professional care services at home in Germany. He co-founded Kenbi to address the shortage of nurses and caregivers, emphasizing a nurse-centric approach. Raemy’s investment check size ranges from pre-seed to Series A with total equity financing exceeding â¬30 million. Kenbi’s partnership style is digitally driven, prioritizing nurse independence through a communication platform.

Soumitra Sengupta is a Venture Partner at Elevate VC located in Kirkland, Washington. His investment range is $25K – $2.0M, with a sweet spot at $1M. Soumitra focuses on sectors such as Pre-seed Biotech, Seed Biotech, and Series A Biotech. He has recently invested in Pre-seed Biotech startups with co-investors like Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni. Soumitra Sengupta’s collaboration style includes working with investors such as Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni.

Scale is an early-stage venture capital firm focused on intelligent business software.

Adam Sackstein, the Founder and Medical Director of Innovative Spine and Pain LLC, New Jersey, is a respected healthcare professional with a wealth of experience. As a Co-Founder and Managing Member of Physician Management Services LLC, he demonstrates leadership in healthcare management. With significant roles such as President and Vice President at the NEW JERSEY SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS, Adam has a strong background in pain management. He has served on the Executive Board of multiple healthcare organizations, including The Surgery Center at Hamilton and Premier Surgical Center, showcasing his diverse expertise. As Northeast Medical Director at Prospira PainCare, Adam has enhanced his medical leadership skills. His impressive career includes positions as CEO of VasoPrep Surgical and Owner of The Pain Management Center. Adam’s commitment to healthcare excellence and his extensive involvement in various medical organizations underscore his dedication to the field.

Frederik Groenewegen is a Co-Founder and General Partner of 415 Capital. He specializes in investing in innovative medical technology companies, with investments in companies such as Supira, CorFlow, Cardiac Success, Aktiia, Distalmotion, R3 Vascular, and TRiCares. Frederik has a strong track record and professional career, with experience in business development and finance from roles at Regis Medical and HSBC. His investment check sizes typically range from $250K to $5M per company. In partnerships and collaborations, Frederik emphasizes supporting mission-driven founders and early-stage companies to foster growth and success.

OTV is a global digital health venture capital fund with offices in Tel Aviv, Israel and Shanghai

Zak Slayback is a venture capital professional and writer working at 1517 Fund. He focuses on pre-seed Deeptech startups, has a proven track record with successful investments, and is connected to various partners. His investment range, sweet spot, and identified sector and stage rankings align with his current position. Specific investments include a company in the pre-seed stage with details on the round size, date, and co-investors.

Nathan Owen is a General Partner at Grand Ventures, with a focus on investing in the DevOps and Developer Toolchain sectors. He evaluates Open Source Startups and values founders who are resourceful and possess multidisciplinary skill sets. Grand Ventures manages early-stage investments primarily in North America and Europe, with a typical check size of $4.7M. Nathan’s previous investments include Payload. His professional career includes working at Blue Medora and holding leadership roles in various organizations. Grand Ventures emphasizes diverse work styles and collaboration within its partnerships.

Jake Lodwick is an investor with a focus on seed-stage investments. His investment thesis emphasizes supporting technologies that transform industries. He has invested in companies such as HowGood, MakerBot Industries, Francis and the Lights, Muxtape, Bleacher Report, and Tumblr, with successful exits like MakerBot. His check sizes range based on the stage and need of the companies. Jake Lodwick prefers partnerships that help companies succeed post-investment, as evidenced by his track record in transformative technologies.

Christie Iacomini, the VP of Engineering & Partner at Prime Movers Lab, has a background in aerospace with experience at Blue Origin, Lockheed Martin, and advisory roles at Prime Movers Lab. Previous projects include the X-38 Crew Return Vehicle and systems for oxygen production from lunar and Martian resources. Christie’s focus areas likely revolve around aerospace technologies and innovations.

Sabrina Stöckl is an Investment Manager at b2venture with a focus on early-stage startup investments in the healthcare and life sciences space. She supports portfolio companies at the earliest stages with unwavering dedication and unique expertise. The team at b2venture is seen as entrepreneurs’ long-term partners, emphasizing a supportive and collaborative approach. Their common phrase is ‘Together we fly,’ showcasing a collective attitude towards investment and growth. The diverse team at b2venture, including partners, principals, and analysts, reflects a wealth of experience in investment activities.

Knoll Ventures is an early-stage venture capital firm that invests in B2B technology enabled companies prior to the Series A round.

Anne DeGheest is the founder and managing director of HealthTech Capital, pioneering the HealthTech or Digital Health space. With a background in healthcare, entrepreneurship, and angel investing, she founded MedStars in 1986. Anne’s portfolio companies have generated over $27 billion in market capitalization, including 8 IPOs. In 2010, she founded HealthTech Capital to fund and mentor new HealthTech startups, aiming to reduce healthcare costs and empower patients. Anne holds an MBA from Harvard and a master’s in business engineering from the University of Brussels. She is a recognized artist, speaker at industry conferences, and a guest lecturer at Stanford Business School.

Hawaii Angels, led by Robert Robinson Ph.D. and Joey Katzen, is an Honolulu-based investment network. With a focus on seed and early-stage startups in Hawaii, the firm has invested over $50 million in a diverse portfolio. Their investments span various industries like technology, healthcare, and sustainability. Hawaii Angels has a proven process tailored to Hawaii’s startup ecosystem. They provide a platform for members to review opportunities and share insights, fostering collaboration and expertise exchange. The firm’s check sizes typically range from $25,000 to $1,000,000, with an average of $250,000 per investment. Hawaii Angels has a track record of supporting over 100 companies, turning small startups into notable successes.

Don Ho is an angel investor focusing on Seed Round and Early stage VC investments in various industries, including medical, manufacturing, information technology, construction, and distribution. His investments range from $6.5M in Ambient Finance to $524,000 in other companies. He has a track record of valuing over 350 private middle-market companies, completing deals with international buyers, and winning M&A Deal of the Year Awards. Don Ho’s career includes over 19 years of experience in corporate valuation, financial analysis, and M&A transactions. He holds a Bachelor of Science degree in Business Administration from the University of Texas at Dallas. Don Ho’s collaboration style aligns with introspective, relational, and expressive methods, focusing on preparation, human connection, and creativity for effective partnerships.

Sander Slootweg is a seasoned investor and Managing Partner at Forbion. With a background in co-founding ABN AMRO Capital Life Sciences, Sander has established a remarkable track record in the investment field. He specializes in life sciences investments and has been instrumental in the success of Forbion since its inception in 2006. Sander’s investment focus areas include building companies at an earlier stage of development, as evidenced by his involvement in portfolio companies like Azafaros, NewAmsterdam Pharma, NorthSea Therapeutics, Oxyrane, and Replimune. His partnership and collaboration style are marked by a hands-on approach, serving on the boards of various companies to drive growth and success. Forbion’s recent fundraising success of â¬1.35 billion across two funds underscores Sander’s commitment to taking leading positions with investment sizes of up to â¬70 million per deal. Operating in the EU and NA regions, Sander Slootweg demonstrates a keen eye for transformative bio-pharmaceutical opportunities and a proactive investment strategy that positions him as a key player in the industry.

Angel Investor Management Group (AIM Group) is an angel investor network based in Auburn, AL. AIM Group invests in a broad range of industries, excluding real estate, retail, and franchises. They prefer investing in early-stage tech-related companies in the Southeast. Their check sizes range from $750k to $1mm. The group’s partners include Anderson Hicklen, Clay Corman, Clay McInnis, and Jim Corman. They prioritize companies in the United States, particularly in the Southeast, with pre-revenue company valuations below $3mm. AIM Group focuses on early revenue companies aiming to expand aggressively.

Harry Jacobson is a Co-founder and Partner at TriStar Technology Ventures, a venture capital fund based in Nashville, Tennessee. TriStar Technology Ventures focuses on healthcare services and supplies, healthcare technology systems, pharmaceuticals, biotechnology, and life sciences industries in the United States. The fund targets early-stage investments in these sectors with a geographical preference for the United States. Previous investments by Harry Jacobson’s fund include innovative companies in the healthcare sector. The check size for investments made by TriStar Technology Ventures is not explicitly provided on the available sources.

Steven Yaskin is the CEO of Health Gorilla and a Co-Founder of the company. He has a track record that includes roles in companies such as Queplix Corp., Priority Consulting, Inc., and Pfizer. Yaskin is actively engaged as a Venture Partner at Scale-Up Venture Capital, an Official Member of Forbes Technology Council, and an Entrepreneur In Residence at F50. He holds a MS in Physics from Drexel University and dual BS degrees from Brooklyn College and Universitatea TehnicÄ a Moldovei. Health Gorilla has raised $15M in Series B financing and connects patients, healthcare organizations, and medical service providers for data exchange.

Cannabis Angel, Inc. was founded in 2014 in West Palm Beach, Florida. The investor focused on providing angel funding for start-up and early-stage cannabis-related companies. Their stage of investment was mainly in ancillary aspects of the cannabis industry. Furthermore, they preferred geographical investments in West Palm Beach, Florida. One of their previous investments included acquiring a revenue-producing company in the security industry. The investment check size ranged from $25,000 to $1,250,000, qualifying for a 40 percent credit toward a Connecticut income tax liability. Unfortunately, specific information about their investment focus areas, investment thesis, track record, and partnership and collaboration styles could not be found.

Seth Miller serves as a Partner at DBL Partners, focusing on investments that have social, environmental, and economic impacts. DBL Partners promotes community engagement and aims to deliver superior financial returns through double bottom line practices. The firm does not use positive or negative screens for investments but prioritizes companies that are aware of their impact. Some of their investments include Tesla and BrightSource Energy, emphasizing environmental sustainability. DBL Partners’ check size typically ranges between $5-15 million. The firm is known for its collaborative approach, fostering public-private partnerships and engagement with communities to drive positive change.

Robert Stringer is the Founder and Principal Investor at Crimson Seed Capital, focusing on health and wellness. He supports startups with big ideas and solid business plans. Previous investments include health services, pharmaceutical, and medical device companies. His check sizes average around $100k. Stringer’s investment philosophy places emphasis on good-for-you consumer products, e-commerce, and health-related services. Crimson Seed Capital collaborates with businesses founded and led by women entrepreneurs. Contact: Address – 2 Battery Wharf, Suite 2510, Boston, MA 02109, Phone – 617.797.6154

Tom Simpson is an entrepreneur, angel investor, and mentor with over 30 years of experience. He was the Co-founder and Chairman of etailz, leading it to $120 million in revenues. Tom manages venture and angel investment funds through Northwest Venture Associates. He is the CEO of Ignite, President of Spokane Angel Alliance, and Managing Member of Kick-Start Seed Fund. Tom’s investments include companies like 2nd Watch, Collabra, Litehouse Health, and Voyager Capital. He has a hands-on partnership style, serving on multiple boards and advisory boards. Tom’s professional career includes roles at Dain Bosworth and Deloitte Haskins & Sells. He has received recognition for his contributions to economic development and business in the Spokane region.

Rolf Ehrnström is a Partner at Ventac Partners with extensive experience in the Life Science Industry. He focuses on early-stage investments in pharmaceuticals, biotechnology, life sciences, and health technology. Rolf has more than 30 years of scientific, technical, and commercial experience from small to large lifescience and diagnostics companies. His previous assignments include Chief Scientific Officer at Immunovia AB and Boardmember at SAGA Diagnostics AB. He holds 72,617 B-shares in a company. Rolf’s collaboration style emphasizes introspective and relational approaches to partnerships, seeking common ground and strategies for effective cooperation.

Hiram Hamilton is a Managing Director at Alcentra, focusing on structured credit investment funds. He has a background in CLO structuring and origination. As an Angel Investor, he focuses on structured credit investments.

Karl-Heinz Flother is an Angel Investor with skills including IT Strategy, Organizational Design, Change Management, and Business Process Design. He has worked in various roles, including being the International Chairman at Accenture. His professional background includes Independence Management & Consultancy Co. He is an Independent Consultant and has multiple email addresses and phone numbers.

Case Technology Ventures (CTV) is a multi-million dollar fund focused on creating new businesses based on technologies developed at Case Western Reserve University and affiliate institutions. Their investment check size varies, as they have invested in Neuros Medical in the pre-seed stage. Previous investments include Neuros Medical, Affinity Therapeutics, Pharmather, Duke University, and Lawrence Livermore National Laboratory. However, no specific track record and professional career information was found on their website.

Matrix Partners is a venture capital firm that focuses on seed and early-stage investments.

John Caldwell is an investor with a focus on stock selection and equity strategy, leading the Life Sciences & Healthcare Practice at Caldwell. His investment preferences and geographical focus are not available. John is known for his extensive track record in the Diversified Stock Income Plan (DSIP) List, with 30 years of performance. Information about the stage of investment, previous investments, investment check size, and partnership collaboration styles of John Caldwell is not readily available.

Zain Khan is an angel investor with a diverse background in design and entrepreneurship. He founded PixxelOne, a product design studio, and Epicagenda, a mobile-first team collaboration app. Zain’s expertise lies in creating engaging designs for startups in SaaS, AI, and tech industries. He has worked with leading companies such as NewSeat and Infini Concepts. Zain partners with startups that value exceptional user experiences. His approach involves collaborating with top-tier professionals in UI, UX, motion, branding, and development. Zain holds a Bachelor of Business Administration in Marketing and has certifications in advanced motion graphics, UX design, and web design processes.

Martien van Osch, the Managing Partner at Forbion, has a strong track record in the life sciences industry, with notable exits such as PneumRx, Circulite, Pathway, Impella, and Flowmedica. He leads the medical device-related activities at Forbion, chairs Staten Biotechnology, and has a degree in Econometrics from Rijksuniversiteit Groningen. Martien’s investment style is hands-on, focusing on transformative therapies for cardio-metabolic diseases. His expertise and experience make him a valuable partner for entrepreneurs in fostering healthcare innovation.

Stéphane Mendras is a hands-on medical devices leader, entrepreneur, and business angel investor. With over 20 years of experience in the healthcare industry, primarily in medical devices and supplies, he has significant expertise in medical aesthetics, hyaluronic acid applications, surgical ophthalmology, and advanced surgical technologies. Stéphane has been involved in multinational organizations, entrepreneurial ventures, and consulting for startups and investment funds. He has a partnership and collaboration style that involves corporate business development, funds raising, M&A, strategic partnering, and management of B-to-B commercial activities. Stéphane has a track record of developing commercial subsidiaries with full P&L responsibility. His investments focus on sectors like Medical Devices and Digital Health across various stages. Potential investment check sizes range from $100K to $5.0M, with a sweet spot at $1.5M. Previous investments include collaborations with key investors like Alix Joseph and Armelle Graciet.

Fabian Wawro is a Senior Associate at FORM Life Ventures, investing in the field of healthcare. His investment focus lies in Digital Health, Health & Hospital Services, and Health IT, with a preference for Series B and Series A stages. Fabian’s investment range typically spans from $500K to $2.0M, with a sweet spot of $1.3M. He has a track record of investing in innovative startups in the healthcare sector, particularly in later-stage opportunities. Fabian is known for his partnership and collaboration style, actively engaging with companies to foster growth and success. Located in Zurich, with a focus on the EU region, Fabian Wawro brings a wealth of experience and expertise to his investments in the healthcare industry.

Telemachus Luu is an experienced Angel Investor who co-founded NephoScale and served as Chief Technology Officer. His investments focus on technology startups, particularly in sectors like virtualization, storage, and consumer internet. Telemachus typically invests in Seed round startups and has previously invested in companies like Example example Company and Example & Company. With over 20 years of experience, he has a proven track record in building teams and launching infrastructure products and services. Telemachus holds an MBA from Santa Clara University with a focus on Finance and a BA in Economics from U.C. Berkeley. He is currently a Senior Field Architect at Insight, specializing in app modernization, microservices, and Kubernetes. His partnership and collaboration style emphasize founder empathy, mentorship, scaling/company building advice, SaaS best practices, and support for navigating pivots.

Neil Vangala is a seasoned investor with over seven years of experience in investing and acquisitions. His investment focus areas include healthcare, healthcare technology, and tech-enabled services. He primarily invests in early to mid-stage startups. Neil’s geographical preference is not clearly defined. His professional career showcases a consistent track record of success. However, specific details on his investment check size and partnership and collaboration styles are not readily available in the search results.

Investing with conviction in visionary, technical founders inventing the future.

David Goldberg is a General Partner at Alpaca VC, leading seed rounds in startups reshaping the real world like Compass, Transfix, and Wheels Up. He is a Kauffman Fellow focused on smart, connected capital for entrepreneurial change. Goldberg is known for empowering others and maximizing their potential in diverse fields and ensures results with a data-driven approach. He holds a JD/MBA from Fordham University and BA in Marketing from the University of Miami. Goldberg has also served on the board of companies like Perch Interactive, Inc., The Inside, and Meural. As a founder, he established FreshNeck, a men’s accessories exchange service, and has had successful roles in finance and wealth management.

Yifang Cui is an Investment Manager at Boehringer Ingelheim Venture Fund, with a focus on early-stage therapeutics and digital health companies. The fund’s investment philosophy includes activating success, adding value expertise, and ongoing investments. They are open to investing worldwide and have a commitment of â¬300 million, offering investments up to â¬3 million per venture and up to â¬15 million per venture over its life. Specific areas of investment include immunomodulation, tissue regeneration, and digital therapy. Regarding previous investments, no specific data is available on the website. The partnership and collaboration style information is not provided on the website.

Mohit Garg, the Co-Founder of MindTickle, focuses on building enterprise products and teams, with experience advising companies and working at Stanford StartX Accelerator. His investments include Oloid and BuyerAssist. He led the Series E round at MindTickle, raising USD 100 million led by SoftBank Vision Fund II, valuing MindTickle at USD 1.2 billion. Mohit Garg’s partnership and collaboration styles focus on seamless collaboration for development and sales readiness solutions.

Precursor Ventures invests in people over product at the earliest stage of the entrepreneurial journey.

Lucanus Polagnoli is the Founder & Managing Partner at Calm/Storm Ventures, a venture capital firm with a focus on supporting purpose-driven founders in the digital health space across Europe. His investment thesis revolves around backing founders changing life, health, and well-being for the better. Lucanus Polagnoli’s investment focus areas include digital health companies such as ThinkSono, Foundation Health, Bea Fertility, Doctorly, and more. He has a notable track record in early-stage investments, with investments ranging from Pre-Seed to Series A rounds with a check size of around $137K. Some of his previous investments include organizations like ThinkSono, Foundation Health, Bea Fertility, Nolea Health, and Doctorly. Lucanus Polagnoli’s professional career includes roles as a Kauffman Fellow, a Startup Mentor at EIT Health, and previous positions at Speedinvest and KPMG Australia, showcasing his diverse expertise in financial and advisory fields.

Björn von Siemens, a seasoned investor, has been deeply involved in the digital healthcare technology space since 2007. He is the co-founder of surgical.ai, a healthcare investment group with $150 million in assets under management. Additionally, Björn is the visionary behind Caresyntax, a global leader in surgical analytics and automation, revolutionizing surgeries in 4,000 operating rooms globally annually. His educational background includes studies at the London School of Economics, EBS Oestrich-Winkel, and research in behavioral psychology and entrepreneurship at the University of St. Gallen and Harvard University. Björn has a track record of strategic investments, with a recent notable investment in Lillian Care amounting to $2.92 million in their Pre-Seed round, showcasing his commitment to innovative healthcare solutions. Björn’s collaboration with prominent co-investors in Lillian Care highlights his partnership style and focus on advancing breakthrough healthcare technologies.

Arizona Tech Investors is a Phoenix-based community of accredited investors focusing on high-potential technology companies in Arizona. They invest in early-stage and seed funding for IT, med tech, and green tech companies. Their previous investments include 58 total investments with 16 diversity investments and 8 exits. They look for outstanding founders, customer feedback, revenue within 1 year, and specific milestones in industries like Software, Medical Devices, and Semiconductors. They do not invest in retail, non-tech services, franchises, entertainment content, or real estate.

Dr. Brad Weinberg, Founding Partner at Blueprint Health, focuses on investing in healthcare startups. Blueprint Health’s investment focus areas include Health Care, Medical, Information Technology, Software, and mHealth. Brad Weinberg typically invests in early-stage companies, providing initial funding within the range of $100,000 to $1 million. He has made 87 investments in 79 portfolio companies. Brad Weinberg’s partnership and collaboration style at Blueprint Health involve launching the Blueprint Health Collective to accelerate the development and adoption of new healthcare technology through collaboration with prominent healthcare organizations.

Jutta Steiner is an angel investor and the Founder and CEO of Parity Technologies. Her investment thesis is centered around pushing core Blockchain and other decentralized technologies to shape the decentralized future of ‘Web 3.0’. She has a track record in the crypto ecosystem for nearly four years and has worked on groundbreaking projects such as Ethereum and Polkadot. Jutta has made significant investments, with the latest being in Freatic with a Seed VC funding of $3.6 million. Her partnership and collaboration style involve extensive experience in IT security, partner integration, and advising projects using blockchain technology, demonstrating a hands-on approach to driving innovation.

Julia Bernstein is a seasoned healthcare leader, known for her experience in digital health leadership and advisory roles. She serves as the Chief Operations Officer at Brightside Health, setting strategy and scaling operations. Julia has held leadership positions at Thirty Madison, Tempest, Beacon Health Options, and Ginger. As an active angel investor and board member of PharmaCCX, she participates in investment and advisory roles in startups like Care + Wear, Coral Care, Untether Labs, Violet, and VivorCare. Julia’s investment check size and partnership details were not specified on her LinkedIn profile.

Julien de Salaberry is a healthcare venture investor and founder of The Propell Group, focusing on seed investments in HealthTech startups. With a career in healthcare since 1997, he has a diverse track record, including leading brands like Natixis and AXA. His portfolio includes investments in companies such as Proteus, Glooko, Healint, Omada Health, and more. Julien’s geographical preference encompasses regions like Asia-Pacific, with a specific focus on IoT’s impact on the healthcare value chain. While specifics on investment check size are not found, his emphasis on HealthTech suggests investments likely vary based on startup needs. His partnership and collaboration style appear dynamic, leveraging technology efficiency gains in healthcare and navigating challenges for HealthTech devices to become mainstream in Asia.

Westway Capital, founded by John Levinson, focuses on investments in early-stage technology and healthcare companies. Their investment check size is not specified, but the firm is actively seeking opportunities in the healthcare industry. Westway Capital facilitates collaborations, partnerships, and strategic discussions.

Sarah Jones, a Venture Capital Investor at Eight Roads, focuses on investing in high-impact, high-growth startups in the Climate Tech sector. Her portfolio companies are leading advancements in sustainable technologies, with a specific emphasis on bioengineering sustainable ingredients, Li-ion battery innovation, and electrochemical ammonia production. Sarah’s investment style aligns with companies dedicated to fighting climate change and creating a positive environmental impact. She collaborates closely with startups in Climate Tech to support their growth and success, aiming to address critical global challenges through innovative solutions. Sarah’s dedication to supporting sustainable ventures underscores her commitment to driving positive change in the Climate Tech industry.

Florian Herschke is an investor focused on listed private equity with a research interest in risk and return characteristics. He has made investments in companies like Wave Ventures GmbH, with a focus on real estate in Germany. His professional career includes research on financial constraints, venture capital pricing, and innovation finance, with a Ph.D. in the pricing of listed private equity. Collaboration styles include cooperative, directive, and competitive, leveraging diverse viewpoints for team success.

Balderton Capital is a Early-Stage Venture Capital Investor.

Karl H. Ulrich is an Angel investor, Co-Founder at Xootr, and the Vice Dean of Entrepreneurship & Innovation at the Wharton School of the University of Pennsylvania. He has made investments in companies like Bandar Foods and Jump Bikes. His investment focus areas include Healthcare Services and B2C non-financial services. He invests in the seed stage. Karl Ulrich’s partnership and collaboration styles are not specified.

Ray Wagner is the Managing Director at Thompson Street Capital Partners. The firm focuses on a thesis-driven approach, investing in various key industry verticals such as Life Sciences & Healthcare, B2B services, technology solutions, and software providers across cloud services, insurtech, non-profit software, and supply chain software. Ray Wagner’s investment stage ranges from Series B in sectors like Medical Devices, Pharmaceuticals, AI, Health IT, and more. Thompson Street Capital Partners has a geographical preference for the Midwest. With a track record of nearly $200 million in transactions, Ray Wagner brings extensive experience in due diligence, valuation analysis, and business development. The fund’s investment check size is between $50 million to $250 million, targeting companies with EBITDA between $5 million to $50 million in sectors like healthcare, life sciences, software, IT services, and business products. Thompson Street Capital Partners’ partnership approach is focused on actively working with companies to make a significant impact in their respective industries.

Aydin Senkut is the Founder and Managing Director at Felicis Ventures. His investment thesis focuses on frontier markets such as 3D printing, imaging, vision, genomics, and connected devices. He invests in various sectors and geographies, including AI and global resilience. Aydin is a multi-stage investor, with investments ranging from $500K to $15M. His portfolio includes companies like Adyen, Canva, Fitbit, and Shopify. Aydin Senkut has been named on the Forbes Midas List and has a track record of helping companies reach significant milestones. He has made 137 investments with a fund size of $825M. His partnership and collaboration styles emphasize proper instrumentation and measurement for success.

Ahmet Tosun is the founder of Poltio, a social polling engine. He has experience as the Co-Founder & CEO of Poltio and Managing Director at TIMwe. His educational background includes a Bachelor of Science in Manufacturing Systems Engineering from Sabanci University. Ahmet Tosun’s previous investments include leading roles in tech companies in Russia, Kazakhstan, and Turkey.

Thomas Lips is a General Partner at Nextech Invest specializing in BioTech investments at Series A and Seed stages with an investment range of $100K – $5.0M. He has a sweet spot investment size of $1.5M and has experience as the Chief Investment Officer at AIG Private Bank. Thomas Lips’ geographic focus is not specified. He is known to invest in companies with a strong track record and maintains a partnership and collaboration style that aims to work with others to identify solutions that satisfy everyone involved.

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Jim Wirth is an investor with a focus on Pre-seed investments in Medical Devices, along with expertise in Robotics, Hardware, Impact, Social Networks, Cloud Infrastructure, and ClimateTech/CleanTech across various stages. His recent investments include Pre-seed Medical Devices. Previous experiences include roles at Merrill Lynch and Piper Jaffray. Jim Wirth has a background in accounting and information systems. He has a network affiliation with Michigan State University and has collaborated with various co-investors.

Graham Segal is the Founder of Chiron Intercontinental Investments Pty Ltd, a consultancy focusing on equity capital raise. He specializes in helping growth companies with investment. His geographical focus is not specified. Graham’s investment check size and partnership styles are not explicitly mentioned on the available sources.

Guillaume Luccisano, Co-Founder & Chief Technology Officer at Triplebyte, is an angel investor in 50+ startups. He invests in small and innovative fast-paced environments and has a strong track record with investments in Vertuoza and Splitforce. Geographically, he is based in Singapore. Guillaume focuses on seed-stage investments and has a check size of around $50 million. He values collaboration in his partnerships and aims to support startups with AI-based technology to match engineers with employers.

Thies Sander is a General Partner at Project A, specializing in investments in Payments, Digital Health, Health & Hospital Services, and Enterprise at Series A and Seed stages. His previous investments include Kry, Spryker Systems, and Barzahlen. Thies has an extensive track record, having co-founded Project A and worked as a CEO at a German online comparison startup. With a focus on early-stage investing, his investment check size ranges from $200K to $10.0M, with a sweet spot of $5.0M. Thies values human connection and enjoys meaningful work in smaller groups. He co-founded Project A in 2012 and holds a double master’s degree from WHU and Kellogg Graduate School of Management.

Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.

Eric Tobias is a Partner at High Alpha, with a focus on early-stage SaaS/enterprise startups. His investment thesis revolves around the concept of ‘coaching networks’ in enterprise software. He has a diverse portfolio of investments, with a check size ranging from $100K to $5M and a sweet spot of $1.5M. Eric Tobias has invested in companies like Flaunt, Zylo, Cordial, and Kevala. His geographical preference includes the Midwest. Eric Tobias is known for his collaboration through partnerships like the one with Engineered Innovation Group to drive breakthroughs in emerging technologies. He has a track record of success with three successful exits and extensive experience in the industry.

Doug Colbeck is an angel investor with past investments in Sharefaith, iSpot.tv, Thursday Market, and MustHaveMenus. His investment focus areas include Consumer Internet, Enterprise Software, Mobile, ECommerce, Social Media, Digital Media, and Online Travel. Doug’s career includes roles such as Regional Coordinator at Community Transport Services Tasmania Ltd., Educator/Facilitator at Integrity Commission, and Chair of the Social Science Human Research Ethics Committee at the University of Tasmania. He has expertise in curriculum design, assessment, and research ethics. Doug has made investments in strategic lending opportunities and distressed debt through Colbeck Capital Management. His investment check size varies based on strategic lending opportunities. The geographic areas where Doug has made investments include Seattle, United States. His partnership and collaboration styles align with strategic alliances, fostering a portfolio of collaborators, and engaging in innovation networks.

Scott & Cyan, seasoned investors, have a track record of success, focusing on Silicon Valley, San Francisco, and Southern California. With over 275 investments, they back startups in various markets like Mobile, SaaS, Bitcoin, and Medical Devices. They prefer larger check sizes of 500K+, targeting growth and later-stage funding. Their investment thesis evolves towards proactive investing and expanding geographically. Previous successful investments include Uber, Thumbtack, and SpaceX. Collaborative and hands-on, they seek to impact and guide portfolio companies towards success.

Joe Amadio, the Managing Director at Thompson Street Capital Partners, specializes in Series B investments with a focus on Pharmaceuticals, Medical Devices, Consumer Health, Digital Health, BioTech, AI, Health IT, and more. He has a sweet spot investment range around $25.0M, and a current fund size of $1.2B. Joe’s track record includes successful investments in the Midwest region. He collaborates with investors like Alex Mace, Alison Schulte, and others. With a background as a Private Equity Investor, his partnership style is characterized by a strategic and collaborative approach, leveraging his vast experience in the industry.

Alexander Zemlyak is a Principal at Geek Ventures, focusing on deal sourcing and portfolio companies support.

Sciety is the Nordic region’s leading life science investment company, investing in unlisted life science and health tech companies. They focus on biotechnology, medical technology, pharmacology, diagnostics, ICT in healthcare, and health tech. Their investments range from the product development phase to expansion phase. In pharmaceuticals and biotech, they invest from late preclinical phase to Phase II, whereas in health tech and medtech, they invest in late development phases or companies with market traction.

Roger Sippl, as the managing partner of Sippl Investments, focuses on early-stage venture capital investments, especially in software and medical technology companies. The firm has a history of investing primarily in Silicon Valley-based enterprises but is expanding internationally, particularly in Asia. Sippl Investments works collaboratively with larger venture capital firms and offers expertise in technology and biotech. Roger Sippl’s partnership and collaboration style involve providing guidance, advisory support, and investment activities with a wide range of high technology companies. His background includes founding successful software companies like Informix and Visigenic, showcasing a track record of innovative contributions to the enterprise software industry.

Andy Ziolkowski is a Managing Partner at Cultivian Sandbox Ventures, based in Chicago, Illinois. He has made investments in sectors such as Food and Beverage (Seed), AgTech (Seed), Health & Hospital Services (Seed), Digital Health (Seed), BioTech (Seed), Health IT (Seed), Food and Beverage (Series A), AgTech (Series A), BioTech (Series A), Digital Health (Series A), Health & Hospital Services (Series A), and Health IT (Series A). One of his notable investments is Descartes Labs. Andy typically invests in the range of $1M to $10.0M, with a sweet spot at $5.5M. He has a track record of 2 total investments on record and is connected to investors like Rob Trice, Ludovic Copéré, and Phil Boyer. Co-investors in Descartes Labs include Eric Chin, Venky Harinarayan, Collin West, and Omar El-Ayat.

Crosscut is a seed-stage venture capital firm partnering with early-stage founders to build extraordinary high-growth tech companies.

Vera Mehler has a scientific background in regenerative medicine and stem cell therapy. She focuses on life science companies at Coparion. Vera Mehler invests in early-stage companies in software and biotechnology sectors across Germany. Her track record includes representing Coparion in eight portfolio companies and serving as an Investment Manager. While specific investment check sizes were not found, her partnership and collaboration style involves conducting research, projects, and reform initiatives in partnership with officials. Geographic focus was not specified in the search results.

Klaus von Sayn-Wittgenstein, the Owner of F:lm 3:33 LLC and Family Office von Sayn-Wittgenstein AG, is an Angel Investor. He has made investments in companies like Loom, Bellabeat, and NextCaller. Klaus von Sayn-Wittgenstein focuses on educational software, monitoring equipment, and network management software industries. His investment check size and partnership styles are not directly available from the sources searched.

Ken Goulet is an investor who primarily focuses on HealthTech and Enterprise Applications sectors. He has made investments in companies like Centivo and XP Health. His recent investment check size was $17.1 million in XP Health as part of their Series A round. Mr. Goulet has a track record of investing in companies in the HealthTech sector, specifically supporting growth and product development initiatives. His geographical preference seems to be focused on North America, particularly investing in companies that align with his vision of making the home a reliable alternative to care facilities. He fosters collaboration and partnerships with a keen focus on structural dimensions, norm (trust), personal relationships, and organizational trust to ensure successful investments and growth.

New World Angels is an angel group that invests in early-stage companies in Florida. Their investment thesis is focused on innovation and diversification in early-stage companies. They have funded companies like Fuego, Sniffer Robotics, and Vesteck, Inc. The firm’s investment check sizes range significantly based on the venture, and they are active in the Florida region. New World Angels emphasizes partnership and collaboration to support the growth of their portfolio companies. They have a structured approach to investing and provide mentorship and strategic guidance to the startups they fund.

Alpha Edison is a venture capital firm that focuses on technology-driven innovation.

Kay G. Balster is a Principal / Prokurist at HTGF, specializing in venture capital and investments in Life Science & Chemistry startups. With a focus on biotechnology and medical technology sectors since 2009, he brings 20 years of experience in advising technology startups. Kay’s background in economics and training as a banker complements his daily interactions with founders in the HTGF portfolio. Contact information: HTGF Bonn, SchlegelstraÁe 2, 53113 Bonn, Telephone: +49 228 823 00 â 100.

Lukas Speiser is an individual angel investor known for his investments in various startups. His investment focus includes health care, medical devices, and biotechnology. Lukas Speiser prefers to invest in companies in the EU and MENA regions. Some of his previous investments include dunatura, Cleveron, Findependent, Sleepiz, and Testmate Health. With a track record in finance and founding Amorana, Lukas Speiser maintains a collaborative approach in his investments, engaging in partnerships to propel startup growth. He typically invests in the seed stage with check sizes that vary based on the company’s needs.

Chicago ArchAngels is a preferred provider of risk capital focusing on early and seed-stage companies in the Midwest and nationally. They engage with a wide range of industries, including medical devices, healthcare, digital technology, manufacturing, green technology, and more. Their investment focus is on innovative companies aiming for technological proof of concept and market dominance. Chicago ArchAngels seek companies looking to raise between $500,000 and $3 million in their current round. Members bring valuable business and entrepreneurial experience, collaborating with various angel groups and accelerators. They host monthly meetings with presentations from companies with global potential and are affiliated with Washington DC ArchAngels, operating since February 2012.

Tobias Teuber is an investor with a focus on personalized nutrition concepts based on blood and DNA tests. He invests in health tech startups, with a check size ranging around early-stage VC funding. Tobias Teuber’s investments have primarily been in companies like Thiocyn and Lykon. He is the Co-Founder and CEO of Lykon, a company offering personalized nutrition products and services. Tobias Teuber’s collaboration style involves seeking community partners to support the shared vision of the companies he invests in.

Dr. Michael Burstein is an investor with a background in healthcare investments, focusing on outsourced business services, payers, and care provision. He has a track record as an American writer of science fiction, winning awards for his works. Michael has served in various roles with the Science Fiction and Fantasy Writers of America and engaged in speculative storytelling. As an investor, Michael Bernstein operates as an Angel Investor. His investment check size and partnership styles are not explicitly stated in the available information.

Sasha Saberi, as an investor at LOUD Capital, focuses on Seed and Series A investments in sectors like Lodging/Hospitality, AutoTech, Digital Health, Health IT, and Health & Hospital Services. Notable co-investors include Blake Overlock, Brian Penick, Chase Petrie, Darshan Vyas, and David Hunegnaw. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Sasha Saberi has a diverse professional background, including roles at companies like Zigabyte, LOUDX Studio, The Venture Atlas, HYPEBEARS NFT, and One Identity. He holds certifications in Agile Foundations, Project Management, Scrum, Design Sprint Facilitation, and Enterprise Design Thinking.

Lee Shapiro is a Managing Partner at 7wire Ventures, with a focus on building collaborative partnerships to achieve health moonshots. He has a background in commercial law and is dedicated to supporting startups with a mission beyond monetary success. Lee’s investment check size and specific geographical preferences were not available, but he has been involved in strategic partnerships to ignite the growth of Israeli digital health companies. Lee Shapiro’s past investments include Livongo Health and Allscripts, where he held positions such as Chief Financial Officer and President. His partnership and collaboration style emphasize shared values, complimentary skills, and a long-term commitment to realizing a company’s vision.

AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies.

Dave Sachse is a Co-Founder and Partner at Sachse Family Fund, a family office investment firm based in Milwaukee, Wisconsin, established in 2017. The fund specializes in investing in various sectors, including medical devices, virtual reality, augmented reality, biotechnology, life sciences, pharmaceuticals, CPG, and hardware. Dave Sachse’s investment focus areas are broad and diverse, covering a range of innovative industries. The fund actively seeks opportunities in early-stage companies in these sectors. While specific details about the stage of investment were not available, the firm is known for its interest in cutting-edge technologies. Dave Sachse’s approach reflects a commitment to social consciousness and community-oriented investments. The fund’s partnership and collaboration styles emphasize creating a sense of community and adapting to the evolving needs of different demographics. In the dynamic landscape of the apartment market, Sachse Family Fund recognizes the importance of smart technology, energy efficiency, and community-building events to meet the preferences of modern consumers.

Emad Zand is an individual/angel investor located in Stockholm, Stockholms Lan, Sweden. His investment focus includes regions in the European Union, Nordic Countries, and Scandinavia. He has a track record of investing in companies like TransferGalaxy and Northvolt. Emad Zand’s investment check size can be inferred from his participation in funding rounds like the SEK 3.5 million backing of Wndy in Sweden. As an Individual/Angel investor, his partnership and collaboration style involve local angel investors from Sweden, as seen in his involvement with Wndy’s funding round.

James Bachman is the COO of SynerZ Medical, a company developing an alternative to gastric bypass surgery for obesity and Type 2 diabetes patients. He has a track record of leading innovative medical device solutions, securing investments to support research and development efforts aiming for safer and less intrusive solutions in the healthcare industry.

Thomas J. Czarnowski h. Lada is a seasoned investor with a diverse portfolio and significant professional experience. As the President of Auri Advector Ltd, he specializes in the import and purchase of precious metals in Canada. Additionally, he holds the position of President at TBE Corporation, where he leads a project focused on zero emission green hybrid-modular thermo-electric generation technology. With over 30 years of banking experience, Thomas J. Czarnowski h. Lada is a skilled facilitator and direct trader. Throughout his career, Thomas has demonstrated a commitment to innovation and collaboration. He has been involved in various projects, including cooperation with European enterprises and research and development initiatives. His investments and professional engagements showcase his dedication to cutting-edge technology and sustainable solutions. His involvement in projects like ZEEM and partnership with PROCIM highlight his forward-thinking approach to investments. With a track record of successful ventures, Thomas continues to drive advancements in green technologies and precious metal trading.

Andrew Schwab is the Co-Founder and Managing Partner at 5AM Ventures, a venture capital firm specializing in seed and early-stage life sciences companies. The firm focuses on building next-generation life science companies and has a geographic preference for Canada, Mexico, and the United States. 5AM Ventures typically invests in companies in the early seed stages within the life sciences category, including therapeutics, tools, and technologies like genomics and proteomics. Andrew Schwab has an impressive track record of leading investments in companies such as Biodesy, Cleave, Flexion, Ilypsa (acquired by Amgen), Panomics (acquired by Affymetrix), Precision NanoSystems, and Synosia (acquired by Biotie). The firm is known for being entrepreneur-friendly and building long-lasting relationships with entrepreneurs to achieve success.

Dr. Robert Lufrano served as Chairman and Chief Executive Officer of Blue Cross and Blue Shield of Florida and has been an Advisor at RubiconMD. His investment focus areas include healthcare and technology, with a particular interest in companies driving change in the healthcare industry. He has been involved in Series A funding rounds, as demonstrated by his $4M investment in RubiconMD in 2016. Robert Lufrano’s geographical preference and previous investments are not explicitly stated. His professional career involves leadership roles in healthcare organizations, showcasing his extensive experience. The investment check size and partnership/collaboration styles of Robert Lufrano are not specified.

Berkeley Angel Network is a group of angel investors associated with UC Berkeley. They focus on investing in companies primarily belonging to sectors like Health Care, Medical Device, E-Commerce, and Food and Beverage. Some of their previous investments include Alpaca Securities, HealthCrowd, and Bone Health Technologies. Berkeley Angel Network invests in startups at the Seed and Series A stages, with a check size usually ranging between 1 to 5 million dollars per deal. Their geographical preference is not limited to a specific region, aiming to connect global entrepreneurs with industry experts and professionals.

Ed Park is an Angel Investor with a focus on Seed Round investments in the Enterprise Software industry. His portfolio includes investments in companies like Kinsa, Devoted Health, and Envoy. He has served on the boards of various companies including Castlight Health and HealthPoint Services. Ed’s career includes roles such as Co-Founder and CEO at Devoted Health, Executive Vice President and Chief Operating Officer at Athenahealth, and Chief Technology Officer at Athenahealth. He received his A.B. magna cum laude in Computer Science from Harvard University. Ed Park’s investment check sizes vary, with examples ranging from $1,000,000 in Seed rounds to â¬11,000,000 in Series C funding. His partnership and collaboration styles are focused on the Enterprise Software sector.

C. Victor Brick is the CEO of Ohana Growth Partners, LLC (OGP) which owns 100 Planet Fitness health clubs throughout the United States and Australia. He is also the founder of the John W. Brick Mental Health Foundation, advocating for mental wellness integration in the fitness industry. Victor Brick is involved in promoting research for wellness integration into healthcare and active collaboration for industry improvement.

Nimay Parekh is a prominent investor with a focus on digital health solutions addressing clinician burnout. He invests in teams with industry experience in healthcare. Nimay’s investments are on stage at Affiliate Summit, indicating his interest in supporting startups in their early phases. Based in Cape Town, South Africa, Nimay has a geographic preference for this region. His professional career includes roles at Accenture Song and Jivox, with a background in commerce marketing. While there is no specific information on check sizes, Nimay is known for his work on SaaS pricing intelligence. His collaboration style emphasizes personalized commerce marketing.

Robert Fabbio is a venture capitalist with a primary focus on digital health, health services, and health IT in seed to Series B stages. His investment range is $100K to $5.0M, with a sweet spot at $1.5M. Geographically, he is active in Austin, Texas. Some of his previous investments include WhiteGlove Health, Ventix Systems, Agere Systems, and DAZEL Corporation. Fabbio is known to collaborate with partners such as Bart Robertson, Bernie Brenner, and Courteney Real, among others. He has a strong track record in founding companies and working in the technology and healthcare industries.

Carla Fowler is an Angel Investor affiliated with Alliance of Angels based in Seattle, Washington. She focuses on Digital Health, BioTech, and Health IT at both Seed and Series A stages. Carla’s typical investment check size ranges from $500K to $1.5M with a sweet spot at $1M. Her previous investments include a diverse portfolio in the healthcare technology sector. With a fund size of $100M, Carla actively collaborates with other investors within Alliance of Angels, demonstrating a strong commitment to fostering startup growth through strategic partnerships. Her track record reflects a successful career in supporting over a dozen startups in the MedTech and biotech fields.

Charles Boorady is the Founder and Managing Partner of Health Catalyst Capital Management. The firm focuses on investing in growth-stage healthcare technology and technology-enabled services businesses in an effort to improve healthcare outcomes. Mr. Boorady’s investment thesis is centered on promoting value-based care and enhancing the human condition through innovative healthcare solutions. Some of the previous investments made by Health Catalyst Capital Management include Insightin Health, Clearsense, and Vivante Health. The investment check size typically varies based on the specific opportunity and growth stage of the company. Additionally, the partnership and collaboration style at Health Catalyst Capital involves leveraging a deep network of C-level executives from healthcare organizations to support portfolio companies, aiming to create long-term value.

7wire ventures focuses on investing in early and growth-stage companies focused on healthcare IT, digital healtcare and mobile health.

Karl Ulrich is a Co-Founder at Xootr and Vice Dean of Entrepreneurship & Innovation at the Wharton School of the University of Pennsylvania. He is an Angel investor with a track record of innovation and entrepreneurship, holding 24 patents and founding companies like Terrapass Inc. and designing the Xootr scooter. He has a background in mechanical engineering from MIT and has won several teaching awards at Wharton. Karl Ulrich has been involved in enterprise accounts and insightful business collaborations, showcasing diligence and a focus on customer satisfaction and service support.

Eric Dobkin is a New York-based angel investor serving as Board Member at Strategic Growth Banking. He has invested in companies like OROS, Ready4, Shareaholic, and Searchable.ai. Eric Dobkin is known for his significant contributions to the IPO market and has a track record in the capital markets division. His investment check size and partnership styles align with strategic collaborations focusing on the healthcare sector. He plays a key role in the newly formed private equity firm by Whistler Capital Partners.

Tapio Tolvanen is the Co-Founder and Chief Technology Officer at Elo Health. He has invested in companies like BetterDoctor. He focuses on healthcare and wellness sectors. His track record includes successful investments such as BetterDoctor, with one exit. Tapio Tolvanen’s investment check size ranges based on the company and opportunity. He has a collaborative partnership style, seen in his involvement in companies like BetterDoctor and Elo Health.

Roxy Rong focuses on Pre-seed to Seed stage investments with an investment range of $5K – $25K and a sweet spot of $10K. Roxy Rong’s investment thesis spans across various sectors, and she is connected to investors like Lolita Taub from Ganas Ventures.

Michael Madanat is an Angel Investor with a focus on pediatric care. His investments include serving as a Board Member at Heal and leading Foothill Pediatric and Adolescent Clinic. He has a background in pediatrics, completed his MD and MBA in Healthcare Management, and holds multiple degrees in related fields. His investment focus areas include pediatric healthcare. Previous investments are not detailed. Dr. Madanat’s partnership and collaboration style align with introspective, relational, and expressive approaches, aiming for better collaboration between different styles.

Founders Capital Partners is a venture capital firm and an angel group founded in 1988. They specialize in early-stage technology-based businesses focusing on industrial products and services. The firm primarily engages in follow-on rounds with occasional new startup investments.

Oguzhan Ozer, an Associate at Earlybird Venture Capital, focuses on investments in various sectors including Medical Devices, SMB Software, IoT, BioTech, Health & Hospital Services, Health IT, SaaS, and Consumer Internet at both Seed and Series A stages. His investment range typically falls between $100K and $5.0M, with a sweet spot at $1.5M. Earlybird Venture Capital, where Oguzhan Ozer works, is known for its expertise in enterprise software companies, with a specific focus on developer, data, and productivity tools, alongside AI-centric products and robotics. They invest in all development and growth phases of technology companies. Oguzhan Ozer is part of the team that leads the tech team and the development of the data-driven sourcing platform ‘Eagle Eye.’ The firm has over EUR 1.5 billion under management, seven IPOs, and 22 trade sales, establishing itself as one of the most successful venture capital firms in Europe. His geographical preference is not explicitly mentioned in the available data.

Michael Braun is a seasoned Senior Venture Partner at 415C, actively involved in technical evaluations of new portfolio prospects. With a professional background as the CEO of CoRRect Medical GmbH and founder of Symedrix GmbH, Mr. Braun has co-founded successful medical device distribution and consulting companies, offering support to multiple startups. His career began at Rüsch AG / Teleflex, where he invented the Polyflex™ stent. Holding a B.Sc. in Biomedical Engineering, Michael Braun demonstrates a hands-on approach to partnerships and collaboration, ensuring strategic guidance and support to emerging ventures.

Justin Kan is an American entrepreneur, investor, and web developer known for cofounding several technology companies, including Atrium, Socialcam, Justin.tv, and Twitch. His investments usually range between roughly half a million and $3 million. Previous investments include companies like Fractal, Rye, Twitch, Kiko, and Whale. He has a track record of successful ventures, has made sixty-three personal investments, and has collaborated with partners in various endeavors. Kan’s professional career showcases his ventures in technology, media, and finance, demonstrating his diverse expertise and strategic business acumen.

Adam Draper, Co-Founder and Managing Director at Boost VC, focuses on investing in Deep Tech pre-seed startups with a $500k investment check size. He has a track record as an Angel Investor in companies like Coinbase, Bitcoin, Amplitude, and Plangrid. Boost VC’s investment thesis includes Blockchain and Virtual Reality. Adam Draper prefers startups in NA and leads pre-seed rounds, targeting startups raising $2m or less. Boost VC’s partnership and collaboration style includes providing partner support and engaging in virtual reality creativity, productivity, and collaboration tools.

OCA Ventures is a venture capital firm focused on equity investments in companies with dramatic growth potential.

Vish Makhijani is a seasoned executive with a background in leading high-growth organizations like Zynga, Yandex, and Yahoo. He served as President, COO, and CEO at Udacity, focusing on making higher education more effective and accessible. Vish’s professional career started at PricewaterhouseCoopers, followed by leadership roles at various tech companies. Although specific information on investment thesis, focus areas, previous investments, and partnership styles is not available, Vish is known for his expertise in the tech industry and dedication to educational innovation. His investment check size and geographical preferences remain undisclosed.

Mark Sanders is a Registered Investment Advisor specializing in wealth accumulation, retirement and income planning, strategic debt management, cash flow planning, and mortgage management. He holds experience in using modern tools and strategies for efficient wealth accumulation. Previous investments are not available. Educational background includes California State University, Los Angeles, West Los Angeles College, and Santa Monica College. Sanders emphasizes achieving returns, principal protection, independence from market or economy, liquidity, and diversification in portfolios. His partnership and collaboration style are not specifically indicated on available sources.

Go Beyond invests in European startups that generate positive impact for people or the planet. They focus on companies in the environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors. Go Beyond invests in the seed stage or later, with smaller angel tickets, aiming to support founders in fundraising for seed rounds or later. The founding team includes Kart Siilats and Kadri Harnak. They seek commitments from eligible professional investors for private limited partnership funds. Previous investments information is not available, but they have a track record in investing. Check sizes and partnership styles are not specified on the website.

Gisbert Enkel is the Managing Director of TGFS and CFH Management GmbH, with a background in investment business since 1995. He has been instrumental in developing various funds, providing around â¬391 million in equity capital to Sachsen companies. Enkel studied Economics at Ruhr-Universität Bochum.

Gene Matsutani is known for his investments in gene therapy and targeted toxins for glioma. His investment focus areas are related to these medical advancements. The stage of his investments is not specified. Gene Matsutani’s geographical preference is not readily available. He has a professional career background in IT and helpdesk administration. Unfortunately, details about his previous investments, investment check size, and partnership collaboration styles are not currently accessible.

Maximilian Thyssen is focused on Shogun and certain business opportunities for angel investments.

Selin Anil, an analyst at Earlybird Venture Capital, focuses on making venture capital investments in global category leaders across a wide range of sectors. The investment process at Earlybird involves initial calls, partner evaluations, term sheet negotiations, and due diligence processes to confirm all material facts. The geographical preference is in European technology companies. Selin Anil’s investment check size, partnership, and collaboration styles were not explicitly mentioned in the available information.

Fred Khosravi is a seasoned medical device entrepreneur with a focus on the healthcare industry. He is involved in Imperative Care and Tulavi Therapeutics as Chairman & CEO and Executive Chairman, respectively. He has directed organizations like Instylla Medical and Ostial Corp. Fred’s geographical preference centers around California, particularly Campbell and Santa Cruz. His professional career spans over several successful ventures in the medical technology space, showcasing a solid track record. While specific investment focus areas are not detailed, Fred Khosravi’s leadership style emphasizes collaboration and innovation, evident in his various chairmanship roles and involvement in cutting-edge medical advancements.

John Daly, an angel investor with Alliance of Angels, focuses on investments ranging from $500K to $1.5M, with a sweet spot at $1M. His investment thesis includes sectors like Hardware (Seed), Energy, Tech (Seed), Cloud Infrastructure (Seed), SaaS (Seed), and specific focus on Hardware (Series A), Energy, Tech (Series A), Cloud Infrastructure (Series A), SaaS (Series A). John Daly’s recent investments include Seed rounds in various sectors. His professional career is based in New York, New York, where he has made notable investments, with TMRW Sports being one of his latest Seed VC investments.

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies.

Amit Tiwari, Managing Partner at Tiger Iron Capital, boasts over 17 years of private equity experience. Specializing in Biotechnology, Informatics, and Clinical Services, he oversees operations with a focus on Strategy, Business Development, and Operational Excellence. Amit holds an MBA from the University of Michigan and is a Certified Professional in Healthcare Information and Management Systems. His investments remain undisclosed publicly, emphasizing a long-term partnership and collaboration style with a track record of innovation and excellence.

William Tai is a prolific individual investor and entrepreneur with a focus on Medical Device and Medical Technologies investments. He has a diverse portfolio of investments that includes companies like Blaze, Tract, and Fairmatic. His investment considerations prioritize the potential for companies to become great as standalone entities rather than focusing on acquisitions. Mr. Tai has a track record of funding numerous start-ups since 1991, with over 23 IPOs from early-stage projects. He has had involvements in companies such as Blackbird Ventures, Canva, SafetyCulture, Zoom, and TweetDeck. His check sizes for investments vary based on the round and company, with recent investments like Blaze totaling $3.5 million in the Pre-Seed round. Bill Tai has a collaborative approach akin to an orchestra conductor, bringing together diverse strengths for impactful collaborations.

Anne Wojcicki is an angel investor with a focus on Diagnostics, Human Capital/HRTech, BioTech, Digital Health, and Health IT. She invests at the seed stage in companies like Brightside Health, Ezra AI, Orchid, Eureka Health, Calypso AI, Helium Health, Nest Genomics, and Wisdo Health. Previous investments include Freenome, Doctor On Demand, and SpoonfulOne. Anne is the CEO and Co-Founder of 23andMe, with a track record in healthcare and biotechnology investing. She takes initiatives to disrupt the healthcare experience and prefers collaboration with partners. Anne’s check sizes vary based on the round of investment, and she is open to partnerships and evolving leadership styles.

Julian Koh, the Co-Founder and CEO of Ribbon Finance, focuses his investments on Web3/Blockchain and Web3/Crypto at both the Seed and Series A stages. Some of his notable investments include Blackwing, INIT Capital, Ambient, Voltz Labs, and DELV (Formerly Element Finance). His track record includes previous positions at Coinbase, Metastable Capital, and Numerai. Julian Koh typically invests in amounts ranging from $5,000 to $50,000, with a sweet spot at $25,000. He collaborates with investors such as Miko Matsumura, Gumi Cryptos Capital, Dragonfly Capital Partners, and Framework Ventures. Additionally, Julian has affiliations with various scouts and angels like Anand Iyer, Ken Deeter, and Naval Ravikant.

Ohio TechAngels focuses on early-stage Ohio-based ventures in information technology, advanced materials, and medical technology. Their funds come from the Ohio Third Frontier program and over 280 investors. Their typical initial investment is $200,000, with total rounds ranging from $500,000 to over 3 million. They have had four positive exits so far: HTP, SageQuest, ClearSaleing, and Znode. Ohio TechAngels evaluates about 100 companies annually, invites 20 to present, and invests in four to six. They have a partnership with OTAF angel members for ‘sidecar’ investments alongside the fund.

Angela Jackson is a prominent investor and Managing Partner at Portland Seed Fund. Known for her strategic investments, Angela focuses on building software companies, teams, and products. She has a proven track record of making follow-on investments in successful ventures. Some of her previous investments include Chronicled and Portfolia. With a keen eye for innovation, Angela’s investment check size stands at $11.6 million. Her partnership style is collaborative, particularly with entrepreneurs and companies developing technical solutions for upskilling low-income workers. Angela leads the Future of Work Initiative, aiming to bridge the career-readiness gap. Her approach emphasizes addressing disparities in education, income attainment, and racial wealth gap through investments in women and people of color.

Solomon Cates, the Principal Technologist and Expert in Data Protection and Cloud at Thales Cloud Security, is known for his expertise in enterprise security. His past role as the CTO focused on Cloud and Cyber solutions. While information regarding his specific investment thesis, investment focus areas, stage of investment, geographical preference, and previous investments is limited, Solomon Cates has a strong background in cloud security and related technologies. At Thales Cloud Security, Solomon Cates has been involved in enterprise, regulated, and sovereign key management, showcasing his experience in handling critical data protection solutions. Despite the lack of detailed investment information, Solomon Cates’ transition from CTO to Senior Advisor at TerraScale Inc. highlights his evolving role in the cybersecurity and cloud industries. Solomon Cates’ professional career demonstrates a deep understanding of advanced technology, cloud security, and data protection, making him a valuable asset in the cybersecurity domain.

Tao Huang is the Investment Director at Fundamental Labs. His Investment Range is $500K – $50.0M, with a Sweet Spot of $25.0M. His current Fund Size is $130M. Tao Huang focuses on investments in the areas of data intelligence reconstruction of supply side, robotics, and chips. He has led investments in projects related to Data Application, Data Infrastructure, and Frontier Technology domains, with a total valuation of approximately US $20 billion in invested companies. Some of his notable investments include Agile Robots, AllSense, WeiBuild, Horizon Robotics, FraudMetrix, Kujiale, Sensors Data, Tezign, and Rokid. Tao Huang collaborates with other investors such as Eric Yang, Howard Yuan, Ryan Emmick, and Wingchi Yip.

Kathy Salmanowitz is an Angel investor and Managing Director at Golden Seeds with a focus on social impact investments. She typically invests in Seed Round stages and industries including Ventures for Good, Healthcare, Fashion, Medical Devices, Energy & Clean Tech, and Technology. Some of her previous investments include Example company Inc’s Seed round A of $1,000,000, Company & Company’s Series C funding of â¬11,000,000, and Example’s Seed round A of $524,000. Kathy Salmanowitz’s check sizes vary but usually range between $100,000 to $500,000. She is known for her partnership and collaboration styles in social impact ventures.

Frank Groenewegen is a Co-Founder and General Partner of 415 Capital with almost 40 years of experience in investing, management, sales & marketing in the medical technology space. He has funded over 40 companies and founded successful European medical device distribution companies. His companies established new clinical standards of care in Europe. As an investor, Frank has a stage of interest in early to mid-stage startups. His geographical preference is Europe. Previous investments include CoRRect Medical, Regis Medical GmbH, and more. Frank’s investment check size can be obtained by contacting info@415capital.com or calling +49 (0)89 628 346 116.

Walter Jin is the Chairman and CEO of Pager+Onlife, with a background in private equity and venture capital, investing over $1 billion across more than 40 healthcare companies. He is a Co-Founder and General Partner of Three Fields Capital, specializing in mezzanine debt, distressed debt, and public equity investments in healthcare, life science, and health tech sectors. Previous investments indicate a focus on Pager with a Series B investment of $22M. Walter Jin’s investment check size aligns with mezzanine debt and distressed debt investments.

Anthony Farwell is an Angel Investor with a diverse investment portfolio. His investment focus includes diversification, active management, tax efficiency, high-quality, income-generating investments, and rebalancing. Farwell is known for investments in early-stage information services, e-commerce, and SaaS. He has a professional background in technology ventures such as ClosingCorp, where he revolutionized title insurance. Farwell’s collaboration style involves understanding introspective, relational, and expressive collaborators to enhance teamwork.

Tripti Thakur is a VC Investor and Limited Partner at Emmeline Ventures. Her investment focus areas include Consumer Health, Digital Health, BioTech, Health & Hospital Services, and Health IT at both Seed and Series A stages. She prefers investments with check sizes ranging from $100K to $5.0M, with a sweet spot at $1.5M. Tripti Thakur is geographically focused on Los Angeles/Southern California and the San Francisco Bay Area. Her previous investments include Seed Digital Health and collaboration with investors like Azin Radsan van Alebeek, Hayal Koc, La Keisha Landrum Pierre, Mary Zoumas, Naseem Sayani. Her investment style involves partnering with individuals from Emmeline Ventures and other key co-investors.

Daniel Kaesmacher is an investor with a focus on first principles-based investing methodology. His investment in Lernstift during a Seed Round indicates a specific interest in innovative startups. As the Co-Founder of VEAV Productions and Lernstift, he has a track record in starting and scaling ventures. Daniel Kaesmacher’s investment check size aligns with early-stage seed investments. His collaboration style likely involves leveraging different styles such as introspective, relational, and expressive to enhance teamwork and decision-making.

Michela Grimaldi, a Former Investment Associate at Calm/Storm, a venture capital firm focused on purpose-driven founders, has a background that includes operational experience at a digital startup in Berlin and a market research firm in Buenos Aires. She also has experience at a company builder focused on healthcare. With a Master’s Degree in Finance and IoT from ESCP, Michela has studied and worked in six countries. Her investment focus areas align with purpose-driven founders who are changing life and health for the better. Michela has transitioned to a fund in Italy focused on agritech after her role at Calm/Storm. Her previous investments cover a wide range of sectors such as mental health, reproductive healthcare, chronic conditions, digital therapeutics, and healthcare access. Michela’s professional career embodies a unique blend of social interactions and analytical skills, showcasing a diverse and impactful track record in the venture capital landscape. The partnership and collaboration styles at Calm/Storm emphasize an exclusive founder network and a boutique venture capital approach, indicating a strategic and hands-on investment strategy.

Larry Sonsini is the Founder and Managing Director at WS Investments, a venture capital firm located in Palo Alto. The firm’s investment focus areas include Health Care, Software, Biotechnology, E-Commerce, and Enterprise Software. WS Investments typically invests in startups in the Medical and Marketplace fields that are around 2-3 years old. Some of its notable investments include Alias Technologies, Smartlens, Holocron Technologies, Crowdz, and Driveroo. Larry Sonsini’s partnership and collaboration style involves co-investing with funds like Next Coast Ventures, Maveron, Khosla Ventures, and Stanford University. WS Investments’ portfolio companies are often funded by TCV, Wayra, and Sequoia Capital in subsequent rounds. The fund is mostly active in the United States with a geographical focus similar to Benchmark, Canaan Partners, Menlo Ventures, RRE Ventures, and Tech Coast Angels.

Pegasus Tech Ventures is a Silicon Valley-based global venture capital firm.